{"generated":"2026-11-18T09:58:08-08:00","rows":[{"id":"grant-ziamh002857","eid":"nih:ZIAMH002857","cat":"grants","name":"Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect","institute":"NIMH","activity":"ZIA","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":54957445,"fy0":2009,"fy1":2025,"active":1,"drugs":["ketamine"],"pis":["Carlos Zarate"],"src":"https://reporter.nih.gov/project-details/11416881"},{"id":"grant-ziamh002927","eid":"nih:ZIAMH002927","cat":"grants","name":"Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders","institute":"NIMH","activity":"ZIA","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":29586775,"fy0":2015,"fy1":2025,"active":1,"drugs":["ketamine"],"pis":["Carlos Zarate"],"src":"https://reporter.nih.gov/project-details/11416893"},{"id":"grant-u01hd116253","eid":"nih:U01HD116253","cat":"grants","name":"Efficacy of intravenous sub-dissociative ketamine versus intravenous morphine in children with acute pain.","institute":"NICHD","activity":"U01","org":"COLUMBIA UNIVERSITY HEALTH SCIENCES","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":9835607,"fy0":2024,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Amy L Drendel","Daniel Sing-Kwong Tsze"],"src":"https://reporter.nih.gov/project-details/11401174"},{"id":"grant-r01mh107615","eid":"nih:R01MH107615","cat":"grants","name":"Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF MARYLAND BALTIMORE","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28271,"lon":-76.6017,"gp":"institution","usd":7185016,"fy0":2016,"fy1":2025,"active":1,"drugs":["ketamine"],"pis":["Todd D Gould"],"src":"https://reporter.nih.gov/project-details/11018573"},{"id":"grant-ug3ag094957","eid":"nih:UG3AG094957","cat":"grants","name":"Psychedelics for Older Adults with Chronic Pain","institute":"NIA","activity":"UG3","org":"UNIVERSITY OF COLORADO DENVER","city":"Aurora","region":"Colorado","cc":"US","country":"United States","lat":39.73929,"lon":-104.98644,"gp":"institution","usd":6528815,"fy0":2025,"fy1":2026,"active":1,"drugs":["psilocybin","LSD"],"pis":["STACY M FISCHER","Jennifer M. Mitchell","Stephen Ross"],"src":"https://reporter.nih.gov/project-details/11402829"},{"id":"grant-ug3da062088","eid":"nih:UG3DA062088","cat":"grants","name":"Evaluation of psilocybin as an adjunctive treatment for opioid use disorder in methadone-maintained patients who continue to use illicit opioids","institute":"NIDA","activity":"UG3","org":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":6417488,"fy0":2024,"fy1":2025,"active":1,"drugs":["psilocybin"],"pis":["Michael Parks Bogenschutz"],"src":"https://reporter.nih.gov/project-details/11196088"},{"id":"grant-r37da045657","eid":"nih:R37DA045657","cat":"grants","name":"Mechanistic insights into LSD actions at 5-HT2A serotonin receptors","institute":"NIDA","activity":"R37","org":"UNIV OF NORTH CAROLINA CHAPEL HILL","city":"CHAPEL HILL","region":"North Carolina","cc":"US","country":"United States","usd":5808809,"fy0":2018,"fy1":2026,"active":1,"drugs":["LSD"],"pis":["Bryan L. Roth"],"src":"https://reporter.nih.gov/project-details/11285478"},{"id":"grant-uh3ns131532","eid":"nih:UH3NS131532","cat":"grants","name":"Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT)","institute":"NINDS","activity":"UH3","org":"UNIVERSITY OF VIRGINIA","city":"CHARLOTTESVILLE","region":"Virginia","cc":"US","country":"United States","lat":38.03387,"lon":-78.47484,"gp":"institution","usd":5668197,"fy0":2026,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["James Chamberlain","Jaideep Kapur","Eric S. Rosenthal","Robert Silbergleit"],"src":"https://reporter.nih.gov/project-details/11262172"},{"id":"grant-ug3da064403","eid":"nih:UG3DA064403","cat":"grants","name":"Optimization and Development of Non-Hallucinogenic 5-HT2A/2C Agonists as Opioid Use Disorder Therapeutics","institute":"NIDA","activity":"UG3","org":"ATAI THERAPEUTICS, INC.","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":5657616,"fy0":2025,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Glenn Short III"],"src":"https://reporter.nih.gov/project-details/11392482"},{"id":"grant-ug3da060053","eid":"nih:UG3DA060053","cat":"grants","name":"Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use Disorder","institute":"NIDA","activity":"UG3","org":"GILGAMESH PHARMA INC","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":5439548,"fy0":2024,"fy1":2025,"active":1,"drugs":["ibogaine"],"pis":["GERARD JOSEPH MAREK"],"src":"https://reporter.nih.gov/project-details/11513538"},{"id":"grant-ziamh002844","eid":"nih:ZIAMH002844","cat":"grants","name":"Genetic Determinants of Antidepressant Response","institute":"NIMH","activity":"ZIA","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":4562486,"fy0":2019,"fy1":2025,"active":1,"drugs":["psilocybin","ketamine"],"pis":["Francis J McMahon"],"src":"https://reporter.nih.gov/project-details/11416879"},{"id":"grant-r01da050613","eid":"nih:R01DA050613","cat":"grants","name":"Chemistry and Pharmacology of Iboga Alkaloids","institute":"NIDA","activity":"R01","org":"COLUMBIA UNIV NEW YORK MORNINGSIDE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":4080864,"fy0":2020,"fy1":2026,"active":1,"drugs":["ibogaine"],"pis":["DALIBOR SAMES"],"src":"https://reporter.nih.gov/project-details/11297940"},{"id":"grant-u01da052174","eid":"nih:U01DA052174","cat":"grants","name":"5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder","institute":"NIDA","activity":"U01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.30153,"lon":-76.60546,"gp":"institution","usd":3972165,"fy0":2021,"fy1":2024,"active":1,"drugs":["psilocybin"],"pis":["Matthew Wayne Johnson"],"src":"https://reporter.nih.gov/project-details/10669236"},{"id":"grant-r01mh126083","eid":"nih:R01MH126083","cat":"grants","name":"Glutamatergic adaptation to stress as a mechanism for anhedonia and treatment response with ketamine","institute":"NIMH","activity":"R01","org":"EMORY UNIVERSITY","city":"ATLANTA","region":"Georgia","cc":"US","country":"United States","lat":33.75752,"lon":-84.38859,"gp":"institution","usd":3847894,"fy0":2022,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Michael Tilghman Treadway"],"src":"https://reporter.nih.gov/project-details/11248777"},{"id":"grant-p50mh139573","eid":"nih:P50MH139573","cat":"grants","name":"Neural Components of Stress Response and Suicide Behavior: Preventive Impact of Ketamine","institute":"NIMH","activity":"P50","org":"NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.77755,"lon":-73.95886,"gp":"institution","usd":3670916,"fy0":2026,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Joseph John Mann"],"src":"https://reporter.nih.gov/project-details/11349211"},{"id":"grant-ziada000522","eid":"nih:ZIADA000522","cat":"grants","name":"Preclinical medication development for stimulant use disorder","institute":"NIDA","activity":"ZIA","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.98251,"lon":-77.09362,"gp":"institution","usd":3358209,"fy0":2019,"fy1":2025,"active":1,"drugs":["DMT"],"pis":["Michael Baumann"],"src":"https://reporter.nih.gov/project-details/11414520"},{"id":"grant-r01mh129371","eid":"nih:R01MH129371","cat":"grants","name":"AMPA Receptor Components of the Antidepressant Response to Ketamine in Humans","institute":"NIMH","activity":"R01","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.30566,"lon":-72.92134,"gp":"institution","usd":3342174,"fy0":2023,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["NAOMI R DRIESEN","Dewan Syed Fahmeed Hyder","John H. Krystal"],"src":"https://reporter.nih.gov/project-details/11326712"},{"id":"grant-r01ca268521","eid":"nih:R01CA268521","cat":"grants","name":"Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress","institute":"NCI","activity":"R01","org":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":3295487,"fy0":2022,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["STACY M FISCHER","Stephen Ross"],"src":"https://reporter.nih.gov/project-details/11348885"},{"id":"grant-r01mh134045","eid":"nih:R01MH134045","cat":"grants","name":"Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI","institute":"NIMH","activity":"R01","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.72401,"lon":-74.01392,"gp":"institution","usd":3066243,"fy0":2023,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["James Warren Murrough"],"src":"https://reporter.nih.gov/project-details/11311804"},{"id":"grant-u01da054330","eid":"nih:U01DA054330","cat":"grants","name":"Cross platform analysis of drug targets and toxicity of bath salts","institute":"NIDA","activity":"U01","org":"UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS","city":"TOLEDO","region":"Ohio","cc":"US","country":"United States","usd":3039803,"fy0":2022,"fy1":2026,"active":1,"drugs":["MDMA"],"pis":["Isaac T Schiefer"],"src":"https://reporter.nih.gov/project-details/11371103"},{"id":"grant-rf1mh136052","eid":"nih:RF1MH136052","cat":"grants","name":"MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach","institute":"NIMH","activity":"RF1","org":"MCLEAN HOSPITAL","city":"BELMONT","region":"Massachusetts","cc":"US","country":"United States","lat":42.39504,"lon":-71.17862,"gp":"institution","usd":2876123,"fy0":2026,"fy1":2026,"active":1,"drugs":["MDMA"],"pis":["BRUCE E BLOUGH","Brian D. Kangas"],"src":"https://reporter.nih.gov/project-details/11307600"},{"id":"grant-r01mh128217","eid":"nih:R01MH128217","cat":"grants","name":"Cellular basis of psilocybin actions in frontal cortex","institute":"NIMH","activity":"R01","org":"CORNELL UNIVERSITY","city":"ITHACA","region":"New York","cc":"US","country":"United States","lat":42.43155,"lon":-76.50221,"gp":"institution","usd":2863135,"fy0":2022,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["CHUN-HAY ALEX KWAN"],"src":"https://reporter.nih.gov/project-details/11377441"},{"id":"grant-r01mh136179","eid":"nih:R01MH136179","cat":"grants","name":"1/2 A Brief Automated Neurocognitive Training to Enhance the Real-World Impact of Ketamine's Rapid Antidepressant Effect","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF PITTSBURGH AT PITTSBURGH","city":"PITTSBURGH","region":"Pennsylvania","cc":"US","country":"United States","usd":2816290,"fy0":2024,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Rebecca Price"],"src":"https://reporter.nih.gov/project-details/11345783"},{"id":"grant-r01mh136178","eid":"nih:R01MH136178","cat":"grants","name":"A brief automated neurocognitive training to enhance the real-world impact of ketamine's rapid antidepressant effect","institute":"NIMH","activity":"R01","org":"TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR","city":"COLLEGE STATION","region":"Texas","cc":"US","country":"United States","usd":2759680,"fy0":2024,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["SANJAY J MATHEW"],"src":"https://reporter.nih.gov/project-details/11592105"},{"id":"grant-rf1mh136381","eid":"nih:RF1MH136381","cat":"grants","name":"Synaptic circuit mechanisms underlying psilocybin's therapeutic effects in the stressed brain","institute":"NIMH","activity":"RF1","org":"UNIVERSITY OF CALIFORNIA SANTA CRUZ","city":"SANTA CRUZ","region":"California","cc":"US","country":"United States","lat":36.98123,"lon":-122.02661,"gp":"institution","usd":2725051,"fy0":2025,"fy1":2025,"active":1,"drugs":["psilocybin"],"pis":["Yi Zuo"],"src":"https://reporter.nih.gov/project-details/11196774"},{"id":"grant-r01da056365","eid":"nih:R01DA056365","cat":"grants","name":"High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF CALIFORNIA AT DAVIS","city":"DAVIS","region":"California","cc":"US","country":"United States","usd":2713840,"fy0":2022,"fy1":2026,"active":1,"drugs":["ibogaine"],"pis":["David E Olson"],"src":"https://reporter.nih.gov/project-details/11292383"},{"id":"grant-r01da056660","eid":"nih:R01DA056660","cat":"grants","name":"Target Specificity of Tabernanthalog Treatment in Opioid Use Disorder","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF ALABAMA AT BIRMINGHAM","city":"BIRMINGHAM","region":"Alabama","cc":"US","country":"United States","lat":33.51948,"lon":-86.8,"gp":"institution","usd":2591494,"fy0":2022,"fy1":2026,"active":1,"drugs":["DMT","ibogaine"],"pis":["Jasper Heinsbroek","JAMIE PETERS"],"src":"https://reporter.nih.gov/project-details/11393913"},{"id":"grant-dp2da066200","eid":"nih:DP2DA066200","cat":"grants","name":"Psilocybin Therapy for Methamphetamine Use Disorder and HIV","institute":"NIDA","activity":"DP2","org":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","lat":37.76782,"lon":-122.41749,"gp":"institution","usd":2460000,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Nicky Mehtani"],"src":"https://reporter.nih.gov/project-details/11394951"},{"id":"grant-ug3da064414","eid":"nih:UG3DA064414","cat":"grants","name":"Safety and preliminary efficacy of ibogaine as a treatment for opioid use disorder","institute":"NIDA","activity":"UG3","org":"BRIGHAM AND WOMEN'S HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.36563,"lon":-71.05718,"gp":"institution","usd":2288947,"fy0":2026,"fy1":2026,"active":1,"drugs":["ibogaine"],"pis":["Joji Suzuki"],"src":"https://reporter.nih.gov/project-details/11252682"},{"id":"grant-r01mh134538","eid":"nih:R01MH134538","cat":"grants","name":"Ketamine to reduce postpartum depression and pain after cesarean delivery","institute":"NIMH","activity":"R01","org":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","city":"SALT LAKE CITY","region":"Utah","cc":"US","country":"United States","usd":2288446,"fy0":2023,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Grace Lim"],"src":"https://reporter.nih.gov/project-details/11509433"},{"id":"grant-r01mh130591","eid":"nih:R01MH130591","cat":"grants","name":"Mapping Neural Circuit Activity Mediating MDMA's Prosocial Effect","institute":"NIMH","activity":"R01","org":"STANFORD UNIVERSITY","city":"STANFORD","region":"California","cc":"US","country":"United States","lat":37.43131,"lon":-122.16537,"gp":"institution","usd":2262326,"fy0":2023,"fy1":2026,"active":1,"drugs":["MDMA"],"pis":["Boris Dov Heifets"],"src":"https://reporter.nih.gov/project-details/11251605"},{"id":"grant-r01mh133849","eid":"nih:R01MH133849","cat":"grants","name":"Structure-based Design of Selective Serotonin Biased Agonists as Chemical Probes for Psychedelic Potential","institute":"NIMH","activity":"R01","org":"MEDICAL COLLEGE OF WISCONSIN","city":"MILWAUKEE","region":"Wisconsin","cc":"US","country":"United States","lat":43.03669,"lon":-87.90783,"gp":"institution","usd":2081888,"fy0":2023,"fy1":2026,"active":1,"pis":["John D McCorvy"],"src":"https://reporter.nih.gov/project-details/11321151"},{"id":"grant-r01da060207","eid":"nih:R01DA060207","cat":"grants","name":"Investigating the Ketamine Landscape: Availability, Medical and Recreational Use, and Effects","institute":"NIDA","activity":"R01","org":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":2080131,"fy0":2024,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Joseph J Palamar"],"src":"https://reporter.nih.gov/project-details/11324255"},{"id":"grant-r01aa031417","eid":"nih:R01AA031417","cat":"grants","name":"Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder.","institute":"NIAAA","activity":"R01","org":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":2026326,"fy0":2024,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Michael Parks Bogenschutz"],"src":"https://reporter.nih.gov/project-details/11401907"},{"id":"grant-dp5od036172","eid":"nih:DP5OD036172","cat":"grants","name":"MDMA as a Treatment for Social Deficits in Schizophrenia","institute":"OD","activity":"DP5","org":"UNIVERSITY OF CALIFORNIA LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.05482,"lon":-118.25389,"gp":"institution","usd":1967604,"fy0":2023,"fy1":2026,"active":1,"drugs":["MDMA"],"pis":["Anya K Bershad"],"src":"https://reporter.nih.gov/project-details/11385444"},{"id":"grant-r01mh129282","eid":"nih:R01MH129282","cat":"grants","name":"Circuit Mechanisms of Psilocybin Following Chronic Stress","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF MICHIGAN AT ANN ARBOR","city":"ANN ARBOR","region":"Michigan","cc":"US","country":"United States","usd":1950000,"fy0":2022,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Omar Jamil Ahmed"],"src":"https://reporter.nih.gov/project-details/11353951"},{"id":"grant-r01mh130610","eid":"nih:R01MH130610","cat":"grants","name":"A synaptic substrate for ketamine-mediated amelioration of stress-induced anhedonia","institute":"NIMH","activity":"R01","org":"WASHINGTON UNIVERSITY","city":"SAINT LOUIS","region":"Missouri","cc":"US","country":"United States","lat":38.63343,"lon":-90.20217,"gp":"institution","usd":1948125,"fy0":2022,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Marco Pignatelli"],"src":"https://reporter.nih.gov/project-details/11380643"},{"id":"grant-r01mh137047","eid":"nih:R01MH137047","cat":"grants","name":"Role of cortical GABAergic interneurons in psychedelic drug action","institute":"NIMH","activity":"R01","org":"CORNELL UNIVERSITY","city":"ITHACA","region":"New York","cc":"US","country":"United States","lat":42.44585,"lon":-76.48847,"gp":"institution","usd":1875635,"fy0":2024,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["CHUN-HAY ALEX KWAN"],"src":"https://reporter.nih.gov/project-details/11377652"},{"id":"grant-r01ns125482","eid":"nih:R01NS125482","cat":"grants","name":"Identifying and targeting the neural basis of depression in Parkinson's disease","institute":"NINDS","activity":"R01","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.29671,"lon":-72.92651,"gp":"institution","usd":1808147,"fy0":2024,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Sophie Holmes"],"src":"https://reporter.nih.gov/project-details/11308687"},{"id":"grant-r01da054977","eid":"nih:R01DA054977","cat":"grants","name":"Neurophysiological impacts of hallucinogens on hippocampal and cortical neural circuits","institute":"NIDA","activity":"R01","org":"BAYLOR COLLEGE OF MEDICINE","city":"HOUSTON","region":"Texas","cc":"US","country":"United States","lat":29.75495,"lon":-95.35805,"gp":"institution","usd":1800000,"fy0":2022,"fy1":2026,"active":1,"drugs":["LSD"],"pis":["Daoyun Ji"],"src":"https://reporter.nih.gov/project-details/11294314"},{"id":"grant-r01mh125155","eid":"nih:R01MH125155","cat":"grants","name":"IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trial","institute":"NIMH","activity":"R01","org":"NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.78018,"lon":-73.97392,"gp":"institution","usd":1758666,"fy0":2020,"fy1":2022,"active":1,"drugs":["ketamine"],"pis":["Michael F Grunebaum"],"src":"https://reporter.nih.gov/project-details/10469693"},{"id":"grant-r33mh129559","eid":"nih:R33MH129559","cat":"grants","name":"Using Ketamine to enhance memory reconsolidation and extinction of overgeneralized fear in individuals diagnosed with PTSD","institute":"NIMH","activity":"R33","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31403,"lon":-72.93865,"gp":"institution","usd":1698061,"fy0":2026,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["ILAN HARPAZ-ROTEM"],"src":"https://reporter.nih.gov/project-details/11195277"},{"id":"grant-ug3mh141096","eid":"nih:UG3MH141096","cat":"grants","name":"Dynamic Decision Support Tools for Precision Treatment-Resistant Depression Care","institute":"NIMH","activity":"UG3","org":"BRIGHAM AND WOMEN'S HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.36281,"lon":-71.05295,"gp":"institution","usd":1688034,"fy0":2025,"fy1":2025,"active":1,"drugs":["ketamine"],"pis":["Rajendra Aldis","Shan Siddiqi","Alejandro Szmulewicz","Philip S Wang"],"src":"https://reporter.nih.gov/project-details/11218855"},{"id":"grant-r01da061199","eid":"nih:R01DA061199","cat":"grants","name":"A Psilocybin-Sensitive Neuroimmune Circuit Controlling Stress Behaviors","institute":"NIDA","activity":"R01","org":"BRIGHAM AND WOMEN'S HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.36732,"lon":-71.06716,"gp":"institution","usd":1659087,"fy0":2024,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Michael Alex Wheeler"],"src":"https://reporter.nih.gov/project-details/11285205"},{"id":"grant-u54da066461","eid":"nih:U54DA066461","cat":"grants","name":"P3 - Simulated Psilocybin Models and Emulated Trials for Estimated Consequences and Effectiveness (SPACE)","institute":"NIDA","activity":"U54","org":"OREGON HEALTH & SCIENCE UNIVERSITY","city":"PORTLAND","region":"Oregon","cc":"US","country":"United States","lat":45.52745,"lon":-122.68614,"gp":"institution","usd":1560797,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Philip Todd Korthuis"],"src":"https://reporter.nih.gov/project-details/11421899"},{"id":"grant-r33at012317","eid":"nih:R33AT012317","cat":"grants","name":"Psilocybin and Affective Function in Chronic Lower Back Pain and Depression","institute":"NCCIH","activity":"R33","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.3021,"lon":-76.6049,"gp":"institution","usd":1518560,"fy0":2023,"fy1":2025,"active":1,"drugs":["psilocybin"],"pis":["Patrick Finan","David Bryce Yaden"],"src":"https://reporter.nih.gov/project-details/11077883"},{"id":"grant-r01da061433","eid":"nih:R01DA061433","cat":"grants","name":"Investigations into 5-HT2A signaling mechanisms of psychedelic drugs for the treatment of stimulant use disorder","institute":"NIDA","activity":"R01","org":"MEDICAL COLLEGE OF WISCONSIN","city":"MILWAUKEE","region":"Wisconsin","cc":"US","country":"United States","lat":43.04243,"lon":-87.91725,"gp":"institution","usd":1470263,"fy0":2024,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["ADAM L. Halberstadt","John D McCorvy","Kevin Sean Murnane"],"src":"https://reporter.nih.gov/project-details/11323981"},{"id":"grant-ug3da062112","eid":"nih:UG3DA062112","cat":"grants","name":"Psilocybin-Assisted Treatment of Cocain Use Disorder","institute":"NIDA","activity":"UG3","org":"CARILION MEDICAL CENTER","city":"ROANOKE","region":"Virginia","cc":"US","country":"United States","usd":1266062,"fy0":2025,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["ALBERT JOSEPH ARIAS"],"src":"https://reporter.nih.gov/project-details/11471090"},{"id":"grant-p50da042012","eid":"nih:P50DA042012","cat":"grants","name":"Brain-wide circuit mapping to delineate therapeutic strategies for amphetamine abuse","institute":"NIDA","activity":"P50","org":"STANFORD UNIVERSITY","city":"STANFORD","region":"California","cc":"US","country":"United States","lat":37.4218,"lon":-122.16829,"gp":"institution","usd":1259983,"fy0":2023,"fy1":2026,"active":1,"drugs":["MDMA"],"pis":["ROBERT C MALENKA"],"src":"https://reporter.nih.gov/project-details/11365054"},{"id":"grant-r61da061206","eid":"nih:R61DA061206","cat":"grants","name":"Psilocybin: Capturing brain mechanisms of motivation and neurocognition in individuals with opioid use disorder","institute":"NIDA","activity":"R61","org":"UNIVERSITY OF PENNSYLVANIA","city":"PHILADELPHIA","region":"Pennsylvania","cc":"US","country":"United States","lat":39.94414,"lon":-75.16338,"gp":"institution","usd":967111,"fy0":2024,"fy1":2025,"active":1,"drugs":["psilocybin"],"pis":["Anna Rose Childress","KYLE Matthew KAMPMAN"],"src":"https://reporter.nih.gov/project-details/11127767"},{"id":"grant-k23mh126202","eid":"nih:K23MH126202","cat":"grants","name":"Elucidating the Neurocircuitry of Irritability with Ultra-High-Field Neuroimaging to Identify Novel Therapeutic Targets","institute":"NIMH","activity":"K23","org":"UT SOUTHWESTERN MEDICAL CENTER","city":"DALLAS","region":"Texas","cc":"US","country":"United States","usd":918045,"fy0":2021,"fy1":2025,"active":1,"drugs":["ketamine"],"pis":["Manish Kumar Jha"],"src":"https://reporter.nih.gov/project-details/11141847"},{"id":"grant-dp5od039401","eid":"nih:DP5OD039401","cat":"grants","name":"Examining the effects of naturalistic hallucinogen use on internalizing symptoms in a longitudinal sample of young adults","institute":"OD","activity":"DP5","org":"MASSACHUSETTS GENERAL HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.36817,"lon":-71.05953,"gp":"institution","usd":825000,"fy0":2025,"fy1":2026,"active":1,"drugs":["MDMA","LSD","ketamine"],"pis":["Grant Jones"],"src":"https://reporter.nih.gov/project-details/11385917"},{"id":"grant-r01at013263","eid":"nih:R01AT013263","cat":"grants","name":"The effects and mechanisms supporting psilocybin induced pain relief","institute":"NCCIH","activity":"R01","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.7135,"lon":-117.16401,"gp":"institution","usd":788967,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin","DMT"],"pis":["ADAM L. Halberstadt","Fadel Zeidan"],"src":"https://reporter.nih.gov/project-details/11295725"},{"id":"grant-r01aa033010","eid":"nih:R01AA033010","cat":"grants","name":"PATH: Psilocybin for Alcohol  Treatment among people living with HIV","institute":"NIAAA","activity":"R01","org":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","lat":37.76397,"lon":-122.42681,"gp":"institution","usd":754267,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin","DMT"],"pis":["Glenn-Milo Santos","Josh Woolley"],"src":"https://reporter.nih.gov/project-details/11482252"},{"id":"grant-r01da060253","eid":"nih:R01DA060253","cat":"grants","name":"Psilocybin Research and Implementation Study for Mental health and substance use (PRISM)","institute":"NIDA","activity":"R01","org":"OREGON HEALTH & SCIENCE UNIVERSITY","city":"PORTLAND","region":"Oregon","cc":"US","country":"United States","lat":45.5346,"lon":-122.67588,"gp":"institution","usd":736713,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Ryan Cook","Philip Todd Korthuis","Adrianne Rae Wilson-Poe"],"src":"https://reporter.nih.gov/project-details/11294790"},{"id":"grant-r01da061818","eid":"nih:R01DA061818","cat":"grants","name":"The Health Outcomes of Psychedelics Use Survey (POCUS): a Nationally Representative Survey Study","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF MICHIGAN AT ANN ARBOR","city":"ANN ARBOR","region":"Michigan","cc":"US","country":"United States","usd":726696,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Kevin Foxman Boehnke","Daniel James Kruger","Adrianne Rae Wilson-Poe"],"src":"https://reporter.nih.gov/project-details/11222912"},{"id":"grant-r01da067060","eid":"nih:R01DA067060","cat":"grants","name":"Psilocybin-Assisted ACT for Co-Occurring Cocaine Use Disorder and Major Depressive Disorder","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","city":"HOUSTON","region":"Texas","cc":"US","country":"United States","usd":699431,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Thomas Daniel Meyer","JOY Marie SCHMITZ","Angela L Stotts"],"src":"https://reporter.nih.gov/project-details/11458025"},{"id":"grant-r01ca312541","eid":"nih:R01CA312541","cat":"grants","name":"Psilocybin-assisted Psychotherapy to Treat Fear of Cancer Recurrence in Early- Stage Breast Cancer","institute":"NCI","activity":"R01","org":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":693638,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["STACY M FISCHER","Stephen Ross"],"src":"https://reporter.nih.gov/project-details/11344227"},{"id":"grant-r01da066452","eid":"nih:R01DA066452","cat":"grants","name":"The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28459,"lon":-76.61807,"gp":"institution","usd":692689,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Carlos Austin Zamarripa"],"src":"https://reporter.nih.gov/project-details/11422600"},{"id":"grant-r01aa032237","eid":"nih:R01AA032237","cat":"grants","name":"The effects of psilocybin and brain stimulation on the treatment of alcohol use disorder","institute":"NIAAA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.30125,"lon":-76.60715,"gp":"institution","usd":689697,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Zeynep Ceyda Sayali"],"src":"https://reporter.nih.gov/project-details/11446309"},{"id":"grant-r01da066503","eid":"nih:R01DA066503","cat":"grants","name":"Mechanistic Evaluation of Psilocybin in Opioid Use Disorder: A Randomized, Double-Blind, Active-Placebo-Controlled Crossover Trial with Pharmacokinetic/Pharmacodynamic Modeling","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.27979,"lon":-76.61751,"gp":"institution","usd":683851,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Suky Martinez"],"src":"https://reporter.nih.gov/project-details/11425436"},{"id":"grant-r01at013610","eid":"nih:R01AT013610","cat":"grants","name":"Brain mechanisms supporting mindfulness-assisted psilocybin therapy for chronic pain","institute":"NCCIH","activity":"R01","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.72197,"lon":-117.16731,"gp":"institution","usd":669942,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Fadel Zeidan"],"src":"https://reporter.nih.gov/project-details/11449894"},{"id":"grant-ug3da067126","eid":"nih:UG3DA067126","cat":"grants","name":"Psilocybin in the treatment of methamphetamine use disorder","institute":"NIDA","activity":"UG3","org":"UNIVERSITY OF ALABAMA AT BIRMINGHAM","city":"BIRMINGHAM","region":"Alabama","cc":"US","country":"United States","lat":33.52711,"lon":-86.79661,"gp":"institution","usd":662322,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Peter S. Hendricks"],"src":"https://reporter.nih.gov/project-details/11443899"},{"id":"grant-r01da064612","eid":"nih:R01DA064612","cat":"grants","name":"National Survey Investigating Hallucinogenic Trends (NSIHT)","institute":"NIDA","activity":"R01","org":"DENVER HEALTH AND HOSPITAL AUTHORITY","city":"DENVER","region":"Colorado","cc":"US","country":"United States","usd":634042,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin","MDMA","LSD"],"pis":["Joshua Curtis Black","Andrew Albert Monte"],"src":"https://reporter.nih.gov/project-details/11273973"},{"id":"grant-r01da064555","eid":"nih:R01DA064555","cat":"grants","name":"Psilocybin Outside the Clinic: A Comprehensive Study of Acute and Long-Term Effects on Mood and Behavior","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF COLORADO DENVER","city":"Aurora","region":"Colorado","cc":"US","country":"United States","lat":39.72988,"lon":-104.98023,"gp":"institution","usd":628657,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin","MDMA","LSD"],"pis":["KENT E. HUTCHISON","Hollis C Karoly"],"src":"https://reporter.nih.gov/project-details/11446564"},{"id":"grant-r61at013404","eid":"nih:R61AT013404","cat":"grants","name":"Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes","institute":"NCCIH","activity":"R61","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.29897,"lon":-72.92275,"gp":"institution","usd":586358,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Joao Paulo De Aquino","Robert Ross MacLean"],"src":"https://reporter.nih.gov/project-details/11359203"},{"id":"grant-r56mh137464","eid":"nih:R56MH137464","cat":"grants","name":"Circuit and subcellular basis of MDMA effects on innate and learned fear","institute":"NIMH","activity":"R56","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.30321,"lon":-72.93094,"gp":"institution","usd":508952,"fy0":2025,"fy1":2025,"active":1,"drugs":["MDMA"],"pis":["Alfred P Kaye"],"src":"https://reporter.nih.gov/project-details/11324056"},{"id":"grant-r34at013077","eid":"nih:R34AT013077","cat":"grants","name":"Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder","institute":"NCCIH","activity":"R34","org":"UNIVERSITY OF CALIFORNIA LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.04531,"lon":-118.23752,"gp":"institution","usd":472500,"fy0":2025,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Marc Joshua Weintraub"],"src":"https://reporter.nih.gov/project-details/11248770"},{"id":"grant-r21mh140169","eid":"nih:R21MH140169","cat":"grants","name":"The Neuroimmune Circuitry in Depression: A Multimodal Mapping Approach","institute":"NIMH","activity":"R21","org":"MASSACHUSETTS GENERAL HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.36412,"lon":-71.06763,"gp":"institution","usd":466175,"fy0":2026,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Chiara Maffei"],"src":"https://reporter.nih.gov/project-details/11302964"},{"id":"grant-ziatr000562","eid":"nih:ZIATR000562","cat":"grants","name":"Bioactive small molecule development- Ketamine metabolite program","institute":"NCATS","activity":"ZIA","org":"NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES","cc":"US","country":"United States","lat":39.07878,"lon":-77.16184,"gp":"institution","usd":455928,"fy0":2025,"fy1":2025,"active":1,"drugs":["ketamine"],"pis":["Craig Thomas"],"src":"https://reporter.nih.gov/project-details/11412127"},{"id":"grant-r21da062252","eid":"nih:R21DA062252","cat":"grants","name":"Psilocybin effects on brainwide activity dynamics supporting accelerated task acquisition","institute":"NIDA","activity":"R21","org":"PRINCETON UNIVERSITY","city":"Princeton","region":"New Jersey","cc":"US","country":"United States","lat":40.34745,"lon":-74.66023,"gp":"institution","usd":451000,"fy0":2025,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Samuel Sheng-Hung Wang"],"src":"https://reporter.nih.gov/project-details/11346058"},{"id":"grant-r21mh133198","eid":"nih:R21MH133198","cat":"grants","name":"Gamma oscillations as a prognostic marker for ketamine therapy in treatment resistant depression","institute":"NIMH","activity":"R21","org":"TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR","city":"COLLEGE STATION","region":"Texas","cc":"US","country":"United States","usd":433917,"fy0":2024,"fy1":2025,"active":1,"drugs":["ketamine"],"pis":["SANJAY J MATHEW","Nicholas Murphy"],"src":"https://reporter.nih.gov/project-details/11511948"},{"id":"grant-k24da061664","eid":"nih:K24DA061664","cat":"grants","name":"Mentoring Clinical Investigators in Psychedelic-Assisted Therapy for HIV (Mentor-PATH)","institute":"NIDA","activity":"K24","org":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","lat":37.77262,"lon":-122.4238,"gp":"institution","usd":433312,"fy0":2025,"fy1":2026,"active":1,"pis":["Parya Saberi"],"src":"https://reporter.nih.gov/project-details/11370016"},{"id":"grant-r21mh144686","eid":"nih:R21MH144686","cat":"grants","name":"Psychedelic neuroplastogen rescue of cognitive flexibily in autism spectrum disorder","institute":"NIMH","activity":"R21","org":"UNIVERSITY OF MICHIGAN AT ANN ARBOR","city":"ANN ARBOR","region":"Michigan","cc":"US","country":"United States","usd":429000,"fy0":2026,"fy1":2026,"active":1,"pis":["Omar Jamil Ahmed"],"src":"https://reporter.nih.gov/project-details/11353237"},{"id":"grant-r01at013689","eid":"nih:R01AT013689","cat":"grants","name":"CRCNS: Dynamics of inter-area interactions during sleep and psychedelic states","institute":"NCCIH","activity":"R01","org":"PRINCETON UNIVERSITY","city":"Princeton","region":"New Jersey","cc":"US","country":"United States","lat":40.35743,"lon":-74.65656,"gp":"institution","usd":410000,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Tatiana Engel","SABINE KASTNER"],"src":"https://reporter.nih.gov/project-details/11328611"},{"id":"grant-r21da061700","eid":"nih:R21DA061700","cat":"grants","name":"Characterizing chemsex patterns and adoption of harm reduction measures among men in the South","institute":"NIDA","activity":"R21","org":"UNIVERSITY OF GEORGIA","city":"ATHENS","region":"Georgia","cc":"US","country":"United States","lat":33.96551,"lon":-83.37893,"gp":"institution","usd":405490,"fy0":2025,"fy1":2025,"active":1,"drugs":["MDMA","ketamine"],"pis":["NATHAN B HANSEN","Mohammad Rifat Haider"],"src":"https://reporter.nih.gov/project-details/11190053"},{"id":"grant-r21aa030649","eid":"nih:R21AA030649","cat":"grants","name":"The potential therapeutic effects of N, N-dimethyltryptamine (DMT) on alcohol use disorder (AUD)","institute":"NIAAA","activity":"R21","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.30274,"lon":-72.93103,"gp":"institution","usd":343613,"fy0":2023,"fy1":2024,"active":1,"drugs":["DMT"],"pis":["Anahita Bassir Nia","DEEPAK Cyril D'SOUZA"],"src":"https://reporter.nih.gov/project-details/10904027"},{"id":"grant-r43aa032947","eid":"nih:R43AA032947","cat":"grants","name":"Enhancing Oral Bioavailability of DMT with a Proprietary Reversible Monoamine Oxidase Inhibitor (RIMA) for Alcohol Use Disorder Therapy","institute":"NIAAA","activity":"R43","org":"REMEDI, INC.","city":"NORWELL","region":"Massachusetts","cc":"US","country":"United States","lat":53.38264,"lon":-1.45512,"gp":"institution","usd":293684,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin","LSD","DMT"],"pis":["Thomas Krenitsky"],"src":"https://reporter.nih.gov/project-details/11311775"},{"id":"grant-k00aa031926","eid":"nih:K00AA031926","cat":"grants","name":"Role of parasubthalamic astrocytic dysfunction in alcohol use disorder","institute":"NIAAA","activity":"K00","org":"SCRIPPS RESEARCH INSTITUTE, THE","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.72442,"lon":-117.1674,"gp":"institution","usd":279579,"fy0":2024,"fy1":2026,"active":1,"drugs":["MDMA"],"pis":["Allison White"],"src":"https://reporter.nih.gov/project-details/11259532"},{"id":"grant-k23mh142800","eid":"nih:K23MH142800","cat":"grants","name":"Understanding, Measuring, and Addressing Adverse Effects of Psychedelics for Clinical Research and Harm Reduction","institute":"NIMH","activity":"K23","org":"EMORY UNIVERSITY","city":"ATLANTA","region":"Georgia","cc":"US","country":"United States","lat":33.73822,"lon":-84.39414,"gp":"institution","usd":195390,"fy0":2026,"fy1":2026,"active":1,"pis":["Roman Palitsky"],"src":"https://reporter.nih.gov/project-details/11283331"},{"id":"grant-k23aa033457","eid":"nih:K23AA033457","cat":"grants","name":"Ketamine therapy for alcohol use disorder: real-world insights and hospital-based clinical trial","institute":"NIAAA","activity":"K23","org":"DENVER HEALTH AND HOSPITAL AUTHORITY","city":"DENVER","region":"Colorado","cc":"US","country":"United States","usd":189000,"fy0":2026,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Dale J Terasaki"],"src":"https://reporter.nih.gov/project-details/11436150"},{"id":"grant-k23ag093106","eid":"nih:K23AG093106","cat":"grants","name":"Safety and Mechanisms of Psilocybin Therapy in Older Adults","institute":"NIA","activity":"K23","org":"EMORY UNIVERSITY","city":"ATLANTA","region":"Georgia","cc":"US","country":"United States","lat":33.761,"lon":-84.39546,"gp":"institution","usd":175189,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["ALI JOHN ZARRABI"],"src":"https://reporter.nih.gov/project-details/11371245"},{"id":"grant-r03da058238","eid":"nih:R03DA058238","cat":"grants","name":"Set and setting: the effects of psilocybin on nicotine self-administration in rats","institute":"NIDA","activity":"R03","org":"STATE UNIVERSITY OF NEW YORK AT BUFFALO","city":"AMHERST","region":"New York","cc":"US","country":"United States","usd":160938,"fy0":2024,"fy1":2025,"active":1,"drugs":["psilocybin"],"pis":["Paul J Meyer"],"src":"https://reporter.nih.gov/project-details/11053594"},{"id":"grant-k99aa032334","eid":"nih:K99AA032334","cat":"grants","name":"Transdiagnostic and addiction-specific neural mechanisms of psilocybin therapy in alcohol use disorder","institute":"NIAAA","activity":"K99","org":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":155885,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Broc Anthony Pagni"],"src":"https://reporter.nih.gov/project-details/11301985"},{"id":"grant-f32da062467","eid":"nih:F32DA062467","cat":"grants","name":"Neural mechanisms of psilocybin action in the frontal cortex","institute":"NIDA","activity":"F32","org":"CORNELL UNIVERSITY","city":"ITHACA","region":"New York","cc":"US","country":"United States","lat":42.43117,"lon":-76.49327,"gp":"institution","usd":153560,"fy0":2025,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Olesia M Bilash"],"src":"https://reporter.nih.gov/project-details/11311806"},{"id":"grant-k99mh145782","eid":"nih:K99MH145782","cat":"grants","name":"Dissecting Circuit and Cell-Type Mechanisms of MDMA-Evoked Sociability and Fear Extinction to Identify New PTSD Targets","institute":"NIMH","activity":"K99","org":"STANFORD UNIVERSITY","city":"STANFORD","region":"California","cc":"US","country":"United States","lat":37.41437,"lon":-122.16519,"gp":"institution","usd":124794,"fy0":2026,"fy1":2026,"active":1,"drugs":["MDMA"],"pis":["Austen Brooks Casey"],"src":"https://reporter.nih.gov/project-details/11439035"},{"id":"grant-f31da063346","eid":"nih:F31DA063346","cat":"grants","name":"Therapeutic potential of psilocybin on stress-cued reinstatement","institute":"NIDA","activity":"F31","org":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","city":"CHARLESTON","region":"South Carolina","cc":"US","country":"United States","lat":32.77524,"lon":-79.92734,"gp":"institution","usd":94562,"fy0":2025,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Megan Jane Francis"],"src":"https://reporter.nih.gov/project-details/11324917"},{"id":"grant-f31da062491","eid":"nih:F31DA062491","cat":"grants","name":"Transcriptomic and Epigenomic Investigation of Antidepressant and Non-Hallucinogenic Serotonin Receptor Agonists","institute":"NIDA","activity":"F31","org":"UNIVERSITY OF CALIFORNIA AT DAVIS","city":"DAVIS","region":"California","cc":"US","country":"United States","usd":86366,"fy0":2025,"fy1":2026,"active":1,"drugs":["DMT"],"pis":["Ethan Marsh Fenton"],"src":"https://reporter.nih.gov/project-details/11322515"},{"id":"grant-f32da065349","eid":"nih:F32DA065349","cat":"grants","name":"Tabernanthalog as a dual treatment for chronic pain and opioid use disorder","institute":"NIDA","activity":"F32","org":"UNIVERSITY OF ALABAMA AT BIRMINGHAM","city":"BIRMINGHAM","region":"Alabama","cc":"US","country":"United States","lat":33.51092,"lon":-86.81129,"gp":"institution","usd":78508,"fy0":2026,"fy1":2026,"active":1,"pis":["Abigail Margaret Schwarz"],"src":"https://reporter.nih.gov/project-details/11317562"},{"id":"grant-f30mh146024","eid":"nih:F30MH146024","cat":"grants","name":"Mechanisms of Psilocybin-Induced Restoration of Cognitive Flexibility Following Chronic Stress","institute":"NIMH","activity":"F30","org":"MEDICAL COLLEGE OF WISCONSIN","city":"MILWAUKEE","region":"Wisconsin","cc":"US","country":"United States","lat":43.03264,"lon":-87.90943,"gp":"institution","usd":52114,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Joseph J Hennessey"],"src":"https://reporter.nih.gov/project-details/11459280"},{"id":"grant-f30mh146473","eid":"nih:F30MH146473","cat":"grants","name":"Characterizing the Brain Microstructure Underlying Reward and Motivation in Major Depressive Disorder","institute":"NIMH","activity":"F30","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.71093,"lon":-74.00225,"gp":"institution","usd":51274,"fy0":2026,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Stuti Bansal"],"src":"https://reporter.nih.gov/project-details/11464279"},{"id":"grant-f31mh140536","eid":"nih:F31MH140536","cat":"grants","name":"Exploring the neural architecture of psychedelic experience with high-density electrophysiology","institute":"NIMH","activity":"F31","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28516,"lon":-76.624,"gp":"institution","usd":50114,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Tate Eileen DeWeese"],"src":"https://reporter.nih.gov/project-details/11384961"},{"id":"grant-f31mh144832","eid":"nih:F31MH144832","cat":"grants","name":"Investigating the role of ketamine in modulating intrinsic neural timescales in treatment resistant depression","institute":"NIMH","activity":"F31","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.71375,"lon":-73.99933,"gp":"institution","usd":50114,"fy0":2026,"fy1":2026,"active":1,"drugs":["ketamine"],"pis":["Elizabeth Alcantara"],"src":"https://reporter.nih.gov/project-details/11389086"},{"id":"grant-f31da066218","eid":"nih:F31DA066218","cat":"grants","name":"Restoring Cognitive Flexibility After Adolescent Cocaine Exposure Using Psilocybin","institute":"NIDA","activity":"F31","org":"ALBERT EINSTEIN COLLEGE OF MEDICINE","city":"BRONX","region":"New York","cc":"US","country":"United States","lat":40.85423,"lon":-73.86768,"gp":"institution","usd":50114,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Julia Rose Benville"],"src":"https://reporter.nih.gov/project-details/11390019"},{"id":"grant-f31ey038625","eid":"nih:F31EY038625","cat":"grants","name":"The inhibitory mechanism underlying psychedelic disruption of visual processing","institute":"NEI","activity":"F31","org":"CORNELL UNIVERSITY","city":"ITHACA","region":"New York","cc":"US","country":"United States","lat":42.45263,"lon":-76.5039,"gp":"institution","usd":46594,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Cory Knox"],"src":"https://reporter.nih.gov/project-details/11318302"},{"id":"grant-f31aa033513","eid":"nih:F31AA033513","cat":"grants","name":"Determining mechanisms of psychedelic action on reducing alcohol consumption","institute":"NIAAA","activity":"F31","org":"VIRGINIA COMMONWEALTH UNIVERSITY","city":"RICHMOND","region":"Virginia","cc":"US","country":"United States","lat":37.55004,"lon":-77.45692,"gp":"institution","usd":45102,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Alexia Lynne Zylko"],"src":"https://reporter.nih.gov/project-details/11462736"},{"id":"grant-f30da062499","eid":"nih:F30DA062499","cat":"grants","name":"Therapeutic efficacy and mechanisms of psilocybin for traumatic stress-induced anxiety and pain hypersensitivity","institute":"NIDA","activity":"F30","org":"PENNSYLVANIA STATE UNIV HERSHEY MED CTR","city":"HERSHEY","region":"Pennsylvania","cc":"US","country":"United States","usd":37108,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["Charles N Zawatsky"],"src":"https://reporter.nih.gov/project-details/11318647"},{"id":"grant-i01rd001520","eid":"nih:I01RD001520","cat":"grants","name":"A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans","institute":"VA","activity":"I01","org":"BIRMINGHAM VA MEDICAL CENTER","city":"BIRMINGHAM","region":"Alabama","cc":"US","country":"United States","lat":33.51525,"lon":-86.80047,"gp":"institution","usd":0,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["LORI L. DAVIS"],"src":"https://reporter.nih.gov/project-details/11298677"},{"id":"grant-i01bx006920","eid":"nih:I01BX006920","cat":"grants","name":"Facilitating inhibition of fear with psilocybin: Mitochondria Dynamics and Mechanisms of Enhanced Plasticity","institute":"VA","activity":"I01","org":"BALTIMORE VA MEDICAL CENTER","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.30191,"lon":-76.61318,"gp":"institution","usd":0,"fy0":2026,"fy1":2026,"active":1,"drugs":["psilocybin"],"pis":["JAYLYN Waddell WADDELL"],"src":"https://reporter.nih.gov/project-details/11190038"},{"id":"grant-i01rx005603","eid":"nih:I01RX005603","cat":"grants","name":"MDMA-Assisted Therapy for Veterans with PTSD and Alcohol Use Disorder: A Randomized Controlled Trial","institute":"VA","activity":"I01","org":"PROVIDENCE VA  MEDICAL CENTER","city":"PROVIDENCE","region":"Rhode Island","cc":"US","country":"United States","lat":41.82827,"lon":-71.40497,"gp":"institution","usd":0,"fy0":2026,"fy1":2026,"active":1,"drugs":["MDMA"],"pis":["Erica Eaton"],"src":"https://reporter.nih.gov/project-details/11106125"},{"id":"grant-i01bx006860","eid":"nih:I01BX006860","cat":"grants","name":"Psychedelic treatment to improve social and cognitive function in preclinical models of schizophrenia","institute":"VA","activity":"I01","org":"VA SAN DIEGO HEALTHCARE SYSTEM","city":"SAN DIEGO","region":"California","cc":"US","country":"United States","lat":32.72602,"lon":-117.16241,"gp":"institution","usd":0,"fy0":2025,"fy1":2026,"active":1,"drugs":["psilocybin","MDMA"],"pis":["Susan B Powell"],"src":"https://reporter.nih.gov/project-details/11281763"},{"id":"grant-i01rd001353","eid":"nih:I01RD001353","cat":"grants","name":"Serotonergic Modulation of Extinction Learning as a Model of Exposure Therapy in Rats","institute":"VA","activity":"I01","org":"SOUTH TEXAS VETERANS HEALTH CARE SYSTEM","city":"SAN ANTONIO","region":"Texas","cc":"US","country":"United States","lat":29.42633,"lon":-98.49405,"gp":"institution","usd":0,"fy0":2026,"fy1":2026,"active":1,"pis":["David A Morilak"],"src":"https://reporter.nih.gov/project-details/11294822"},{"id":"grant-ziatr000042","eid":"nih:ZIATR000042","cat":"grants","name":"Development of (R,R)-dehydronorketamine for treatment resistant depression","institute":"NCATS","activity":"ZIA","org":"NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES","cc":"US","country":"United States","lat":39.08866,"lon":-77.16034,"gp":"institution","usd":18547689,"fy0":2015,"fy1":2022,"active":0,"drugs":["ketamine"],"pis":["Craig Thomas"],"src":"https://reporter.nih.gov/project-details/10675394"},{"id":"grant-p01da012923","eid":"nih:P01DA012923","cat":"grants","name":"Hallucinogens and 5-HT Receptors: Mechanisms and Effects","institute":"NIDA","activity":"P01","org":"WEILL MEDICAL COLL OF CORNELL UNIV","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":9466120,"fy0":2000,"fy1":2011,"active":0,"pis":["HAREL WEINSTEIN"],"src":"https://reporter.nih.gov/project-details/8075607"},{"id":"grant-ug3ns131532","eid":"nih:UG3NS131532","cat":"grants","name":"Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT)","institute":"NINDS","activity":"UG3","org":"UNIVERSITY OF VIRGINIA","city":"CHARLOTTESVILLE","region":"Virginia","cc":"US","country":"United States","lat":38.02936,"lon":-78.47042,"gp":"institution","usd":9296510,"fy0":2025,"fy1":2025,"active":0,"drugs":["ketamine"],"pis":["James Chamberlain","Jaideep Kapur","Eric S. Rosenthal","Robert Silbergleit"],"src":"https://reporter.nih.gov/project-details/10983488"},{"id":"grant-r01da002925","eid":"nih:R01DA002925","cat":"grants","name":"Monoamine and Hallucinogen Effects on Rodent Behavior","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.72592,"lon":-117.15441,"gp":"institution","usd":6939817,"fy0":1985,"fy1":2015,"active":0,"drugs":["psilocybin","LSD","DMT","mescaline"],"pis":["MARK A GEYER"],"src":"https://reporter.nih.gov/project-details/8814189"},{"id":"grant-u01mh110008","eid":"nih:U01MH110008","cat":"grants","name":"Perturbation of the treatment resistant depression connectome by fast-acting therapies","institute":"NIMH","activity":"U01","org":"UNIVERSITY OF CALIFORNIA LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.0567,"lon":-118.24928,"gp":"institution","usd":5525791,"fy0":2016,"fy1":2019,"active":0,"drugs":["ketamine"],"pis":["Randall Espinoza","Katherine L Narr","Danny JJ WANG"],"src":"https://reporter.nih.gov/project-details/9698987"},{"id":"grant-uh3ca261067","eid":"nih:UH3CA261067","cat":"grants","name":"Optimizing the use of ketamine to reduce chronic postsurgical pain","institute":"NCI","activity":"UH3","org":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":5247593,"fy0":2021,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["Lisa Doan","Jing Wang"],"src":"https://reporter.nih.gov/project-details/11092570"},{"id":"grant-r01mh093897","eid":"nih:R01MH093897","cat":"grants","name":"Role of GABA Interneurons in the Rapid Antidepressant Actions of NMDA Receptor Blockade","institute":"NIMH","activity":"R01","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31817,"lon":-72.93969,"gp":"institution","usd":5045304,"fy0":2011,"fy1":2021,"active":0,"drugs":["ketamine"],"pis":["RALPH J DILEONE"],"src":"https://reporter.nih.gov/project-details/10246314"},{"id":"grant-ziahd000711","eid":"nih:ZIAHD000711","cat":"grants","name":"Neuregulin-ErbB Signaling in Neuronal Development and Psychiatric Disorders","institute":"NICHD","activity":"ZIA","org":"EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT","cc":"US","country":"United States","lat":38.98909,"lon":-77.10012,"gp":"institution","usd":4677632,"fy0":2015,"fy1":2018,"active":0,"drugs":["ketamine"],"pis":["ANDRES BUONANNO"],"src":"https://reporter.nih.gov/project-details/9790669"},{"id":"grant-r01da003889","eid":"nih:R01DA003889","cat":"grants","name":"Clinical Pharmacology/Mechanisms of Action of Emerging Abused Drugs (Club Drugs)","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29598,"lon":-76.61177,"gp":"institution","usd":4478733,"fy0":2007,"fy1":2017,"active":0,"drugs":["psilocybin","DMT"],"pis":["Roland R Griffiths"],"src":"https://reporter.nih.gov/project-details/9235269"},{"id":"grant-r01mh105461","eid":"nih:R01MH105461","cat":"grants","name":"NMDAR Modulation As A Therapeutic Target and Probe of Neural Dysfunction in OCD","institute":"NIMH","activity":"R01","org":"STANFORD UNIVERSITY","city":"STANFORD","region":"California","cc":"US","country":"United States","lat":37.42642,"lon":-122.15916,"gp":"institution","usd":4249662,"fy0":2015,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["Carolyn I Rodriguez"],"src":"https://reporter.nih.gov/project-details/9982175"},{"id":"grant-r01da005938","eid":"nih:R01DA005938","cat":"grants","name":"MDMA Neurotoxicity in Humans: Occurence & Consequences","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28704,"lon":-76.61939,"gp":"institution","usd":4095057,"fy0":1989,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["GEORGE A RICAURTE"],"src":"https://reporter.nih.gov/project-details/7045950"},{"id":"grant-rc2da028915","eid":"nih:RC2DA028915","cat":"grants","name":"Chimeric anti-Methamphetamine Monoclonal Antibody for Treating Stimulant Toxicity","institute":"NIDA","activity":"RC2","org":"INTERVEXION THERAPEUTICS, LLC","city":"LITTLE ROCK","region":"Arkansas","cc":"US","country":"United States","usd":3964137,"fy0":2009,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["W BROOKS GENTRY","R. BARRY HOLTZ"],"src":"https://reporter.nih.gov/project-details/7943897"},{"id":"grant-r01da003385","eid":"nih:R01DA003385","cat":"grants","name":"Behavioral & Pharmacological Analysis of Drugs of Abuse","institute":"NIDA","activity":"R01","org":"STATE UNIVERSITY OF NEW YORK AT BUFFALO","city":"BUFFALO","region":"New York","cc":"US","country":"United States","usd":3522359,"fy0":1989,"fy1":2005,"active":0,"drugs":["LSD"],"pis":["JERROLD Clyne WINTER"],"src":"https://reporter.nih.gov/project-details/6911502"},{"id":"grant-r01da007427","eid":"nih:R01DA007427","cat":"grants","name":"Determinants and Consequences of MDMA Neurotoxicity","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF CINCINNATI","city":"CINCINNATI","region":"Ohio","cc":"US","country":"United States","lat":39.13864,"lon":-84.51641,"gp":"institution","usd":3517717,"fy0":1992,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["GARY GUDELSKY"],"src":"https://reporter.nih.gov/project-details/7816725"},{"id":"grant-r01mh107183","eid":"nih:R01MH107183","cat":"grants","name":"Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF ALABAMA AT BIRMINGHAM","city":"BIRMINGHAM","region":"Alabama","cc":"US","country":"United States","lat":33.51402,"lon":-86.8143,"gp":"institution","usd":3512205,"fy0":2015,"fy1":2019,"active":0,"drugs":["ketamine"],"pis":["Yogesh Dwivedi","Richard Charles Shelton"],"src":"https://reporter.nih.gov/project-details/9689094"},{"id":"grant-r01mh108643","eid":"nih:R01MH108643","cat":"grants","name":"Rapid actions of ketamine in the prefrontal cortex","institute":"NIMH","activity":"R01","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31742,"lon":-72.92077,"gp":"institution","usd":3286756,"fy0":2016,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["AMY F.T. ARNSTEN"],"src":"https://reporter.nih.gov/project-details/9901576"},{"id":"grant-r01mh125205","eid":"nih:R01MH125205","cat":"grants","name":"A feasibility trial of esketamine plus cognitive behavioral therapy for patients with major depressive disorder who are hospitalized for suicidal ideation","institute":"NIMH","activity":"R01","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.29681,"lon":-72.92821,"gp":"institution","usd":3236865,"fy0":2020,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["SAMUEL WILKINSON"],"src":"https://reporter.nih.gov/project-details/10688291"},{"id":"grant-r01da010217","eid":"nih:R01DA010217","cat":"grants","name":"PET Imaging MDMA Neurotoxicity","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28977,"lon":-76.60593,"gp":"institution","usd":3068516,"fy0":1995,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["UNA D MCCANN"],"src":"https://reporter.nih.gov/project-details/7097984"},{"id":"grant-ziada000523","eid":"nih:ZIADA000523","cat":"grants","name":"Pharmacology and toxicology of newly-emerging designer drugs of abuse","institute":"NIDA","activity":"ZIA","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.97723,"lon":-77.09438,"gp":"institution","usd":2988091,"fy0":2009,"fy1":2017,"active":0,"drugs":["MDMA"],"pis":["Michael Baumann"],"src":"https://reporter.nih.gov/project-details/9551869"},{"id":"grant-r01da019158","eid":"nih:R01DA019158","cat":"grants","name":"Neurobehavioral Effects of MDMA in Adolescent Monkeys","institute":"NIDA","activity":"R01","org":"NORTHEASTERN UNIVERSITY","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.3533,"lon":-71.05248,"gp":"institution","usd":2923844,"fy0":2004,"fy1":2009,"active":0,"drugs":["MDMA"],"pis":["CRAIG F FERRIS"],"src":"https://reporter.nih.gov/project-details/7925091"},{"id":"grant-r01da014488","eid":"nih:R01DA014488","cat":"grants","name":"MDMA/Club Drug Use & STD/HIV Sex Risk Behavior in Ohio","institute":"NIDA","activity":"R01","org":"WRIGHT STATE UNIVERSITY","city":"DAYTON","region":"Ohio","cc":"US","country":"United States","lat":39.76201,"lon":-84.18507,"gp":"institution","usd":2914559,"fy0":2001,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["Robert Geoffrey Carlson"],"src":"https://reporter.nih.gov/project-details/6897950"},{"id":"grant-r01mh096784","eid":"nih:R01MH096784","cat":"grants","name":"Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression","institute":"NIMH","activity":"R01","org":"NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.7767,"lon":-73.96639,"gp":"institution","usd":2782343,"fy0":2012,"fy1":2016,"active":0,"drugs":["ketamine"],"pis":["Michael F Grunebaum"],"src":"https://reporter.nih.gov/project-details/9056462"},{"id":"grant-r01da014910","eid":"nih:R01DA014910","cat":"grants","name":"Developmental Outcomes of Prenatal Exposure to MDMA ('E*","institute":"NIDA","activity":"R01","org":"CASE WESTERN RESERVE UNIVERSITY","city":"CLEVELAND","region":"Ohio","cc":"US","country":"United States","lat":41.49898,"lon":-81.70647,"gp":"institution","usd":2779826,"fy0":2001,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["Lynn T Singer"],"src":"https://reporter.nih.gov/project-details/6943061"},{"id":"grant-r01mh125203","eid":"nih:R01MH125203","cat":"grants","name":"Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine","institute":"NIMH","activity":"R01","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.30189,"lon":-72.93451,"gp":"institution","usd":2628351,"fy0":2020,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["Michael H Bloch"],"src":"https://reporter.nih.gov/project-details/10689070"},{"id":"grant-r01da005707","eid":"nih:R01DA005707","cat":"grants","name":"MDMA Neurotoxicity in Nonhuman Primates","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28591,"lon":-76.61704,"gp":"institution","usd":2595592,"fy0":1995,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["GEORGE A RICAURTE"],"src":"https://reporter.nih.gov/project-details/6940774"},{"id":"grant-r01da001642","eid":"nih:R01DA001642","cat":"grants","name":"CHEMICAL/BEHAVIORAL STUDIES ON HALLUCINOGENIC AGENTS","institute":"NIDA","activity":"R01","org":"VIRGINIA COMMONWEALTH UNIVERSITY","city":"RICHMOND","region":"Virginia","cc":"US","country":"United States","lat":37.56265,"lon":-77.45522,"gp":"institution","usd":2582979,"fy0":1999,"fy1":2007,"active":0,"drugs":["MDMA"],"pis":["RICHARD A GLENNON"],"src":"https://reporter.nih.gov/project-details/7214199"},{"id":"grant-r01da009862","eid":"nih:R01DA009862","cat":"grants","name":"DRUGS OF ABUSE IN SEROTONIN RECEPTORS KNOCKOUT MICE","institute":"NIDA","activity":"R01","org":"COLUMBIA UNIVERSITY HEALTH SCIENCES","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":2571887,"fy0":1995,"fy1":2003,"active":0,"drugs":["MDMA"],"pis":["Rene Hen"],"src":"https://reporter.nih.gov/project-details/6634220"},{"id":"grant-r01da015631","eid":"nih:R01DA015631","cat":"grants","name":"Ketamine Injection and HIV Risk Among High Risk Youth","institute":"NIDA","activity":"R01","org":"CHILDREN'S HOSPITAL OF LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.04428,"lon":-118.2506,"gp":"institution","usd":2557491,"fy0":2003,"fy1":2006,"active":0,"drugs":["MDMA","ketamine"],"pis":["Stephen E Lankenau"],"src":"https://reporter.nih.gov/project-details/7222911"},{"id":"grant-r01da005181","eid":"nih:R01DA005181","cat":"grants","name":"Hallucinogens and Serotonin Signal Transduction","institute":"NIDA","activity":"R01","org":"VANDERBILT UNIVERSITY","city":"Nashville","region":"Tennessee","cc":"US","country":"United States","lat":36.16368,"lon":-86.77291,"gp":"institution","usd":2550995,"fy0":1992,"fy1":2008,"active":0,"drugs":["LSD"],"pis":["ELAINE SANDERS BUSH"],"src":"https://reporter.nih.gov/project-details/7479825"},{"id":"grant-zianr000019","eid":"nih:ZIANR000019","cat":"grants","name":"Investigating Correlates and Therapeutics of Fatigue","institute":"NINR","activity":"ZIA","org":"NATIONAL INSTITUTE OF NURSING RESEARCH","cc":"US","country":"United States","lat":38.99145,"lon":-77.0925,"gp":"institution","usd":2547872,"fy0":2024,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["Leorey Saligan"],"src":"https://reporter.nih.gov/project-details/11196002"},{"id":"grant-r01mh125181","eid":"nih:R01MH125181","cat":"grants","name":"Double-Blind Randomized Controlled Trial of Acute-Course of Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents","institute":"NIMH","activity":"R01","org":"UT SOUTHWESTERN MEDICAL CENTER","city":"DALLAS","region":"Texas","cc":"US","country":"United States","usd":2514491,"fy0":2020,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["MADHUKAR H. TRIVEDI"],"src":"https://reporter.nih.gov/project-details/10689903"},{"id":"grant-r01mh057635","eid":"nih:R01MH057635","cat":"grants","name":"Structural Domains Essential for Serotonin Receptor Pharmacology","institute":"NIMH","activity":"R01","org":"CASE WESTERN RESERVE UNIVERSITY","city":"CLEVELAND","region":"Ohio","cc":"US","country":"United States","lat":41.50228,"lon":-81.6931,"gp":"institution","usd":2508244,"fy0":1997,"fy1":2006,"active":0,"drugs":["psilocybin","LSD","mescaline"],"pis":["Bryan L. Roth"],"src":"https://reporter.nih.gov/project-details/6998953"},{"id":"grant-r01mh125214","eid":"nih:R01MH125214","cat":"grants","name":"Ketamine Treatment of Youth Suicide Attempters for Fast Reduction of Severe Suicide Risk and Facilitation of Long-term Collaborative Clinical Engagement: A Randomized Placebo Controlled Trial","institute":"NIMH","activity":"R01","org":"CLEVELAND CLINIC LERNER COM-CWRU","city":"CLEVELAND","region":"Ohio","cc":"US","country":"United States","usd":2493320,"fy0":2020,"fy1":2025,"active":0,"drugs":["ketamine"],"pis":["Amit Anand","Tatiana Falcone"],"src":"https://reporter.nih.gov/project-details/10917013"},{"id":"grant-r61mh129559","eid":"nih:R61MH129559","cat":"grants","name":"Using Ketamine to enhance memory reconsolidation and extinction of overgeneralized fear in individuals diagnosed with PTSD","institute":"NIMH","activity":"R61","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31855,"lon":-72.93498,"gp":"institution","usd":2440264,"fy0":2023,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["ILAN HARPAZ-ROTEM"],"src":"https://reporter.nih.gov/project-details/10840953"},{"id":"grant-r01mh099851","eid":"nih:R01MH099851","cat":"grants","name":"GABAergic Control of Depression Related Brain States","institute":"NIMH","activity":"R01","org":"PENNSYLVANIA STATE UNIVERSITY, THE","city":"UNIVERSITY PARK","region":"Pennsylvania","cc":"US","country":"United States","lat":40.80031,"lon":-77.86278,"gp":"institution","usd":2436095,"fy0":2013,"fy1":2017,"active":0,"drugs":["ketamine"],"pis":["BERNHARD LUSCHER"],"src":"https://reporter.nih.gov/project-details/9260949"},{"id":"grant-r01mh113857","eid":"nih:R01MH113857","cat":"grants","name":"Testing a Synergistic, Neuroplasticity-Based Intervention for Depressive Neurocognition","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF PITTSBURGH AT PITTSBURGH","city":"PITTSBURGH","region":"Pennsylvania","cc":"US","country":"United States","usd":2428497,"fy0":2017,"fy1":2021,"active":0,"drugs":["ketamine"],"pis":["Rebecca Price"],"src":"https://reporter.nih.gov/project-details/10201427"},{"id":"grant-r01da025158","eid":"nih:R01DA025158","cat":"grants","name":"Physiological Implications of Serotonin Receptor Regulation","institute":"NIDA","activity":"R01","org":"SCRIPPS RESEARCH INSTITUTE, THE","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.72065,"lon":-117.17333,"gp":"institution","usd":2397735,"fy0":2009,"fy1":2013,"active":0,"drugs":["MDMA","LSD"],"pis":["Laura M. Bohn"],"src":"https://reporter.nih.gov/project-details/8470141"},{"id":"grant-r01mh093637","eid":"nih:R01MH093637","cat":"grants","name":"The Antidepressant Action of Ketamine:Brain Chemistry","institute":"NIMH","activity":"R01","org":"COLUMBIA UNIVERSITY HEALTH SCIENCES","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":2282678,"fy0":2011,"fy1":2014,"active":0,"drugs":["ketamine"],"pis":["MATE ISTVAN MILAK"],"src":"https://reporter.nih.gov/project-details/8658471"},{"id":"grant-r01mh122742","eid":"nih:R01MH122742","cat":"grants","name":"Deconvoluting Polypharmacologic Contributions of Rapidly-Acting Antidepressants","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF WISCONSIN-MADISON","city":"MADISON","region":"Wisconsin","cc":"US","country":"United States","lat":43.06698,"lon":-89.40627,"gp":"institution","usd":2245007,"fy0":2020,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["Cody James Wenthur"],"src":"https://reporter.nih.gov/project-details/10767796"},{"id":"grant-r01da016776","eid":"nih:R01DA016776","cat":"grants","name":"Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines","institute":"NIDA","activity":"R01","org":"CALIFORNIA PACIFIC MED CTR RES INSTITUTE","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","usd":2201716,"fy0":2004,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["JOHN E. MENDELSON"],"src":"https://reporter.nih.gov/project-details/7749581"},{"id":"grant-r01da018418","eid":"nih:R01DA018418","cat":"grants","name":"BEHAVIORAL TOXICITY OF MDMA IN RHESUS MONKEYS","institute":"NIDA","activity":"R01","org":"SCRIPPS RESEARCH INSTITUTE, THE","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.7247,"lon":-117.16458,"gp":"institution","usd":2009023,"fy0":2005,"fy1":2009,"active":0,"drugs":["MDMA"],"pis":["MICHAEL A. TAFFE"],"src":"https://reporter.nih.gov/project-details/7603131"},{"id":"grant-r01da017231","eid":"nih:R01DA017231","cat":"grants","name":"Structural Brain Correlates of MDMA Use","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28798,"lon":-76.6176,"gp":"institution","usd":1984030,"fy0":2004,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["SUSAN SPEAR BASSETT"],"src":"https://reporter.nih.gov/project-details/7488425"},{"id":"grant-r01mh070727","eid":"nih:R01MH070727","cat":"grants","name":"Antidepressants and Intracellular Signaling Linked to BDNF","institute":"NIMH","activity":"R01","org":"UT SOUTHWESTERN MEDICAL CENTER","city":"DALLAS","region":"Texas","cc":"US","country":"United States","usd":1952959,"fy0":2010,"fy1":2014,"active":0,"drugs":["ketamine"],"pis":["LISA M MONTEGGIA"],"src":"https://reporter.nih.gov/project-details/8660072"},{"id":"grant-ziamh002946","eid":"nih:ZIAMH002946","cat":"grants","name":"Structure, Function and Pharmacology of Neurotransmitter Reuptake Systems","institute":"NIMH","activity":"ZIA","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":1944597,"fy0":2024,"fy1":2024,"active":0,"drugs":["MDMA"],"pis":["Susan Amara"],"src":"https://reporter.nih.gov/project-details/11196121"},{"id":"grant-r01da023210","eid":"nih:R01DA023210","cat":"grants","name":"Long-term neurobehavioral effects of ketamine exposure in adolescent mice","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF PENNSYLVANIA","city":"PHILADELPHIA","region":"Pennsylvania","cc":"US","country":"United States","lat":39.95374,"lon":-75.17091,"gp":"institution","usd":1933549,"fy0":2008,"fy1":2012,"active":0,"drugs":["ketamine"],"pis":["STEVEN J SIEGEL"],"src":"https://reporter.nih.gov/project-details/8228142"},{"id":"grant-r01mh086828","eid":"nih:R01MH086828","cat":"grants","name":"Stress, depression and effects of novel antidepressants on excitatory synapses","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF MARYLAND BALTIMORE","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.30182,"lon":-76.60781,"gp":"institution","usd":1909535,"fy0":2015,"fy1":2019,"active":0,"drugs":["ketamine"],"pis":["SCOTT M. THOMPSON"],"src":"https://reporter.nih.gov/project-details/9692039"},{"id":"grant-r01da017716","eid":"nih:R01DA017716","cat":"grants","name":"MDMA Dependence and Discontinuation Syndrome","institute":"NIDA","activity":"R01","org":"CALIFORNIA PACIFIC MED CTR RES INSTITUTE","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","usd":1900364,"fy0":2005,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["JOHN E. MENDELSON"],"src":"https://reporter.nih.gov/project-details/7418344"},{"id":"grant-ziada000468","eid":"nih:ZIADA000468","cat":"grants","name":"Neurobiology and Pharmacokinetics of Acute MDMA Administration","institute":"NIDA","activity":"ZIA","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.97648,"lon":-77.09833,"gp":"institution","usd":1889501,"fy0":2009,"fy1":2013,"active":0,"drugs":["MDMA"],"pis":["MARILYN A HUESTIS"],"src":"https://reporter.nih.gov/project-details/8736729"},{"id":"grant-r01mh101180","eid":"nih:R01MH101180","cat":"grants","name":"Circuit-based Study of Depression/Anhedonia in Rats","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF PITTSBURGH AT PITTSBURGH","city":"PITTSBURGH","region":"Pennsylvania","cc":"US","country":"United States","usd":1887555,"fy0":2014,"fy1":2018,"active":0,"drugs":["ketamine"],"pis":["ANTHONY A GRACE"],"src":"https://reporter.nih.gov/project-details/9418096"},{"id":"grant-r01mh099085","eid":"nih:R01MH099085","cat":"grants","name":"Sex Differences in Ketamine Antidepressant Effects","institute":"NIMH","activity":"R01","org":"FLORIDA STATE UNIVERSITY","city":"TALLAHASSEE","region":"Florida","cc":"US","country":"United States","lat":30.43228,"lon":-84.28934,"gp":"institution","usd":1875302,"fy0":2013,"fy1":2017,"active":0,"drugs":["ketamine"],"pis":["MOHAMED KABBAJ","YI ZHOU"],"src":"https://reporter.nih.gov/project-details/9247036"},{"id":"grant-r01da024105","eid":"nih:R01DA024105","cat":"grants","name":"Determinants of transition states in MDMA self-administration","institute":"NIDA","activity":"R01","org":"SCRIPPS RESEARCH INSTITUTE, THE","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.71745,"lon":-117.15705,"gp":"institution","usd":1853715,"fy0":2011,"fy1":2015,"active":0,"drugs":["MDMA"],"pis":["MICHAEL A. TAFFE"],"src":"https://reporter.nih.gov/project-details/8773581"},{"id":"grant-r01da043461","eid":"nih:R01DA043461","cat":"grants","name":"Neurobiology of Ketamine Addiction","institute":"NIDA","activity":"R01","org":"FLORIDA STATE UNIVERSITY","city":"TALLAHASSEE","region":"Florida","cc":"US","country":"United States","lat":30.44386,"lon":-84.27607,"gp":"institution","usd":1849286,"fy0":2018,"fy1":2022,"active":0,"drugs":["ketamine"],"pis":["MOHAMED KABBAJ"],"src":"https://reporter.nih.gov/project-details/10471826"},{"id":"grant-ug3da062106","eid":"nih:UG3DA062106","cat":"grants","name":"Targeting Treatment-Resistant OUD with Ketamine-Assisted Mindfulness-Oriented Recovery Enhancement","institute":"NIDA","activity":"UG3","org":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","city":"SALT LAKE CITY","region":"Utah","cc":"US","country":"United States","usd":1837541,"fy0":2024,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["Eric Lee Garland","Edward V. Nunes"],"src":"https://reporter.nih.gov/project-details/11045218"},{"id":"grant-r01da021616","eid":"nih:R01DA021616","cat":"grants","name":"The reinforcing and discriminative stimulus effects of orally administered MDMA","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29673,"lon":-76.60028,"gp":"institution","usd":1819320,"fy0":2008,"fy1":2012,"active":0,"drugs":["MDMA"],"pis":["Nancy A. Ator"],"src":"https://reporter.nih.gov/project-details/8261993"},{"id":"grant-r01da003817","eid":"nih:R01DA003817","cat":"grants","name":"NEUROBEHAVIORAL MECHANISMS OF DRUG ADDICTION","institute":"NIDA","activity":"R01","org":"ALBANY MEDICAL COLLEGE","city":"ALBANY","region":"New York","cc":"US","country":"United States","lat":42.65677,"lon":-73.74978,"gp":"institution","usd":1814482,"fy0":1986,"fy1":2001,"active":0,"drugs":["ibogaine"],"pis":["STANLEY D GLICK"],"src":"https://reporter.nih.gov/project-details/6362792"},{"id":"grant-r01gm128997","eid":"nih:R01GM128997","cat":"grants","name":"Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids","institute":"NIGMS","activity":"R01","org":"UNIVERSITY OF CALIFORNIA AT DAVIS","city":"DAVIS","region":"California","cc":"US","country":"United States","usd":1790696,"fy0":2018,"fy1":2022,"active":0,"drugs":["ketamine"],"pis":["David E Olson"],"src":"https://reporter.nih.gov/project-details/10406167"},{"id":"grant-r01da017333","eid":"nih:R01DA017333","cat":"grants","name":"Brain Functional Correlates of MDMA Use in Adolescence","institute":"NIDA","activity":"R01","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.30999,"lon":-72.92821,"gp":"institution","usd":1718213,"fy0":2004,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["LESLIE K JACOBSEN"],"src":"https://reporter.nih.gov/project-details/7488985"},{"id":"grant-r01da013800","eid":"nih:R01DA013800","cat":"grants","name":"COGNITIVE NEUROPSYCHOLOGY OF HIV AND MDMA ABUSE","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF ILLINOIS AT CHICAGO","city":"CHICAGO","region":"Illinois","cc":"US","country":"United States","usd":1704123,"fy0":2000,"fy1":2004,"active":0,"drugs":["MDMA","ketamine"],"pis":["Eileen Martin"],"src":"https://reporter.nih.gov/project-details/6804668"},{"id":"grant-r01da015806","eid":"nih:R01DA015806","cat":"grants","name":"PET Imaging of Serotonin Transmission in MDMA Users","institute":"NIDA","activity":"R01","org":"NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.78432,"lon":-73.9566,"gp":"institution","usd":1655430,"fy0":2003,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["Anissa Abi-Dargham"],"src":"https://reporter.nih.gov/project-details/7060972"},{"id":"grant-r01da023525","eid":"nih:R01DA023525","cat":"grants","name":"Hepatic Metabolism and Susceptibility to Ecstasy Toxicity","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF ARIZONA","city":"TUCSON","region":"Arizona","cc":"US","country":"United States","lat":32.21209,"lon":-110.92963,"gp":"institution","usd":1643029,"fy0":2008,"fy1":2012,"active":0,"drugs":["MDMA"],"pis":["TERRENCE J. MONKS"],"src":"https://reporter.nih.gov/project-details/8268447"},{"id":"grant-r01da017204","eid":"nih:R01DA017204","cat":"grants","name":"Diterpines as Selective Kappa Opioid Receptor Agonists","institute":"NIDA","activity":"R01","org":"UNIV OF NORTH CAROLINA CHAPEL HILL","city":"CHAPEL HILL","region":"North Carolina","cc":"US","country":"United States","usd":1638281,"fy0":2010,"fy1":2014,"active":0,"drugs":["psilocybin","LSD","mescaline"],"pis":["Bryan L. Roth"],"src":"https://reporter.nih.gov/project-details/8604145"},{"id":"grant-r01da008692","eid":"nih:R01DA008692","cat":"grants","name":"MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29749,"lon":-76.60188,"gp":"institution","usd":1629262,"fy0":1994,"fy1":1998,"active":0,"drugs":["ibogaine"],"pis":["MARK E MOLLIVER"],"src":"https://reporter.nih.gov/project-details/2733535"},{"id":"grant-r01da020393","eid":"nih:R01DA020393","cat":"grants","name":"MDMA and STD/HIV Risk among Hidden Networks of Ecstasy-using Young Adults","institute":"NIDA","activity":"R01","org":"INSTITUTE FOR COMMUNITY RESEARCH","city":"HARTFORD","region":"Connecticut","cc":"US","country":"United States","lat":41.77326,"lon":-72.68467,"gp":"institution","usd":1625267,"fy0":2007,"fy1":2009,"active":0,"drugs":["MDMA"],"pis":["Jean J Schensul"],"src":"https://reporter.nih.gov/project-details/7646217"},{"id":"grant-r01ns122805","eid":"nih:R01NS122805","cat":"grants","name":"Mechanisms of Low-Dose Ketamine Treatment for Parkinson's Disease","institute":"NINDS","activity":"R01","org":"UNIVERSITY OF ARIZONA","city":"TUCSON","region":"Arizona","cc":"US","country":"United States","lat":32.2263,"lon":-110.9238,"gp":"institution","usd":1624779,"fy0":2021,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["TORSTEN FALK"],"src":"https://reporter.nih.gov/project-details/10874836"},{"id":"grant-r01da026867","eid":"nih:R01DA026867","cat":"grants","name":"CNS circuitry and receptors mediating the effects of MDMA","institute":"NIDA","activity":"R01","org":"INDIANA UNIVERSITY INDIANAPOLIS","city":"INDIANAPOLIS","region":"Indiana","cc":"US","country":"United States","lat":39.77492,"lon":-86.1594,"gp":"institution","usd":1619726,"fy0":2010,"fy1":2014,"active":0,"drugs":["MDMA"],"pis":["DANIEL E RUSYNIAK"],"src":"https://reporter.nih.gov/project-details/8655527"},{"id":"grant-r01da016563","eid":"nih:R01DA016563","cat":"grants","name":"Sleep and Nocturnal Endocrine Function in MDMA User","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28779,"lon":-76.61017,"gp":"institution","usd":1580009,"fy0":2003,"fy1":2007,"active":0,"drugs":["MDMA"],"pis":["UNA D MCCANN"],"src":"https://reporter.nih.gov/project-details/7274825"},{"id":"grant-r01da009161","eid":"nih:R01DA009161","cat":"grants","name":"STIMULANTS, DEPRESSANTS & HALLUCINOGENS AS REINFORCERS","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF MICHIGAN AT ANN ARBOR","city":"ANN ARBOR","region":"Michigan","cc":"US","country":"United States","usd":1563494,"fy0":1997,"fy1":2003,"active":0,"drugs":["MDMA","LSD"],"pis":["GAIL D WINGER"],"src":"https://reporter.nih.gov/project-details/6657274"},{"id":"grant-r01da002189","eid":"nih:R01DA002189","cat":"grants","name":"STEREOCHEMICAL ASPECTS OF HALLUCINOGENESIS","institute":"NIDA","activity":"R01","org":"PURDUE UNIVERSITY","city":"WEST LAFAYETTE","region":"Indiana","cc":"US","country":"United States","usd":1559194,"fy0":1985,"fy1":1998,"active":0,"drugs":["LSD","mescaline"],"pis":["DAVID E NICHOLS"],"src":"https://reporter.nih.gov/project-details/2668105"},{"id":"grant-r01da021394","eid":"nih:R01DA021394","cat":"grants","name":"Effects of Neonatal MDMA on Brain and Behavior","institute":"NIDA","activity":"R01","org":"CINCINNATI CHILDRENS HOSP MED CTR","city":"CINCINNATI","region":"Ohio","cc":"US","country":"United States","lat":39.11662,"lon":-84.5182,"gp":"institution","usd":1444618,"fy0":2006,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["Charles V Vorhees"],"src":"https://reporter.nih.gov/project-details/7805428"},{"id":"grant-r01da017399","eid":"nih:R01DA017399","cat":"grants","name":"Neurochemical Sequelae of Prenatal MDMA","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF CINCINNATI","city":"CINCINNATI","region":"Ohio","cc":"US","country":"United States","lat":39.1184,"lon":-84.51086,"gp":"institution","usd":1441792,"fy0":2005,"fy1":2009,"active":0,"drugs":["MDMA"],"pis":["JACK WILLIAM LIPTON"],"src":"https://reporter.nih.gov/project-details/7617969"},{"id":"grant-r01da025528","eid":"nih:R01DA025528","cat":"grants","name":"HIV, Drug Abuse and Neurotoxicity","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF MISSOURI KANSAS CITY","city":"KANSAS CITY","region":"Missouri","cc":"US","country":"United States","lat":39.09084,"lon":-94.57768,"gp":"institution","usd":1440080,"fy0":2009,"fy1":2013,"active":0,"drugs":["MDMA"],"pis":["ANIL KUMAR"],"src":"https://reporter.nih.gov/project-details/8447553"},{"id":"grant-m01rr002719","eid":"nih:M01RR002719","cat":"grants","name":"MDMA NEUROTOXICITY IN HUMANS: OCCURRENCE AND CONSEQUENCES","institute":"NCRR","activity":"M01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29024,"lon":-76.60367,"gp":"institution","usd":1436364,"fy0":1993,"fy1":2007,"active":0,"drugs":["MDMA"],"pis":["GEORGE A RICAURTE"],"src":"https://reporter.nih.gov/project-details/7607441"},{"id":"grant-r01mh081870","eid":"nih:R01MH081870","cat":"grants","name":"Optimization of IV Ketamine for Treatment Resistant Major Depression","institute":"NIMH","activity":"R01","org":"BAYLOR COLLEGE OF MEDICINE","city":"HOUSTON","region":"Texas","cc":"US","country":"United States","lat":29.76464,"lon":-95.36463,"gp":"institution","usd":1415431,"fy0":2009,"fy1":2012,"active":0,"drugs":["ketamine"],"pis":["SANJAY J MATHEW"],"src":"https://reporter.nih.gov/project-details/8270516"},{"id":"grant-r01da013595","eid":"nih:R01DA013595","cat":"grants","name":"NEUROPSYCHOPHARMACOLOGY MDMA--MONOAMINERGIC MECHANISMS","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF TEXAS MED BR GALVESTON","city":"GALVESTON","region":"Texas","cc":"US","country":"United States","usd":1403459,"fy0":2001,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["Kathryn A. Cunningham"],"src":"https://reporter.nih.gov/project-details/6862692"},{"id":"grant-ug3mh137656","eid":"nih:UG3MH137656","cat":"grants","name":"Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression","institute":"NIMH","activity":"UG3","org":"WEILL MEDICAL COLL OF CORNELL UNIV","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":1377361,"fy0":2024,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["Conor M Liston","James Warren Murrough","Nolan R. Williams","Benjamin Zebley"],"src":"https://reporter.nih.gov/project-details/10977993"},{"id":"grant-r01da041336","eid":"nih:R01DA041336","cat":"grants","name":"The Next Generation of Hallucinogens: A New Class of Synthetic Psychoactive Drugs","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.71124,"lon":-117.16166,"gp":"institution","usd":1374989,"fy0":2017,"fy1":2020,"active":0,"drugs":["LSD","DMT","mescaline"],"pis":["ADAM L. Halberstadt"],"src":"https://reporter.nih.gov/project-details/9836838"},{"id":"grant-r01da016866","eid":"nih:R01DA016866","cat":"grants","name":"Chronic Stress and MDMA Neurotoxicity","institute":"NIDA","activity":"R01","org":"BOSTON UNIVERSITY MEDICAL CAMPUS","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","usd":1341188,"fy0":2003,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["Bryan K Yamamoto"],"src":"https://reporter.nih.gov/project-details/7070101"},{"id":"grant-r01da019486","eid":"nih:R01DA019486","cat":"grants","name":"Role of Tyrosine in MDMA Toxicity","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS","city":"TOLEDO","region":"Ohio","cc":"US","country":"United States","usd":1321976,"fy0":2006,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["Bryan K Yamamoto"],"src":"https://reporter.nih.gov/project-details/7795247"},{"id":"grant-r01da009088","eid":"nih:R01DA009088","cat":"grants","name":"RECEPTOR DETERMINANTS OF HALLUCINOGEN ACTIONS","institute":"NIDA","activity":"R01","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.71865,"lon":-74.00357,"gp":"institution","usd":1235784,"fy0":1994,"fy1":1998,"active":0,"pis":["STUART C. SEALFON"],"src":"https://reporter.nih.gov/project-details/2749089"},{"id":"grant-sc1gm092282","eid":"nih:SC1GM092282","cat":"grants","name":"Structure-activity relationship studies on Nantenine","institute":"NIGMS","activity":"SC1","org":"HUNTER COLLEGE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.70406,"lon":-74.01289,"gp":"institution","usd":1213290,"fy0":2012,"fy1":2015,"active":0,"drugs":["MDMA"],"pis":["Wayne Wesley Harding"],"src":"https://reporter.nih.gov/project-details/8796721"},{"id":"grant-z01da000468","eid":"nih:Z01DA000468","cat":"grants","name":"Neurobiology and Pharmacokinetics of Acute MDMA Administration","institute":"NIDA","activity":"Z01","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.99201,"lon":-77.10962,"gp":"institution","usd":1202811,"fy0":2004,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["MARILYN A HUESTIS"],"src":"https://reporter.nih.gov/project-details/7733805"},{"id":"grant-r01da016606","eid":"nih:R01DA016606","cat":"grants","name":"Trace Amine Receptors in Non Human Primates","institute":"NIDA","activity":"R01","org":"HARVARD MEDICAL SCHOOL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","usd":1158534,"fy0":2004,"fy1":2007,"active":0,"drugs":["MDMA","LSD"],"pis":["GREGORY MICHAEL MILLER"],"src":"https://reporter.nih.gov/project-details/7215271"},{"id":"grant-r01da004206","eid":"nih:R01DA004206","cat":"grants","name":"CHEMICAL PHARMACOLOGY OF MDA AND MDMA","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF CALIFORNIA LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.05105,"lon":-118.25455,"gp":"institution","usd":1144863,"fy0":1986,"fy1":1992,"active":0,"drugs":["MDMA"],"pis":["ARTHUR K. CHO"],"src":"https://reporter.nih.gov/project-details/2117073"},{"id":"grant-r01da009083","eid":"nih:R01DA009083","cat":"grants","name":"RECEPTOR MECHANISMS OF HALLUCINOGENIC DRUGS OF ABUSE","institute":"NIDA","activity":"R01","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.72128,"lon":-74.00178,"gp":"institution","usd":1143100,"fy0":1994,"fy1":1998,"active":0,"pis":["HAREL WEINSTEIN"],"src":"https://reporter.nih.gov/project-details/2726436"},{"id":"grant-r01da015137","eid":"nih:R01DA015137","cat":"grants","name":"MR Analysis of Persistent CNS Damage in Human MDMA Users","institute":"NIDA","activity":"R01","org":"VANDERBILT UNIVERSITY","city":"NASHVILLE","region":"Tennessee","cc":"US","country":"United States","lat":36.17365,"lon":-86.79324,"gp":"institution","usd":1112001,"fy0":2004,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["RONALD L COWAN"],"src":"https://reporter.nih.gov/project-details/7056056"},{"id":"grant-k05da000053","eid":"nih:K05DA000053","cat":"grants","name":"NEUROPSYCHOPHARMACOLOGY OF ALTERED CONSCIOUSNESS","institute":"NIDA","activity":"K05","org":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","lat":37.76952,"lon":-122.41815,"gp":"institution","usd":1084637,"fy0":1997,"fy1":2007,"active":0,"drugs":["MDMA","LSD"],"pis":["Reese T. Jones"],"src":"https://reporter.nih.gov/project-details/7242646"},{"id":"grant-u19mh121738","eid":"nih:U19MH121738","cat":"grants","name":"Real-Time Evaluation of Emerging Treatments for Suicide Risk","institute":"NIMH","activity":"U19","org":"KAISER FOUNDATION RESEARCH INSTITUTE","city":"Oakland","region":"California","cc":"US","country":"United States","usd":1063677,"fy0":2019,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["GREGORY E. SIMON"],"src":"https://reporter.nih.gov/project-details/10663086"},{"id":"grant-k05da000060","eid":"nih:K05DA000060","cat":"grants","name":"MOLECULAR DETERMINANTS FOR THE ACTION OF HALLUCINOGENS","institute":"NIDA","activity":"K05","org":"WEILL MEDICAL COLL OF CORNELL UNIV","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":1062298,"fy0":1997,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["HAREL WEINSTEIN"],"src":"https://reporter.nih.gov/project-details/7060955"},{"id":"grant-r01da015345","eid":"nih:R01DA015345","cat":"grants","name":"Serotonin, Drug Use and MDMA Induced Deficits","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","city":"HOUSTON","region":"Texas","cc":"US","country":"United States","usd":1038445,"fy0":2003,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["FREDERICK Gerard MOELLER"],"src":"https://reporter.nih.gov/project-details/6881455"},{"id":"grant-r01da009094","eid":"nih:R01DA009094","cat":"grants","name":"HALLUCINOGENS PHARMACOLOGY ON 5-HT RECEPTORS SUBTYPE","institute":"NIDA","activity":"R01","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.70895,"lon":-74.00301,"gp":"institution","usd":1029729,"fy0":1994,"fy1":1998,"active":0,"pis":["SAUL MAAYANI"],"src":"https://reporter.nih.gov/project-details/2749090"},{"id":"grant-k23mh117219","eid":"nih:K23MH117219","cat":"grants","name":"Characterization of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine Probe","institute":"NIMH","activity":"K23","org":"UNIVERSITY OF MINNESOTA","city":"MINNEAPOLIS","region":"Minnesota","cc":"US","country":"United States","lat":44.97701,"lon":-93.26003,"gp":"institution","usd":1003585,"fy0":2020,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["Cristina Sophia Albott"],"src":"https://reporter.nih.gov/project-details/10837034"},{"id":"grant-r01da004758","eid":"nih:R01DA004758","cat":"grants","name":"STRUCTURE ACTIVITY STUDIES OF MDMA-LIKE SUBSTANCES","institute":"NIDA","activity":"R01","org":"PURDUE UNIVERSITY","city":"WEST LAFAYETTE","region":"Indiana","cc":"US","country":"United States","usd":997061,"fy0":1988,"fy1":1993,"active":0,"drugs":["MDMA"],"pis":["DAVID E NICHOLS"],"src":"https://reporter.nih.gov/project-details/2117283"},{"id":"grant-r01da021833","eid":"nih:R01DA021833","cat":"grants","name":"MDMA alters immunity to infections of the peripheral and central nervous systems","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF NORTH CAROLINA CHARLOTTE","city":"CHARLOTTE","region":"North Carolina","cc":"US","country":"United States","usd":990410,"fy0":2007,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["KENNETH L BOST"],"src":"https://reporter.nih.gov/project-details/7798952"},{"id":"grant-r43mh122063","eid":"nih:R43MH122063","cat":"grants","name":"Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptors 2 & 3 (mGlu2/3) for the Treatment of Depression","institute":"NIMH","activity":"R43","org":"CAMINO PHARMA, LLC","city":"SAN DIEGO","region":"California","cc":"US","country":"United States","usd":919316,"fy0":2020,"fy1":2021,"active":0,"drugs":["ketamine"],"pis":["Reto Andreas Gadient"],"src":"https://reporter.nih.gov/project-details/10183332"},{"id":"grant-k23mh094707","eid":"nih:K23MH094707","cat":"grants","name":"Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response","institute":"NIMH","activity":"K23","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.70811,"lon":-74.00602,"gp":"institution","usd":911468,"fy0":2011,"fy1":2015,"active":0,"drugs":["ketamine"],"pis":["James Warren Murrough"],"src":"https://reporter.nih.gov/project-details/8897887"},{"id":"grant-r01da017987","eid":"nih:R01DA017987","cat":"grants","name":"Metabolism and Pharmacogenetics in MDMA-Induced Toxicity","institute":"NIDA","activity":"R01","org":"MUNICIPAL INSTITUTE OF MEDICAL RESEARCH","city":"BARCELONA","cc":"ES","country":"Spain","usd":904005,"fy0":2005,"fy1":2009,"active":0,"drugs":["MDMA"],"pis":["RAFAEL DE LA TORRE"],"src":"https://reporter.nih.gov/project-details/7680170"},{"id":"grant-k24mh102743","eid":"nih:K24MH102743","cat":"grants","name":"Biomarkers of fast acting therapies in major depression","institute":"NIMH","activity":"K24","org":"UNIVERSITY OF CALIFORNIA LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.04249,"lon":-118.23592,"gp":"institution","usd":889490,"fy0":2014,"fy1":2018,"active":0,"drugs":["ketamine"],"pis":["Katherine L Narr"],"src":"https://reporter.nih.gov/project-details/9537678"},{"id":"grant-k23mh101498","eid":"nih:K23MH101498","cat":"grants","name":"Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling","institute":"NIMH","activity":"K23","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31686,"lon":-72.93169,"gp":"institution","usd":879291,"fy0":2013,"fy1":2017,"active":0,"drugs":["ketamine"],"pis":["Chadi Abdallah"],"src":"https://reporter.nih.gov/project-details/9324360"},{"id":"grant-z01mh002871","eid":"nih:Z01MH002871","cat":"grants","name":"Investigation of NMDA receptor antagonist as antidepressant in animals","institute":"NIMH","activity":"Z01","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":826915,"fy0":2006,"fy1":2008,"active":0,"drugs":["ketamine"],"pis":["HUSSEINI K MANJI"],"src":"https://reporter.nih.gov/project-details/7735196"},{"id":"grant-r01da017369","eid":"nih:R01DA017369","cat":"grants","name":"kappa-agonist effects of the hallucinogen Salvinorin A","institute":"NIDA","activity":"R01","org":"ROCKEFELLER UNIVERSITY","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.70331,"lon":-73.99501,"gp":"institution","usd":813983,"fy0":2005,"fy1":2008,"active":0,"pis":["EDUARDO R BUTELMAN"],"src":"https://reporter.nih.gov/project-details/7388911"},{"id":"grant-k01da020485","eid":"nih:K01DA020485","cat":"grants","name":"Linking serotonin and memory functions in MDMA users by concurrent EEG and fMRI","institute":"NIDA","activity":"K01","org":"UNIVERSITY OF CINCINNATI","city":"CINCINNATI","region":"Ohio","cc":"US","country":"United States","lat":39.13102,"lon":-84.52611,"gp":"institution","usd":798431,"fy0":2006,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["JAMES C ELIASSEN"],"src":"https://reporter.nih.gov/project-details/7908706"},{"id":"grant-r01mh099248","eid":"nih:R01MH099248","cat":"grants","name":"Mechanisms underlying fast-onset antidepressant effects of 5-HT2C antagonists - R","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF CHICAGO","city":"CHICAGO","region":"Illinois","cc":"US","country":"United States","lat":41.85092,"lon":-87.66196,"gp":"institution","usd":791390,"fy0":2013,"fy1":2014,"active":0,"drugs":["ketamine"],"pis":["STEPHANIE C DULAWA"],"src":"https://reporter.nih.gov/project-details/8699844"},{"id":"grant-75n95025d00","eid":"nih:75N95025D00","cat":"grants","name":"EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI BILATERAL MODIFICATION TO DESCOPE GMP SYNTHESIS OF BULK DRUG SUBSTANCES.  TASK ORDER NO.75N95025F00001 (TO1), FOR SYNTHESIS OF GMP PSILOCYBIN","institute":"NIDA","activity":"N01","city":"ROUND ROCK","region":"Texas","cc":"US","country":"United States","usd":789897,"fy0":2025,"fy1":2025,"active":0,"drugs":["psilocybin"],"src":"https://reporter.nih.gov/project-details/11456858"},{"id":"grant-k23mh116127","eid":"nih:K23MH116127","cat":"grants","name":"Depression Response to Fast-Acting Treatments: Inflammation and Reward Mechanisms","institute":"NIMH","activity":"K23","org":"UNIVERSITY OF CALIFORNIA LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.05378,"lon":-118.23375,"gp":"institution","usd":789760,"fy0":2018,"fy1":2021,"active":0,"drugs":["ketamine"],"pis":["Jennifer Kruse"],"src":"https://reporter.nih.gov/project-details/10237908"},{"id":"grant-k08mh110610","eid":"nih:K08MH110610","cat":"grants","name":"Neural circuitry and synaptic physiology underlying MDMA's prosocial effect","institute":"NIMH","activity":"K08","org":"STANFORD UNIVERSITY","city":"STANFORD","region":"California","cc":"US","country":"United States","lat":37.42406,"lon":-122.15483,"gp":"institution","usd":780192,"fy0":2017,"fy1":2020,"active":0,"drugs":["MDMA"],"pis":["Boris Dov Heifets"],"src":"https://reporter.nih.gov/project-details/9848624"},{"id":"grant-k01da024760","eid":"nih:K01DA024760","cat":"grants","name":"MR Spectroscopy and Behavior after Clinically Relevant Administration of MDMA","institute":"NIDA","activity":"K01","org":"WAYNE STATE UNIVERSITY","city":"DETROIT","region":"Michigan","cc":"US","country":"United States","lat":42.32988,"lon":-83.05756,"gp":"institution","usd":771908,"fy0":2008,"fy1":2012,"active":0,"drugs":["MDMA"],"pis":["Shane Alan Perrine"],"src":"https://reporter.nih.gov/project-details/8314101"},{"id":"grant-r01mh136052","eid":"nih:R01MH136052","cat":"grants","name":"MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach","institute":"NIMH","activity":"R01","org":"MCLEAN HOSPITAL","city":"BELMONT","region":"Massachusetts","cc":"US","country":"United States","lat":42.39457,"lon":-71.18022,"gp":"institution","usd":766842,"fy0":2025,"fy1":2025,"active":0,"drugs":["MDMA"],"pis":["BRUCE E BLOUGH","Brian D. Kangas"],"src":"https://reporter.nih.gov/project-details/11046212"},{"id":"grant-k23mh122777","eid":"nih:K23MH122777","cat":"grants","name":"The neural correlates of the effects of psilocybin in OCD: randomized controlled study","institute":"NIMH","activity":"K23","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31224,"lon":-72.93677,"gp":"institution","usd":757849,"fy0":2021,"fy1":2024,"active":0,"drugs":["psilocybin"],"pis":["BENJAMIN KELMENDI"],"src":"https://reporter.nih.gov/project-details/10927367"},{"id":"grant-r00aa024142","eid":"nih:R00AA024142","cat":"grants","name":"A Neurobiological Investigation of Ketamine's Enhanced Antidepressant Efficacy in Subjects with a Family History of an Alcohol Use Disorder","institute":"NIAAA","activity":"R00","org":"UNIVERSITY OF IOWA","city":"IOWA CITY","region":"Iowa","cc":"US","country":"United States","lat":41.66268,"lon":-91.52871,"gp":"institution","usd":747000,"fy0":2018,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["MARK J NICIU"],"src":"https://reporter.nih.gov/project-details/10003912"},{"id":"grant-r00mh126098","eid":"nih:R00MH126098","cat":"grants","name":"Cortical GABAergic mechanisms underlying rapid and sustained antidepressant responses","institute":"NIMH","activity":"R00","org":"UNIVERSITY OF ROCHESTER","city":"ROCHESTER","region":"New York","cc":"US","country":"United States","lat":43.16094,"lon":-77.611,"gp":"institution","usd":729566,"fy0":2023,"fy1":2025,"active":0,"drugs":["ketamine"],"pis":["Manoela Fogaca"],"src":"https://reporter.nih.gov/project-details/11042712"},{"id":"grant-k05da020087","eid":"nih:K05DA020087","cat":"grants","name":"Addiction and the Neuropharmacology of Psychostimulants","institute":"NIDA","activity":"K05","org":"UNIVERSITY OF TEXAS MED BR GALVESTON","city":"GALVESTON","region":"Texas","cc":"US","country":"United States","usd":702870,"fy0":2005,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["Kathryn A. Cunningham"],"src":"https://reporter.nih.gov/project-details/8039668"},{"id":"grant-r01da006275","eid":"nih:R01DA006275","cat":"grants","name":"N-METHYLATED ANALOGUES OF MDMA & FENFLURAMINE","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29137,"lon":-76.60075,"gp":"institution","usd":697137,"fy0":1991,"fy1":1993,"active":0,"drugs":["MDMA"],"pis":["GEORGE A RICAURTE"],"src":"https://reporter.nih.gov/project-details/2118583"},{"id":"grant-r56mh113825","eid":"nih:R56MH113825","cat":"grants","name":"The Essential Role of Presynaptic NMDA Receptors in The Fast Antidepressant Actions of Ketamine and Its Metabolite","institute":"NIMH","activity":"R56","org":"SOUTHERN ILLINOIS UNIVERSITY CARBONDALE","city":"CARBONDALE","region":"Illinois","cc":"US","country":"United States","lat":37.72271,"lon":-89.21407,"gp":"institution","usd":682903,"fy0":2017,"fy1":2018,"active":0,"drugs":["ketamine"],"pis":["Xiang Cai"],"src":"https://reporter.nih.gov/project-details/9552924"},{"id":"grant-r01mh136381","eid":"nih:R01MH136381","cat":"grants","name":"Synaptic circuit mechanisms underlying psilocybin's therapeutic effects in the stressed brain","institute":"NIMH","activity":"R01","org":"UNIVERSITY OF CALIFORNIA SANTA CRUZ","city":"SANTA CRUZ","region":"California","cc":"US","country":"United States","lat":36.96626,"lon":-122.02689,"gp":"institution","usd":679118,"fy0":2024,"fy1":2024,"active":0,"drugs":["psilocybin"],"pis":["Yi Zuo"],"src":"https://reporter.nih.gov/project-details/11048951"},{"id":"grant-r01dk128242","eid":"nih:R01DK128242","cat":"grants","name":"Phase 1 Translational Diabetes Research Using The DYRK1A inhibitor, Harmine","institute":"NIDDK","activity":"R01","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.72476,"lon":-74.00592,"gp":"institution","usd":676000,"fy0":2022,"fy1":2023,"active":0,"drugs":["DMT"],"pis":["James Warren Murrough","ANDREW F. STEWART"],"src":"https://reporter.nih.gov/project-details/10665783"},{"id":"grant-ziamh002828","eid":"nih:ZIAMH002828","cat":"grants","name":"Efficacy of an Antiglutamatergic Agents in Treatment-Resistant Depression","institute":"NIMH","activity":"ZIA","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":675569,"fy0":2012,"fy1":2014,"active":0,"drugs":["ketamine"],"pis":["Carlos Zarate"],"src":"https://reporter.nih.gov/project-details/8939977"},{"id":"grant-k23rr016180","eid":"nih:K23RR016180","cat":"grants","name":"MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW","institute":"NCRR","activity":"K23","org":"LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER","city":"TORRANCE","region":"California","cc":"US","country":"United States","usd":666932,"fy0":2000,"fy1":2004,"active":0,"drugs":["ketamine"],"pis":["KELLY D YOUNG"],"src":"https://reporter.nih.gov/project-details/6774738"},{"id":"grant-r01da004944","eid":"nih:R01DA004944","cat":"grants","name":"NEUROTOXIC HALLUCINOGENS:  EFFECTS ON LEARNING","institute":"NIDA","activity":"R01","org":"ALLEGHENY UNIVERSITY OF HEALTH SCIENCES","city":"PHILADELPHIA","region":"Pennsylvania","cc":"US","country":"United States","usd":629220,"fy0":1988,"fy1":1992,"active":0,"drugs":["MDMA","LSD"],"pis":["JOHN A HARVEY"],"src":"https://reporter.nih.gov/project-details/3210793"},{"id":"grant-z01mh002857","eid":"nih:Z01MH002857","cat":"grants","name":"Glutamatergic Modulators for Rapid & Sustained Antidepressant Effect","institute":"NIMH","activity":"Z01","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":620528,"fy0":2005,"fy1":2008,"active":0,"drugs":["ketamine"],"pis":["HUSSEINI K MANJI"],"src":"https://reporter.nih.gov/project-details/7735188"},{"id":"grant-r29da009111","eid":"nih:R29DA009111","cat":"grants","name":"NEUROPSYCHOPHARMACOLOGICAL EFFECTS OF MDMA","institute":"NIDA","activity":"R29","org":"SCRIPPS RESEARCH INSTITUTE, THE","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.72498,"lon":-117.16561,"gp":"institution","usd":603536,"fy0":1994,"fy1":1998,"active":0,"drugs":["MDMA"],"pis":["LISA H. GOLD"],"src":"https://reporter.nih.gov/project-details/2749091"},{"id":"grant-r21da015228","eid":"nih:R21DA015228","cat":"grants","name":"fMRI and Cognition in Adolescent MDMA and Cannabis Users","institute":"NIDA","activity":"R21","org":"VETERANS MEDICAL RESEARCH FDN/SAN DIEGO","city":"SAN DIEGO","region":"California","cc":"US","country":"United States","usd":594900,"fy0":2003,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["Susan F. Tapert"],"src":"https://reporter.nih.gov/project-details/6886107"},{"id":"grant-k20da000225","eid":"nih:K20DA000225","cat":"grants","name":"MOLECULAR MECHANISMS OF IBOGAINE ACTIVITY","institute":"NIDA","activity":"K20","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.30125,"lon":-76.61346,"gp":"institution","usd":593303,"fy0":1994,"fy1":1998,"active":0,"drugs":["ibogaine"],"pis":["ELIZABETH O'HEARN"],"src":"https://reporter.nih.gov/project-details/2770026"},{"id":"grant-k02da018678","eid":"nih:K02DA018678","cat":"grants","name":"Psychostimulant-Induced Craving and Toxicity","institute":"NIDA","activity":"K02","org":"UNIVERSITY OF PENNSYLVANIA","city":"PHILADELPHIA","region":"Pennsylvania","cc":"US","country":"United States","lat":39.94622,"lon":-75.15651,"gp":"institution","usd":584242,"fy0":2006,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["Robert Christopher Pierce"],"src":"https://reporter.nih.gov/project-details/7799901"},{"id":"grant-ziada000532","eid":"nih:ZIADA000532","cat":"grants","name":"Medicinal Chemistry of Drugs Acting on Biogenic Amine Receptors","institute":"NIDA","activity":"ZIA","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.98834,"lon":-77.09711,"gp":"institution","usd":579274,"fy0":2015,"fy1":2016,"active":0,"drugs":["MDMA"],"pis":["Kenner Rice"],"src":"https://reporter.nih.gov/project-details/9352051"},{"id":"grant-r29da005707","eid":"nih:R29DA005707","cat":"grants","name":"MDMA NEUROTOXICITY IN PRIMATE: PERMANENT OR TRANSIENT?","institute":"NIDA","activity":"R29","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29814,"lon":-76.62381,"gp":"institution","usd":573514,"fy0":1989,"fy1":1993,"active":0,"drugs":["MDMA"],"pis":["GEORGE A RICAURTE"],"src":"https://reporter.nih.gov/project-details/2118168"},{"id":"grant-r01da006309","eid":"nih:R01DA006309","cat":"grants","name":"DETECTING 5-HT NEUROTOXICITY WITH PET AND SPECT","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.27932,"lon":-76.61911,"gp":"institution","usd":561222,"fy0":1989,"fy1":1992,"active":0,"drugs":["MDMA"],"pis":["URSULA A. SCHEFFEL"],"src":"https://reporter.nih.gov/project-details/3212967"},{"id":"grant-r01da010832","eid":"nih:R01DA010832","cat":"grants","name":"METABOLISM AS A FACTOR IN DRUG-INDUCED NEUROTOXICITY","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF TEXAS AT AUSTIN","city":"AUSTIN","region":"Texas","cc":"US","country":"United States","lat":30.25891,"lon":-97.74377,"gp":"institution","usd":551081,"fy0":1997,"fy1":1999,"active":0,"drugs":["MDMA","mescaline"],"pis":["TERRENCE J. MONKS"],"src":"https://reporter.nih.gov/project-details/2898112"},{"id":"grant-r01mh099378","eid":"nih:R01MH099378","cat":"grants","name":"Regulation of Protein Translation and Depression by Cortical NMDA Receptors.","institute":"NIMH","activity":"R01","org":"TULANE UNIVERSITY OF LOUISIANA","city":"NEW ORLEANS","region":"Louisiana","cc":"US","country":"United States","usd":548773,"fy0":2013,"fy1":2014,"active":0,"drugs":["ketamine"],"pis":["JEFFREY G TASKER"],"src":"https://reporter.nih.gov/project-details/8635390"},{"id":"grant-r01da014874","eid":"nih:R01DA014874","cat":"grants","name":"CONSEQUENCES OF MDMA IN HUMANS","institute":"NIDA","activity":"R01","org":"WAYNE STATE UNIVERSITY","city":"DETROIT","region":"Michigan","cc":"US","country":"United States","lat":42.32047,"lon":-83.05389,"gp":"institution","usd":548660,"fy0":2002,"fy1":2003,"active":0,"drugs":["MDMA"],"pis":["MANUEL E TANCER"],"src":"https://reporter.nih.gov/project-details/6661371"},{"id":"grant-r21da014115","eid":"nih:R21DA014115","cat":"grants","name":"Neuroelectric Assessment of MDMA (Ecstasy) Use in Adults","institute":"NIDA","activity":"R21","org":"SCRIPPS RESEARCH INSTITUTE, THE","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.70766,"lon":-117.16147,"gp":"institution","usd":547700,"fy0":2001,"fy1":2003,"active":0,"drugs":["MDMA"],"pis":["JOHN M POLICH"],"src":"https://reporter.nih.gov/project-details/6659698"},{"id":"grant-r01da009153","eid":"nih:R01DA009153","cat":"grants","name":"B CARBOLINE HALLUCINOGENS","institute":"NIDA","activity":"R01","org":"VIRGINIA COMMONWEALTH UNIVERSITY","city":"RICHMOND","region":"Virginia","cc":"US","country":"United States","lat":37.54854,"lon":-77.47151,"gp":"institution","usd":546482,"fy0":1997,"fy1":1999,"active":0,"drugs":["LSD"],"pis":["RICHARD A GLENNON"],"src":"https://reporter.nih.gov/project-details/2897935"},{"id":"grant-ziada000525","eid":"nih:ZIADA000525","cat":"grants","name":"Pharmacological characterization of novel opioid drugs","institute":"NIDA","activity":"ZIA","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.98589,"lon":-77.10605,"gp":"institution","usd":540011,"fy0":2012,"fy1":2012,"active":0,"drugs":["LSD","mescaline"],"pis":["Amy Hauck Newman"],"src":"https://reporter.nih.gov/project-details/8553269"},{"id":"grant-r29mh052155","eid":"nih:R29MH052155","cat":"grants","name":"REPEATED MDMA ADMINISTRATION EFFECT ON 5 HT FUNCTION","institute":"NIMH","activity":"R29","org":"ST. JOHN'S UNIVERSITY","city":"QUEENS","region":"New York","cc":"US","country":"United States","lat":40.70735,"lon":-74.00668,"gp":"institution","usd":537277,"fy0":1993,"fy1":1997,"active":0,"drugs":["MDMA"],"pis":["CHARLES R ASHBY"],"src":"https://reporter.nih.gov/project-details/2430975"},{"id":"grant-r01da005860","eid":"nih:R01DA005860","cat":"grants","name":"MDMA--METABOLITE INDENTIFICATION AND NEUROTOXICITY","institute":"NIDA","activity":"R01","org":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","city":"SALT LAKE CITY","region":"Utah","cc":"US","country":"United States","usd":528356,"fy0":1989,"fy1":1991,"active":0,"drugs":["MDMA"],"pis":["Rodger L. Foltz"],"src":"https://reporter.nih.gov/project-details/3212439"},{"id":"grant-ziada000529","eid":"nih:ZIADA000529","cat":"grants","name":"Medicinal Chemistry of Hallucinogenic Drugs","institute":"NIDA","activity":"ZIA","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.97281,"lon":-77.09645,"gp":"institution","usd":523809,"fy0":2009,"fy1":2013,"active":0,"drugs":["MDMA","LSD"],"pis":["Kenner Rice"],"src":"https://reporter.nih.gov/project-details/8736753"},{"id":"grant-ug3ca261067","eid":"nih:UG3CA261067","cat":"grants","name":"Optimizing the use of ketamine to reduce chronic postsurgical pain","institute":"NCI","activity":"UG3","org":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":523335,"fy0":2020,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["Lisa Doan","Jing Wang"],"src":"https://reporter.nih.gov/project-details/10154174"},{"id":"grant-r21da058119","eid":"nih:R21DA058119","cat":"grants","name":"Ketamine for the treatment for opioid use disorder and suicidal ideation in the emergency department","institute":"NIDA","activity":"R21","org":"BRIGHAM AND WOMEN'S HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.35085,"lon":-71.05643,"gp":"institution","usd":492250,"fy0":2023,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["Peter R Chai","Charlotte Goldfine","Joji Suzuki"],"src":"https://reporter.nih.gov/project-details/10838486"},{"id":"grant-r21aa030372","eid":"nih:R21AA030372","cat":"grants","name":"Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial","institute":"NIAAA","activity":"R21","org":"BRIGHAM AND WOMEN'S HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.36761,"lon":-71.0601,"gp":"institution","usd":469876,"fy0":2022,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["Peter R Chai","Joji Suzuki"],"src":"https://reporter.nih.gov/project-details/10703512"},{"id":"grant-r01da004431","eid":"nih:R01DA004431","cat":"grants","name":"NEUROTOXICITY OF HALLUCINOGENIC SUBSTITUTED AMPHETAMINES","institute":"NIDA","activity":"R01","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28742,"lon":-76.62118,"gp":"institution","usd":464297,"fy0":1987,"fy1":1989,"active":0,"drugs":["MDMA"],"pis":["MARK E MOLLIVER"],"src":"https://reporter.nih.gov/project-details/3210058"},{"id":"grant-r21da020645","eid":"nih:R21DA020645","cat":"grants","name":"Effects of self-administered MDMA on brain and behavior in rhesus monkeys","institute":"NIDA","activity":"R21","org":"EMORY UNIVERSITY","city":"ATLANTA","region":"Georgia","cc":"US","country":"United States","lat":33.75667,"lon":-84.38982,"gp":"institution","usd":458624,"fy0":2006,"fy1":2007,"active":0,"drugs":["MDMA"],"pis":["William E Fantegrossi"],"src":"https://reporter.nih.gov/project-details/7229875"},{"id":"grant-r21da014200","eid":"nih:R21DA014200","cat":"grants","name":"MDMA & Amphetamine--Behavioral Organization in Mice","institute":"NIDA","activity":"R21","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.71331,"lon":-117.16806,"gp":"institution","usd":455875,"fy0":2001,"fy1":2003,"active":0,"drugs":["MDMA"],"pis":["MARTIN P. PAULUS"],"src":"https://reporter.nih.gov/project-details/6634370"},{"id":"grant-r01da009483","eid":"nih:R01DA009483","cat":"grants","name":"CEREBRAL BLOOD FLOW PATTERN INDUCED BY KETAMINE","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF MARYLAND BALTIMORE","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28073,"lon":-76.60301,"gp":"institution","usd":453991,"fy0":1994,"fy1":1995,"active":0,"drugs":["ketamine"],"pis":["HENRY HILLIARD HOLCOMB"],"src":"https://reporter.nih.gov/project-details/2122754"},{"id":"grant-r21mh120823","eid":"nih:R21MH120823","cat":"grants","name":"Ketamine-Class Antidepressants in Vesicles","institute":"NIMH","activity":"R21","org":"CALIFORNIA INSTITUTE OF TECHNOLOGY","city":"PASADENA","region":"California","cc":"US","country":"United States","lat":34.145,"lon":-118.13826,"gp":"institution","usd":452375,"fy0":2019,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["Henry A. Lester"],"src":"https://reporter.nih.gov/project-details/9936457"},{"id":"grant-r21mh120614","eid":"nih:R21MH120614","cat":"grants","name":"Microglial brain-derived neurotrophic factor (BDNF) in stress and antidepressant responses","institute":"NIMH","activity":"R21","org":"UNIVERSITY OF CINCINNATI","city":"CINCINNATI","region":"Ohio","cc":"US","country":"United States","lat":39.13817,"lon":-84.52112,"gp":"institution","usd":441375,"fy0":2019,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["Eric S Wohleb"],"src":"https://reporter.nih.gov/project-details/9952427"},{"id":"grant-r21da019261","eid":"nih:R21DA019261","cat":"grants","name":"Prenatal MDMA-Induced Changes in Axonal Guidance Cues","institute":"NIDA","activity":"R21","org":"UNIVERSITY OF CINCINNATI","city":"CINCINNATI","region":"Ohio","cc":"US","country":"United States","lat":39.12057,"lon":-84.51895,"gp":"institution","usd":437897,"fy0":2005,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["JACK WILLIAM LIPTON"],"src":"https://reporter.nih.gov/project-details/7090104"},{"id":"grant-r21at011813","eid":"nih:R21AT011813","cat":"grants","name":"Potentiating Psilocybin","institute":"NCCIH","activity":"R21","org":"VANDERBILT UNIVERSITY","city":"Nashville","region":"Tennessee","cc":"US","country":"United States","lat":36.17149,"lon":-86.77385,"gp":"institution","usd":435875,"fy0":2022,"fy1":2023,"active":0,"drugs":["psilocybin"],"pis":["DAVID E CLIFFEL","Dusty Rose Miller"],"src":"https://reporter.nih.gov/project-details/10602394"},{"id":"grant-r21mh135378","eid":"nih:R21MH135378","cat":"grants","name":"Determining the efficacy of psychedelic agents reversing depression-relevant amotivated behaviors with concomittant EEG biomarkers.","institute":"NIMH","activity":"R21","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.7214,"lon":-117.15799,"gp":"institution","usd":434500,"fy0":2024,"fy1":2025,"active":0,"drugs":["psilocybin"],"pis":["ADAM L. Halberstadt","Jared William Young"],"src":"https://reporter.nih.gov/project-details/11128607"},{"id":"grant-r15mh108043","eid":"nih:R15MH108043","cat":"grants","name":"Antidepressant Actions of Glutamatergic Agents","institute":"NIMH","activity":"R15","org":"DES MOINES UNIV OSTEOPATHIC MEDICAL CTR","city":"WEST DES MOINES","region":"Iowa","cc":"US","country":"United States","lat":41.59889,"lon":-93.60389,"gp":"institution","usd":433616,"fy0":2015,"fy1":2015,"active":0,"drugs":["ketamine"],"pis":["LiLian Yuan"],"src":"https://reporter.nih.gov/project-details/8957702"},{"id":"grant-r21mh103950","eid":"nih:R21MH103950","cat":"grants","name":"BNST GluN2B and CRF signaling in the antidepressant actions of ketamine","institute":"NIMH","activity":"R21","org":"VANDERBILT UNIVERSITY","city":"Nashville","region":"Tennessee","cc":"US","country":"United States","lat":36.16754,"lon":-86.7811,"gp":"institution","usd":431438,"fy0":2014,"fy1":2015,"active":0,"drugs":["ketamine"],"pis":["Danny G. Winder"],"src":"https://reporter.nih.gov/project-details/8829345"},{"id":"grant-r21da033341","eid":"nih:R21DA033341","cat":"grants","name":"Neural mechanisms of increased cortical excitability in human MDMA/Ecstasy users","institute":"NIDA","activity":"R21","org":"VANDERBILT UNIVERSITY","city":"Nashville","region":"Tennessee","cc":"US","country":"United States","lat":36.16829,"lon":-86.79616,"gp":"institution","usd":429000,"fy0":2013,"fy1":2014,"active":0,"drugs":["MDMA"],"pis":["RONALD L COWAN"],"src":"https://reporter.nih.gov/project-details/8604148"},{"id":"grant-r01da009053","eid":"nih:R01DA009053","cat":"grants","name":"LSD, MDMA AND OTHER PSYCHEDELICS--AN EXPLORATORY STUDY","institute":"NIDA","activity":"R01","org":"SCIENTIFIC ANALYSIS CORPORATION","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","usd":428386,"fy0":1994,"fy1":1994,"active":0,"drugs":["MDMA","LSD"],"pis":["JEROME E BECK"],"src":"https://reporter.nih.gov/project-details/2122008"},{"id":"grant-p51rr000168","eid":"nih:P51RR000168","cat":"grants","name":"MDMA ELICITS DIFFERENT BEHAVIORS, GENE EXPRESSION IN ADOLESCENT, ADULT MICE","institute":"NCRR","activity":"P51","org":"HARVARD MEDICAL SCHOOL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","usd":427442,"fy0":2004,"fy1":2011,"active":0,"drugs":["MDMA"],"pis":["Bertha K Madras"],"src":"https://reporter.nih.gov/project-details/8357965"},{"id":"grant-r21da041673","eid":"nih:R21DA041673","cat":"grants","name":"Serotonin transporter phosphorylation in the behavioral effects of salvinorin A","institute":"NIDA","activity":"R21","org":"VIRGINIA COMMONWEALTH UNIVERSITY","city":"RICHMOND","region":"Virginia","cc":"US","country":"United States","lat":37.54298,"lon":-77.46162,"gp":"institution","usd":425313,"fy0":2017,"fy1":2018,"active":0,"pis":["SAMMANDA RAMAMOORTHY"],"src":"https://reporter.nih.gov/project-details/9444477"},{"id":"grant-r21da026570","eid":"nih:R21DA026570","cat":"grants","name":"Is Ecstasy an Empathogen? Effects of MDMA on Social and Emotional Processing","institute":"NIDA","activity":"R21","org":"UNIVERSITY OF CHICAGO","city":"CHICAGO","region":"Illinois","cc":"US","country":"United States","lat":41.84358,"lon":-87.6612,"gp":"institution","usd":424160,"fy0":2009,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["Harriett de Wit"],"src":"https://reporter.nih.gov/project-details/7935210"},{"id":"grant-r21mh099345","eid":"nih:R21MH099345","cat":"grants","name":"An NMDA Glycine Site Antagonist for the Treatment of Major Depressive Disorder","institute":"NIMH","activity":"R21","org":"UNIVERSITY OF MARYLAND BALTIMORE","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29259,"lon":-76.61111,"gp":"institution","usd":422125,"fy0":2013,"fy1":2014,"active":0,"drugs":["ketamine"],"pis":["Todd D Gould","ROBERT SCHWARCZ"],"src":"https://reporter.nih.gov/project-details/8731972"},{"id":"grant-r21mh108901","eid":"nih:R21MH108901","cat":"grants","name":"NMDA RECEPTOR ANTAGONIST NITROUS OXIDE TARGETS AFFECTIVE BRAIN CIRCUITS","institute":"NIMH","activity":"R21","org":"WASHINGTON UNIVERSITY","city":"SAINT LOUIS","region":"Missouri","cc":"US","country":"United States","lat":38.61772,"lon":-90.20904,"gp":"institution","usd":419375,"fy0":2016,"fy1":2017,"active":0,"drugs":["ketamine"],"pis":["CHARLES Richard CONWAY","Peter Nagele"],"src":"https://reporter.nih.gov/project-details/9319812"},{"id":"grant-r21mh113899","eid":"nih:R21MH113899","cat":"grants","name":"Novel mechanisms contributing to the antidepressant-like response of pharmacological hippocampal activation","institute":"NIMH","activity":"R21","org":"UNIVERSITY OF TEXAS HLTH SCIENCE CENTER","city":"SAN ANTONIO","region":"Texas","cc":"US","country":"United States","usd":419375,"fy0":2018,"fy1":2019,"active":0,"drugs":["ketamine"],"pis":["Flavia Carreno"],"src":"https://reporter.nih.gov/project-details/9659381"},{"id":"grant-r21ca197023","eid":"nih:R21CA197023","cat":"grants","name":"Prevention of Depression in Head and Neck Cancer","institute":"NCI","activity":"R21","org":"CEDARS-SINAI MEDICAL CENTER","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.05934,"lon":-118.25013,"gp":"institution","usd":418688,"fy0":2016,"fy1":2017,"active":0,"drugs":["ketamine"],"pis":["SCOTT A IRWIN"],"src":"https://reporter.nih.gov/project-details/9324169"},{"id":"grant-r21da020149","eid":"nih:R21DA020149","cat":"grants","name":"Genetic Factors in Human MDMA Toxicity:  A PET Study","institute":"NIDA","activity":"R21","org":"VANDERBILT UNIVERSITY","city":"Nashville","region":"Tennessee","cc":"US","country":"United States","lat":36.17441,"lon":-86.78496,"gp":"institution","usd":418228,"fy0":2007,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["RONALD L COWAN"],"src":"https://reporter.nih.gov/project-details/7436353"},{"id":"grant-r21mh109818","eid":"nih:R21MH109818","cat":"grants","name":"Endogenous Opioid Modulation by Ketamine","institute":"NIMH","activity":"R21","org":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","city":"SALT LAKE CITY","region":"Utah","cc":"US","country":"United States","usd":416208,"fy0":2016,"fy1":2017,"active":0,"drugs":["ketamine"],"pis":["Brian James Mickey"],"src":"https://reporter.nih.gov/project-details/9344696"},{"id":"grant-r01da006863","eid":"nih:R01DA006863","cat":"grants","name":"NEUROENDOCRINE REFLECTIONS OF MDMA NEUROTOXICITY","institute":"NIDA","activity":"R01","org":"LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER","city":"TORRANCE","region":"California","cc":"US","country":"United States","usd":411892,"fy0":1990,"fy1":1992,"active":0,"drugs":["MDMA"],"pis":["RUSSELL Elliott POLAND"],"src":"https://reporter.nih.gov/project-details/2119134"},{"id":"grant-r21mh128574","eid":"nih:R21MH128574","cat":"grants","name":"Novel mechanisms mediating the rapid antidepressant actions of glyoxylase 1 inhibitors","institute":"NIMH","activity":"R21","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.70964,"lon":-117.17437,"gp":"institution","usd":407725,"fy0":2022,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["STEPHANIE C DULAWA"],"src":"https://reporter.nih.gov/project-details/10557209"},{"id":"grant-r01da019623","eid":"nih:R01DA019623","cat":"grants","name":"MDMA and Other Hallucinogen Use: Onset and Abuse/Dependence","institute":"NIDA","activity":"R01","org":"DUKE UNIVERSITY","city":"DURHAM","region":"North Carolina","cc":"US","country":"United States","lat":35.99699,"lon":-78.90949,"gp":"institution","usd":407410,"fy0":2007,"fy1":2009,"active":0,"drugs":["MDMA"],"pis":["Li-Tzy Wu"],"src":"https://reporter.nih.gov/project-details/7620999"},{"id":"grant-r03da025910","eid":"nih:R03DA025910","cat":"grants","name":"Synthesis and Evaluation of Aporphines as MDMA Antagonists.","institute":"NIDA","activity":"R03","org":"HUNTER COLLEGE","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.72373,"lon":-74.01195,"gp":"institution","usd":406791,"fy0":2009,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["Wayne Wesley Harding"],"src":"https://reporter.nih.gov/project-details/7894966"},{"id":"grant-r21eb031454","eid":"nih:R21EB031454","cat":"grants","name":"Biodegradable microfuses to enable the safe and compliant long-term interval dosing of 5HT2A agonists","institute":"NIBIB","activity":"R21","org":"UNIVERSITY OF MISSISSIPPI","city":"UNIVERSITY","region":"Mississippi","cc":"US","country":"United States","lat":34.37314,"lon":-89.51299,"gp":"institution","usd":401500,"fy0":2021,"fy1":2022,"active":0,"drugs":["psilocybin","LSD","ketamine"],"pis":["Glenn Madison Walker","Thomas A Werfel"],"src":"https://reporter.nih.gov/project-details/10494241"},{"id":"grant-r21da041857","eid":"nih:R21DA041857","cat":"grants","name":"Neural circuit impacts of hallucinogens","institute":"NIDA","activity":"R21","org":"BAYLOR COLLEGE OF MEDICINE","city":"HOUSTON","region":"Texas","cc":"US","country":"United States","lat":29.75344,"lon":-95.36765,"gp":"institution","usd":396250,"fy0":2017,"fy1":2018,"active":0,"drugs":["LSD"],"pis":["Daoyun Ji"],"src":"https://reporter.nih.gov/project-details/9432488"},{"id":"grant-r21at003409","eid":"nih:R21AT003409","cat":"grants","name":"Standardization of Banisteriopsis caapi for Chemical and Biological Markers","institute":"NCCIH","activity":"R21","org":"UNIVERSITY OF MISSISSIPPI","city":"UNIVERSITY","region":"Mississippi","cc":"US","country":"United States","lat":34.37097,"lon":-89.52541,"gp":"institution","usd":391680,"fy0":2007,"fy1":2008,"active":0,"drugs":["DMT"],"pis":["MUHAMMAD ILIAS"],"src":"https://reporter.nih.gov/project-details/7469560"},{"id":"grant-r01mh061019","eid":"nih:R01MH061019","cat":"grants","name":"GLYCINE-KETAMINE INTERACTIONS IN HEALTHY SUBJECTS","institute":"NIMH","activity":"R01","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.29916,"lon":-72.91823,"gp":"institution","usd":386074,"fy0":2000,"fy1":2002,"active":0,"drugs":["ketamine"],"pis":["DEEPAK Cyril D'SOUZA"],"src":"https://reporter.nih.gov/project-details/6539047"},{"id":"grant-r01gm052213","eid":"nih:R01GM052213","cat":"grants","name":"STRUCTURAL DOMAINS AND SEROTONIN RECEPTOR PHARMACOLOGY","institute":"NIGMS","activity":"R01","org":"CASE WESTERN RESERVE UNIVERSITY","city":"CLEVELAND","region":"Ohio","cc":"US","country":"United States","lat":41.50557,"lon":-81.70741,"gp":"institution","usd":385756,"fy0":1994,"fy1":1995,"active":0,"drugs":["LSD"],"pis":["Bryan L. Roth"],"src":"https://reporter.nih.gov/project-details/2191153"},{"id":"grant-r56ns109608","eid":"nih:R56NS109608","cat":"grants","name":"Mechanisms of low-dose ketamine treatment for Parkinson's disease","institute":"NINDS","activity":"R56","org":"UNIVERSITY OF ARIZONA","city":"TUCSON","region":"Arizona","cc":"US","country":"United States","lat":32.22546,"lon":-110.919,"gp":"institution","usd":385139,"fy0":2019,"fy1":2019,"active":0,"drugs":["ketamine"],"pis":["TORSTEN FALK"],"src":"https://reporter.nih.gov/project-details/9938976"},{"id":"grant-r21da023711","eid":"nih:R21DA023711","cat":"grants","name":"Neurochemistry and Neurophysiology of MDMA (ecstasy)","institute":"NIDA","activity":"R21","org":"DREXEL UNIVERSITY","city":"PHILADELPHIA","region":"Pennsylvania","cc":"US","country":"United States","lat":39.9561,"lon":-75.16997,"gp":"institution","usd":371250,"fy0":2007,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["BARRY Dale WATERHOUSE"],"src":"https://reporter.nih.gov/project-details/7486843"},{"id":"grant-k23mh106746","eid":"nih:K23MH106746","cat":"grants","name":"Multimodal MR Imaging of the Glutamate System in Schizophrenia","institute":"NIMH","activity":"K23","org":"NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.79223,"lon":-73.96649,"gp":"institution","usd":369702,"fy0":2015,"fy1":2016,"active":0,"drugs":["ketamine"],"pis":["Ragy Ramsis Girgis"],"src":"https://reporter.nih.gov/project-details/9149329"},{"id":"grant-r21da023684","eid":"nih:R21DA023684","cat":"grants","name":"Mechanisms of MDMA-induced hyperthermia","institute":"NIDA","activity":"R21","org":"UNIVERSITY OF TEXAS AT AUSTIN","city":"AUSTIN","region":"Texas","cc":"US","country":"United States","lat":30.27473,"lon":-97.74753,"gp":"institution","usd":367340,"fy0":2008,"fy1":2009,"active":0,"drugs":["MDMA"],"pis":["Edward M Mills"],"src":"https://reporter.nih.gov/project-details/7568812"},{"id":"grant-r01da008096","eid":"nih:R01DA008096","cat":"grants","name":"TRYPTAMINE HALLUCINOGENS--NEUROPSYCHOPHARMACOLOGY","institute":"NIDA","activity":"R01","org":"UNIVERSITY OF NEW MEXICO","city":"ALBUQUERQUE","region":"New Mexico","cc":"US","country":"United States","lat":35.09075,"lon":-106.64648,"gp":"institution","usd":366680,"fy0":1993,"fy1":1995,"active":0,"drugs":["psilocybin","DMT"],"pis":["NANCY MORRISON"],"src":"https://reporter.nih.gov/project-details/2120576"},{"id":"grant-r21da029826","eid":"nih:R21DA029826","cat":"grants","name":"Characterization of the Response to the Kappa Opiate Agonist Salvinorin A in Heal","institute":"NIDA","activity":"R21","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.29624,"lon":-72.93009,"gp":"institution","usd":359975,"fy0":2011,"fy1":2012,"active":0,"pis":["MOHINI RANGANATHAN"],"src":"https://reporter.nih.gov/project-details/8333331"},{"id":"grant-r21mh125199","eid":"nih:R21MH125199","cat":"grants","name":"Combined EEG and in silico modeling to investigate the mechanisms of ketamine's sustained antidepressant effect in patients","institute":"NIMH","activity":"R21","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31657,"lon":-72.92585,"gp":"institution","usd":359975,"fy0":2021,"fy1":2022,"active":0,"drugs":["ketamine"],"pis":["PATRICK David SKOSNIK","Mohamed Sherif"],"src":"https://reporter.nih.gov/project-details/10376804"},{"id":"grant-r56mh107190","eid":"nih:R56MH107190","cat":"grants","name":"Interactions of 17beta estradiol and ketamine on depression-like behavior, hippocampal synaptic function, and cognition in ovariectomized rats","institute":"NIMH","activity":"R56","org":"UNIVERSITY OF ALABAMA AT BIRMINGHAM","city":"BIRMINGHAM","region":"Alabama","cc":"US","country":"United States","lat":33.52993,"lon":-86.80997,"gp":"institution","usd":345825,"fy0":2016,"fy1":2016,"active":0,"drugs":["ketamine"],"pis":["LORI Lynn MCMAHON"],"src":"https://reporter.nih.gov/project-details/9055092"},{"id":"grant-r21da018161","eid":"nih:R21DA018161","cat":"grants","name":"Maternal MDMA (Ecstasy) Exposure and Fetal Physiology","institute":"NIDA","activity":"R21","org":"DUKE UNIVERSITY","city":"DURHAM","region":"North Carolina","cc":"US","country":"United States","lat":35.99577,"lon":-78.91053,"gp":"institution","usd":341975,"fy0":2005,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["JAMES D REYNOLDS"],"src":"https://reporter.nih.gov/project-details/7019150"},{"id":"grant-r01da007193","eid":"nih:R01DA007193","cat":"grants","name":"HALLUCINOGENS AND SEROTONERGIC RECEPTORS","institute":"NIDA","activity":"R01","org":"STATE UNIVERSITY NEW YORK STONY BROOK","city":"STONY BROOK","region":"New York","cc":"US","country":"United States","usd":331035,"fy0":1992,"fy1":1993,"active":0,"drugs":["LSD","mescaline"],"pis":["REX Y WANG"],"src":"https://reporter.nih.gov/project-details/3213855"},{"id":"grant-r43aa031342","eid":"nih:R43AA031342","cat":"grants","name":"Development of an AI-assisted therapeutic discovery platform for Alcohol Use Disorders using an invertebrate model","institute":"NIAAA","activity":"R43","org":"NEMALIFE INC.","city":"LUBBOCK","region":"Texas","cc":"US","country":"United States","usd":322070,"fy0":2024,"fy1":2024,"active":0,"drugs":["ibogaine"],"pis":["Mohammed Adnan Mohammed Hanif Qureshi"],"src":"https://reporter.nih.gov/project-details/10920501"},{"id":"grant-r43da059054","eid":"nih:R43DA059054","cat":"grants","name":"Determination of Route of Administration and Cardiac Safety of a Novel Psychoplastogen for the treatment of SUDs","institute":"NIDA","activity":"R43","org":"DELIX THERAPEUTICS","city":"PALO ALTO","region":"California","cc":"US","country":"United States","usd":319313,"fy0":2023,"fy1":2023,"active":0,"drugs":["DMT","ibogaine"],"pis":["Stephanie M McTighe"],"src":"https://reporter.nih.gov/project-details/10744481"},{"id":"grant-r43da056089","eid":"nih:R43DA056089","cat":"grants","name":"AI-assisted behavioral profiling of an invertebrate model to identify new psychedelic therapeutics for stimulant use disorders","institute":"NIDA","activity":"R43","org":"NEMALIFE INC.","city":"LUBBOCK","region":"Texas","cc":"US","country":"United States","usd":318373,"fy0":2022,"fy1":2022,"active":0,"pis":["Dhaval Subhas Patel"],"src":"https://reporter.nih.gov/project-details/10467072"},{"id":"grant-k02da000206","eid":"nih:K02DA000206","cat":"grants","name":"MDMA NEUROTOXICITY: PRECLINICAL AND CLINICAL EVALUATION","institute":"NIDA","activity":"K02","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29127,"lon":-76.6048,"gp":"institution","usd":306970,"fy0":1996,"fy1":1998,"active":0,"drugs":["MDMA"],"pis":["GEORGE A RICAURTE"],"src":"https://reporter.nih.gov/project-details/2668100"},{"id":"grant-p51rr000165","eid":"nih:P51RR000165","cat":"grants","name":"PET IMAGING & COCAINE NEUROPHARMACOLOGY IN MONKEYS","institute":"NCRR","activity":"P51","org":"EMORY UNIVERSITY","city":"ATLANTA","region":"Georgia","cc":"US","country":"United States","lat":33.75855,"lon":-84.38304,"gp":"institution","usd":305615,"fy0":2006,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["LEONARD L HOWELL"],"src":"https://reporter.nih.gov/project-details/8172304"},{"id":"grant-r01da004408","eid":"nih:R01DA004408","cat":"grants","name":"EXPLORING ECTASY: A DESCRIPTIVE STUDY OF MDMA USERS","institute":"NIDA","activity":"R01","org":"SCIENTIFIC ANALYSIS CORPORATION","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","usd":299931,"fy0":1987,"fy1":1988,"active":0,"drugs":["MDMA"],"pis":["MARSHA ROSENBAUM"],"src":"https://reporter.nih.gov/project-details/3210011"},{"id":"grant-r15da029863","eid":"nih:R15DA029863","cat":"grants","name":"Mechanisms of sudden onset of malignant MDMA neurotoxicity","institute":"NIDA","activity":"R15","org":"FLORIDA ATLANTIC UNIVERSITY","city":"BOCA RATON","region":"Florida","cc":"US","country":"United States","lat":26.34688,"lon":-80.08108,"gp":"institution","usd":287775,"fy0":2010,"fy1":2010,"active":0,"drugs":["MDMA"],"pis":["RUI TAO"],"src":"https://reporter.nih.gov/project-details/7980976"},{"id":"grant-r56da003385","eid":"nih:R56DA003385","cat":"grants","name":"Behavioral and Pharmacological Analysis of Drugs of Abuse","institute":"NIDA","activity":"R56","org":"STATE UNIVERSITY OF NEW YORK AT BUFFALO","city":"AMHERST","region":"New York","cc":"US","country":"United States","usd":287550,"fy0":2008,"fy1":2008,"active":0,"drugs":["psilocybin","MDMA","LSD","DMT","mescaline"],"pis":["JERROLD Clyne WINTER"],"src":"https://reporter.nih.gov/project-details/7640034"},{"id":"grant-r29da007239","eid":"nih:R29DA007239","cat":"grants","name":"MDMA-INDUCED NEUROTOXICITY--ROLE OF GLUTAMATE & CALCIUM","institute":"NIDA","activity":"R29","org":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","city":"SALT LAKE CITY","region":"Utah","cc":"US","country":"United States","usd":273685,"fy0":1991,"fy1":1994,"active":0,"drugs":["MDMA"],"pis":["KEVIN T FINNEGAN"],"src":"https://reporter.nih.gov/project-details/2119560"},{"id":"grant-r03da042336","eid":"nih:R03DA042336","cat":"grants","name":"Measurement of persisting changes in emotional brain functioning produced by psilocybin","institute":"NIDA","activity":"R03","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.28657,"lon":-76.60311,"gp":"institution","usd":259832,"fy0":2016,"fy1":2016,"active":0,"drugs":["psilocybin","LSD"],"pis":["Frederick Streeter Barrett"],"src":"https://reporter.nih.gov/project-details/9166364"},{"id":"grant-r43da055419","eid":"nih:R43DA055419","cat":"grants","name":"New therapeutic approaches to identifying molecules for opioid abuse treatment","institute":"NIDA","activity":"R43","org":"COLLABORATIONS PHARMACEUTICALS, INC.","city":"FUQUAY VARINA","region":"North Carolina","cc":"US","country":"United States","usd":256220,"fy0":2022,"fy1":2022,"active":0,"pis":["SEAN EKINS"],"src":"https://reporter.nih.gov/project-details/10385998"},{"id":"grant-r03da029679","eid":"nih:R03DA029679","cat":"grants","name":"Effects of MDMA (\"ecstasy\") and THC on Social Processing","institute":"NIDA","activity":"R03","org":"NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.78997,"lon":-73.97345,"gp":"institution","usd":246911,"fy0":2011,"fy1":2011,"active":0,"drugs":["MDMA"],"pis":["Gillinder I. Bedi"],"src":"https://reporter.nih.gov/project-details/8113013"},{"id":"grant-k02da000060","eid":"nih:K02DA000060","cat":"grants","name":"MOLECULAR DETERMINANTS FOR THE ACTION OF HALLUCINOGENS","institute":"NIDA","activity":"K02","org":"MOUNT SINAI SCHOOL OF MEDICINE OF CUNY","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":245916,"fy0":1985,"fy1":1988,"active":0,"drugs":["psilocybin","LSD","mescaline"],"pis":["HAREL WEINSTEIN"],"src":"https://reporter.nih.gov/project-details/3069394"},{"id":"grant-z01mh002828","eid":"nih:Z01MH002828","cat":"grants","name":"Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression","institute":"NIMH","activity":"Z01","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":232920,"fy0":2008,"fy1":2008,"active":0,"drugs":["ketamine"],"pis":["Carlos Zarate"],"src":"https://reporter.nih.gov/project-details/7735168"},{"id":"grant-r56da002189","eid":"nih:R56DA002189","cat":"grants","name":"Stereochemical Aspects of Hallucinogenesis","institute":"NIDA","activity":"R56","org":"PURDUE UNIVERSITY","city":"WEST LAFAYETTE","region":"Indiana","cc":"US","country":"United States","usd":227092,"fy0":2008,"fy1":2008,"active":0,"drugs":["LSD"],"pis":["DAVID E NICHOLS"],"src":"https://reporter.nih.gov/project-details/7668888"},{"id":"grant-k23mh107776","eid":"nih:K23MH107776","cat":"grants","name":"Psychophysiological and Cognitive Biomarkers of Ketamine's Antidepressant Effects","institute":"NIMH","activity":"K23","org":"MASSACHUSETTS GENERAL HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.35697,"lon":-71.05878,"gp":"institution","usd":216017,"fy0":2016,"fy1":2017,"active":0,"drugs":["ketamine"],"pis":["Dawn F. Ionescu"],"src":"https://reporter.nih.gov/project-details/9232219"},{"id":"grant-z01da000523","eid":"nih:Z01DA000523","cat":"grants","name":"Studies on MDMA and Related Compounds","institute":"NIDA","activity":"Z01","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.97516,"lon":-77.08939,"gp":"institution","usd":199196,"fy0":2008,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["Richard Rothman"],"src":"https://reporter.nih.gov/project-details/7733852"},{"id":"grant-m01rr000425","eid":"nih:M01RR000425","cat":"grants","name":"EFFECTS OF PSILOCYBIN IN TERMINAL CANCER PATIENTS WITH ANXIETY","institute":"NCRR","activity":"M01","org":"LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER","city":"TORRANCE","region":"California","cc":"US","country":"United States","usd":198082,"fy0":1995,"fy1":2009,"active":0,"drugs":["psilocybin"],"pis":["CHARLES GROB"],"src":"https://reporter.nih.gov/project-details/7952224"},{"id":"grant-f32mh111193","eid":"nih:F32MH111193","cat":"grants","name":"Structural and Functional Connectivity and Ketamine Therapy for Major Depression","institute":"NIMH","activity":"F32","org":"UNIVERSITY OF CALIFORNIA LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.05312,"lon":-118.24796,"gp":"institution","usd":189930,"fy0":2017,"fy1":2019,"active":0,"drugs":["ketamine"],"pis":["Megha M Vasavada"],"src":"https://reporter.nih.gov/project-details/9699009"},{"id":"grant-z01mh002853","eid":"nih:Z01MH002853","cat":"grants","name":"A pharmacologic strategy to bring about rapid (next day) antidepressants effects","institute":"NIMH","activity":"Z01","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":186336,"fy0":2008,"fy1":2008,"active":0,"drugs":["ketamine"],"pis":["Carlos Zarate"],"src":"https://reporter.nih.gov/project-details/7735185"},{"id":"grant-r03da040855","eid":"nih:R03DA040855","cat":"grants","name":"Automated Speech Analysis: A Marker of Drug Intoxication & Treatment Outcome","institute":"NIDA","activity":"R03","org":"NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.7879,"lon":-73.96969,"gp":"institution","usd":162000,"fy0":2016,"fy1":2017,"active":0,"drugs":["MDMA","LSD"],"pis":["Richard W Foltin"],"src":"https://reporter.nih.gov/project-details/9232130"},{"id":"grant-f32da025412","eid":"nih:F32DA025412","cat":"grants","name":"Mechanisms of hallucinogen effects on exploratory behavior in rats and mice","institute":"NIDA","activity":"F32","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.70587,"lon":-117.16947,"gp":"institution","usd":156942,"fy0":2009,"fy1":2011,"active":0,"drugs":["LSD","DMT"],"pis":["ADAM L. Halberstadt"],"src":"https://reporter.nih.gov/project-details/8063888"},{"id":"grant-r03da015556","eid":"nih:R03DA015556","cat":"grants","name":"Neuropsychiatric Impairments in Adolescent MDMA Abusers","institute":"NIDA","activity":"R03","org":"UNIVERSITY OF MICHIGAN AT ANN ARBOR","city":"ANN ARBOR","region":"Michigan","cc":"US","country":"United States","usd":153910,"fy0":2002,"fy1":2003,"active":0,"drugs":["MDMA"],"pis":["MATTHEW O HOWARD"],"src":"https://reporter.nih.gov/project-details/6997583"},{"id":"grant-k23mh091176","eid":"nih:K23MH091176","cat":"grants","name":"Improving Psychiatric Interventions at the End of Life","institute":"NIMH","activity":"K23","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.71322,"lon":-117.15564,"gp":"institution","usd":152996,"fy0":2012,"fy1":2012,"active":0,"drugs":["ketamine"],"pis":["SCOTT A IRWIN"],"src":"https://reporter.nih.gov/project-details/8725384"},{"id":"grant-r03da013893","eid":"nih:R03DA013893","cat":"grants","name":"HIV RISK AND KETAMINE INJECTION AMONG HIGH RISK YOUTH","institute":"NIDA","activity":"R03","org":"COLUMBIA UNIVERSITY HEALTH SCIENCES","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":151354,"fy0":2000,"fy1":2001,"active":0,"drugs":["MDMA","ketamine"],"pis":["Stephen E Lankenau"],"src":"https://reporter.nih.gov/project-details/6379137"},{"id":"grant-r03da006870","eid":"nih:R03DA006870","cat":"grants","name":"MODE OF ACTION OF MDMA","institute":"NIDA","activity":"R03","org":"STATE UNIVERSITY NEW YORK STONY BROOK","city":"STONY BROOK","region":"New York","cc":"US","country":"United States","usd":150490,"fy0":1991,"fy1":1992,"active":0,"drugs":["MDMA"],"pis":["CHARLES R ASHBY"],"src":"https://reporter.nih.gov/project-details/2119142"},{"id":"grant-r03da025839","eid":"nih:R03DA025839","cat":"grants","name":"Neurobehavioral Effects of Combined MDMA (Ecstasy) and THC Exposure During Adoles","institute":"NIDA","activity":"R03","org":"UNIVERSITY OF MASSACHUSETTS AMHERST","city":"HADLEY","region":"Massachusetts","cc":"US","country":"United States","lat":42.36648,"lon":-72.52429,"gp":"institution","usd":148722,"fy0":2008,"fy1":2009,"active":0,"drugs":["MDMA"],"pis":["JERROLD S MEYER"],"src":"https://reporter.nih.gov/project-details/7691344"},{"id":"grant-r03aa022479","eid":"nih:R03AA022479","cat":"grants","name":"Novel Interventions in Alcohol Induced Depression","institute":"NIAAA","activity":"R03","org":"HOWARD UNIVERSITY","city":"WASHINGTON","region":"District of Columbia","cc":"US","country":"United States","lat":38.89732,"lon":-77.03124,"gp":"institution","usd":148652,"fy0":2014,"fy1":2015,"active":0,"drugs":["ketamine"],"pis":["YOUSEF TIZABI"],"src":"https://reporter.nih.gov/project-details/8843766"},{"id":"grant-r03da006524","eid":"nih:R03DA006524","cat":"grants","name":"HUMAN PSYCHOPHARMACOLOGY & NEUROENDOCRINOLOGY OF DMT","institute":"NIDA","activity":"R03","org":"UNIVERSITY OF NEW MEXICO","city":"ALBUQUERQUE","region":"New Mexico","cc":"US","country":"United States","lat":35.09065,"lon":-106.64432,"gp":"institution","usd":147724,"fy0":1990,"fy1":1991,"active":0,"drugs":["DMT"],"pis":["RICK J STRASSMAN"],"src":"https://reporter.nih.gov/project-details/3424112"},{"id":"grant-f32da016501","eid":"nih:F32DA016501","cat":"grants","name":"MDMA interactions with 5-HT-GABA-DA","institute":"NIDA","activity":"F32","org":"BOSTON UNIVERSITY MEDICAL CAMPUS","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","usd":146896,"fy0":2003,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["MICHAEL Glen BANKSON"],"src":"https://reporter.nih.gov/project-details/6913384"},{"id":"grant-r01da004181","eid":"nih:R01DA004181","cat":"grants","name":"BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF MDMA","institute":"NIDA","activity":"R01","org":"NORTHEAST OHIO MEDICAL UNIVERSITY","city":"ROOTSTOWN","region":"Ohio","cc":"US","country":"United States","lat":41.16805,"lon":-81.2452,"gp":"institution","usd":143437,"fy0":1986,"fy1":1988,"active":0,"drugs":["MDMA","mescaline"],"pis":["MARTIN D SCHECHTER"],"src":"https://reporter.nih.gov/project-details/3209450"},{"id":"grant-r03da027076","eid":"nih:R03DA027076","cat":"grants","name":"Psychopharmacology of plants and their metabolites used as marijuana substitutes","institute":"NIDA","activity":"R03","org":"UNIVERSITY OF MISSISSIPPI","city":"UNIVERSITY","region":"Mississippi","cc":"US","country":"United States","lat":34.35864,"lon":-89.51205,"gp":"institution","usd":143000,"fy0":2011,"fy1":2012,"active":0,"pis":["JORDAN K ZJAWIONY"],"src":"https://reporter.nih.gov/project-details/8279212"},{"id":"grant-f31da059250","eid":"nih:F31DA059250","cat":"grants","name":"Neural Signatures and Cognitive Performance During Rat Morphine Withdrawal, and Subsequent Impact of Psilocybin","institute":"NIDA","activity":"F31","org":"UNIVERSITY OF WASHINGTON","city":"SEATTLE","region":"Washington","cc":"US","country":"United States","lat":47.61294,"lon":-122.33409,"gp":"institution","usd":141512,"fy0":2023,"fy1":2025,"active":0,"drugs":["psilocybin"],"pis":["Victoria Ivanova Hones"],"src":"https://reporter.nih.gov/project-details/11136467"},{"id":"grant-f30da059437","eid":"nih:F30DA059437","cat":"grants","name":"Subcortical targets involved in the action of psilocybin in learned and innate escape behaviors","institute":"NIDA","activity":"F30","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31008,"lon":-72.91832,"gp":"institution","usd":141124,"fy0":2023,"fy1":2025,"active":0,"drugs":["psilocybin"],"pis":["Pasha A Davoudian"],"src":"https://reporter.nih.gov/project-details/11051207"},{"id":"grant-r03da045714","eid":"nih:R03DA045714","cat":"grants","name":"Social Contact and MDMA Use","institute":"NIDA","activity":"R03","org":"DAVIDSON COLLEGE","city":"DAVIDSON","region":"North Carolina","cc":"US","country":"United States","lat":35.49118,"lon":-80.8371,"gp":"institution","usd":136406,"fy0":2018,"fy1":2019,"active":0,"drugs":["MDMA"],"pis":["Mark A Smith"],"src":"https://reporter.nih.gov/project-details/9657746"},{"id":"grant-f32da015165","eid":"nih:F32DA015165","cat":"grants","name":"LSD and Serotonin Receptor Function","institute":"NIDA","activity":"F32","org":"VANDERBILT UNIVERSITY","city":"NASHVILLE","region":"Tennessee","cc":"US","country":"United States","lat":36.16584,"lon":-86.7923,"gp":"institution","usd":136252,"fy0":2001,"fy1":2003,"active":0,"drugs":["LSD"],"pis":["PAUL J GRESCH"],"src":"https://reporter.nih.gov/project-details/6653982"},{"id":"grant-f32da005993","eid":"nih:F32DA005993","cat":"grants","name":"LYSERGIC ACID DIETHYLAMIDE INDUCED GENE EXPRESSION","institute":"NIDA","activity":"F32","org":"VANDERBILT UNIVERSITY","city":"NASHVILLE","region":"Tennessee","cc":"US","country":"United States","lat":36.17375,"lon":-86.79013,"gp":"institution","usd":131256,"fy0":1999,"fy1":2002,"active":0,"drugs":["LSD"],"pis":["CHARLES D NICHOLS"],"src":"https://reporter.nih.gov/project-details/6515413"},{"id":"grant-f32da019748","eid":"nih:F32DA019748","cat":"grants","name":"Total Synthesis of Salvinorin A and Analogues","institute":"NIDA","activity":"F32","org":"HARVARD UNIVERSITY","city":"CAMBRIDGE","region":"Massachusetts","cc":"US","country":"United States","lat":42.36489,"lon":-71.10321,"gp":"institution","usd":126855,"fy0":2005,"fy1":2007,"active":0,"pis":["JOSEPH E PERO"],"src":"https://reporter.nih.gov/project-details/7291505"},{"id":"grant-r03da007316","eid":"nih:R03DA007316","cat":"grants","name":"5 HYDROXTRYPTAMINE MECHANISMS OF HALLUCINOGENIC DRUGS","institute":"NIDA","activity":"R03","org":"UNIVERSITY OF NEW ENGLAND","city":"BIDDEFORD","region":"Maine","cc":"US","country":"United States","usd":126396,"fy0":1991,"fy1":1992,"active":0,"drugs":["MDMA","LSD","DMT"],"pis":["DAVID James MOKLER"],"src":"https://reporter.nih.gov/project-details/3424214"},{"id":"grant-r03mh064903","eid":"nih:R03MH064903","cat":"grants","name":"Neurocognitive Consequences of MDMA Use in HIV","institute":"NIMH","activity":"R03","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.72507,"lon":-117.16477,"gp":"institution","usd":123067,"fy0":2002,"fy1":2003,"active":0,"drugs":["MDMA"],"pis":["MARIANA CHERNER"],"src":"https://reporter.nih.gov/project-details/6627805"},{"id":"grant-f32da006057","eid":"nih:F32DA006057","cat":"grants","name":"5-HT 2A & 5-HT 2C RECEPTORS IN LSD-INDUCED BEHAVIOR","institute":"NIDA","activity":"F32","org":"UNIVERSITY OF TEXAS MED BR GALVESTON","city":"GALVESTON","region":"Texas","cc":"US","country":"United States","usd":118804,"fy0":2000,"fy1":2002,"active":0,"drugs":["LSD"],"pis":["PAUL S FRANKEL"],"src":"https://reporter.nih.gov/project-details/6592785"},{"id":"grant-f30mh129085","eid":"nih:F30MH129085","cat":"grants","name":"Leveraging Rapid-Acting Antidepressants for Personalized Response","institute":"NIMH","activity":"F30","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31243,"lon":-72.92115,"gp":"institution","usd":114543,"fy0":2021,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["Neil Savalia"],"src":"https://reporter.nih.gov/project-details/10687872"},{"id":"grant-f31da059435","eid":"nih:F31DA059435","cat":"grants","name":"Epitranscriptomic mechanisms of the antidepressant response to ketamine in human neurons","institute":"NIDA","activity":"F31","org":"EMORY UNIVERSITY","city":"ATLANTA","region":"Georgia","cc":"US","country":"United States","lat":33.74227,"lon":-84.39829,"gp":"institution","usd":113680,"fy0":2023,"fy1":2025,"active":0,"drugs":["ketamine"],"pis":["BENJAMIN SICILIANO"],"src":"https://reporter.nih.gov/project-details/11023077"},{"id":"grant-r43mh063529","eid":"nih:R43MH063529","cat":"grants","name":"Indole Analogs as Novel Treatments for OCD","institute":"NIMH","activity":"R43","org":"ORGANIX, INC.","city":"WOBURN","region":"Massachusetts","cc":"US","country":"United States","usd":109197,"fy0":2002,"fy1":2002,"active":0,"drugs":["psilocybin"],"pis":["HOWARD P SARD"],"src":"https://reporter.nih.gov/project-details/6443024"},{"id":"grant-m01rr000071","eid":"nih:M01RR000071","cat":"grants","name":"CONTINUOUS INTRAVENOUS KETAMINE IN MAJOR DEPRESSIVE DISORDER","institute":"NCRR","activity":"M01","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.70858,"lon":-73.99453,"gp":"institution","usd":106987,"fy0":2007,"fy1":2009,"active":0,"drugs":["ketamine"],"pis":["Dennis S. Charney"],"src":"https://reporter.nih.gov/project-details/7953711"},{"id":"grant-27120110000","eid":"nih:27120110000","cat":"grants","name":"RAPIDLY-ACTING TREATMENTS FOR TREATMENT-RESISTANT DEPRESSION (RAPID)","institute":"NIMH","activity":"N01","org":"MASSACHUSETTS GENERAL HOSPITAL","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","lat":42.35208,"lon":-71.05831,"gp":"institution","usd":103150,"fy0":2011,"fy1":2011,"active":0,"drugs":["ketamine"],"pis":["MAURIZIO FAVA"],"src":"https://reporter.nih.gov/project-details/8340433"},{"id":"grant-f32da005950","eid":"nih:F32DA005950","cat":"grants","name":"PERIADOLESCENT MDMA--LONG TERM NEUROBEHAVIORAL EFFECTS","institute":"NIDA","activity":"F32","org":"SCRIPPS RESEARCH INSTITUTE, THE","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.72291,"lon":-117.1626,"gp":"institution","usd":102868,"fy0":1999,"fy1":2001,"active":0,"drugs":["MDMA"],"pis":["KYLE J. FRANTZ"],"src":"https://reporter.nih.gov/project-details/6378446"},{"id":"grant-f30mh124269","eid":"nih:F30MH124269","cat":"grants","name":"Neurogenesis, BMP signaling, and mechanisms of Ketamine's antidepressant effects","institute":"NIMH","activity":"F30","org":"NORTHWESTERN UNIVERSITY","city":"CHICAGO","region":"Illinois","cc":"US","country":"United States","lat":42.0489,"lon":-87.68935,"gp":"institution","usd":102788,"fy0":2021,"fy1":2022,"active":0,"drugs":["ketamine"],"pis":["Radhika Rawat"],"src":"https://reporter.nih.gov/project-details/10326367"},{"id":"grant-f31da016486","eid":"nih:F31DA016486","cat":"grants","name":"MDMA Neurotoxicity and 5HT-Glutamate Interactions","institute":"NIDA","activity":"F31","org":"BOSTON UNIVERSITY MEDICAL CAMPUS","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","usd":102339,"fy0":2003,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["JOSEPH M BREIER"],"src":"https://reporter.nih.gov/project-details/6923968"},{"id":"grant-k99mh126098","eid":"nih:K99MH126098","cat":"grants","name":"Cortical GABAergic mechanisms underlying rapid and sustained antidepressant responses","institute":"NIMH","activity":"K99","org":"YALE UNIVERSITY","city":"NEW HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.31196,"lon":-72.92595,"gp":"institution","usd":101953,"fy0":2022,"fy1":2022,"active":0,"drugs":["ketamine"],"pis":["Manoela Fogaca"],"src":"https://reporter.nih.gov/project-details/10370708"},{"id":"grant-r15da017930","eid":"nih:R15DA017930","cat":"grants","name":"Ecstasy's neurotoxicity: role of hyperthermia","institute":"NIDA","activity":"R15","org":"OHIO NORTHERN UNIVERSITY","city":"ADA","region":"Ohio","cc":"US","country":"United States","lat":40.78046,"lon":-83.81899,"gp":"institution","usd":101213,"fy0":2004,"fy1":2004,"active":0,"drugs":["MDMA"],"pis":["JON Eric SPRAGUE"],"src":"https://reporter.nih.gov/project-details/6769058"},{"id":"grant-r41da017529","eid":"nih:R41DA017529","cat":"grants","name":"Norketamine for Treatment of Pain","institute":"NIDA","activity":"R41","org":"YAUPON THERAPEUTICS, INC.","city":"WAYNE","region":"Pennsylvania","cc":"US","country":"United States","usd":100000,"fy0":2003,"fy1":2003,"active":0,"drugs":["ketamine"],"pis":["JOSEPH R HOLTMAN"],"src":"https://reporter.nih.gov/project-details/6735218"},{"id":"grant-f32da005506","eid":"nih:F32DA005506","cat":"grants","name":"THEORETICAL METHODS FOR STUDIES OF HALLUCINOGEN ACTION","institute":"NIDA","activity":"F32","org":"MOUNT SINAI SCHOOL OF MEDICINE OF CUNY","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":97500,"fy0":1991,"fy1":1994,"active":0,"pis":["DAVID R GARMER"],"src":"https://reporter.nih.gov/project-details/2117761"},{"id":"grant-f31da020308","eid":"nih:F31DA020308","cat":"grants","name":"Mechanisms of hallucinogen specific neuronal response","institute":"NIDA","activity":"F31","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.71752,"lon":-74.00253,"gp":"institution","usd":96789,"fy0":2006,"fy1":2009,"active":0,"pis":["Rosalind L Ang"],"src":"https://reporter.nih.gov/project-details/7531807"},{"id":"grant-f31dc020671","eid":"nih:F31DC020671","cat":"grants","name":"The impact of hallucinogens on active sampling and the olfactory bulb","institute":"NIDCD","activity":"F31","org":"UNIVERSITY OF OREGON","city":"EUGENE","region":"Oregon","cc":"US","country":"United States","lat":44.05033,"lon":-123.09339,"gp":"institution","usd":94376,"fy0":2023,"fy1":2024,"active":0,"drugs":["psilocybin","LSD"],"pis":["Amanda Colette Welch"],"src":"https://reporter.nih.gov/project-details/10818381"},{"id":"grant-f99ns139512","eid":"nih:F99NS139512","cat":"grants","name":"Effects of Psychedelics on Brain Function and Neuroplasticity","institute":"NINDS","activity":"F99","org":"WASHINGTON UNIVERSITY","city":"SAINT LOUIS","region":"Missouri","cc":"US","country":"United States","lat":38.62289,"lon":-90.20264,"gp":"institution","usd":87712,"fy0":2024,"fy1":2025,"active":0,"drugs":["psilocybin","DMT"],"pis":["Jonah Padawer-Curry"],"src":"https://reporter.nih.gov/project-details/11127651"},{"id":"grant-r03da030900","eid":"nih:R03DA030900","cat":"grants","name":"Developing adult zebrafish-based models to study hallucinogenic drug action","institute":"NIDA","activity":"R03","org":"TULANE UNIVERSITY OF LOUISIANA","city":"NEW ORLEANS","region":"Louisiana","cc":"US","country":"United States","usd":86985,"fy0":2010,"fy1":2012,"active":0,"drugs":["psilocybin","MDMA","LSD","mescaline"],"pis":["Allan V Kalueff"],"src":"https://reporter.nih.gov/project-details/8471429"},{"id":"grant-f31mh132317","eid":"nih:F31MH132317","cat":"grants","name":"Structural studies of psychedelic activity at the serotonin receptor 5-HT1A","institute":"NIMH","activity":"F31","org":"ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","city":"NEW YORK","region":"New York","cc":"US","country":"United States","lat":40.71912,"lon":-74.01213,"gp":"institution","usd":85426,"fy0":2022,"fy1":2023,"active":0,"drugs":["DMT"],"pis":["Audrey Louise Warren"],"src":"https://reporter.nih.gov/project-details/10710525"},{"id":"grant-f31da016457","eid":"nih:F31DA016457","cat":"grants","name":"5-HT1A receptor and hallucinogens","institute":"NIDA","activity":"F31","org":"STATE UNIVERSITY OF NEW YORK AT BUFFALO","city":"BUFFALO","region":"New York","cc":"US","country":"United States","usd":85308,"fy0":2003,"fy1":2005,"active":0,"pis":["Chad J. Reissig"],"src":"https://reporter.nih.gov/project-details/6944792"},{"id":"grant-m01rr000997","eid":"nih:M01RR000997","cat":"grants","name":"SEROTONERGIC MEDIATION OF N,N-DIMETHYLTRYPTAMINE EFFECTS","institute":"NCRR","activity":"M01","org":"UNIVERSITY OF NEW MEXICO","city":"ALBUQUERQUE","region":"New Mexico","cc":"US","country":"United States","lat":35.08416,"lon":-106.65373,"gp":"institution","usd":83695,"fy0":1993,"fy1":1997,"active":0,"drugs":["DMT"],"src":"https://reporter.nih.gov/project-details/2481946"},{"id":"grant-f31da060045","eid":"nih:F31DA060045","cat":"grants","name":"Efficacy of psychedelic drugs at reversing aberrant reward-seeking behavior","institute":"NIDA","activity":"F31","org":"UNIVERSITY OF CALIFORNIA-IRVINE","city":"IRVINE","region":"California","cc":"US","country":"United States","lat":33.67534,"lon":-117.81356,"gp":"institution","usd":83067,"fy0":2024,"fy1":2025,"active":0,"drugs":["psilocybin"],"pis":["Kate A Lawson"],"src":"https://reporter.nih.gov/project-details/11035071"},{"id":"grant-r03da026905","eid":"nih:R03DA026905","cat":"grants","name":"Hallucinogen self-administration in baboons","institute":"NIDA","activity":"R03","org":"JOHNS HOPKINS UNIVERSITY","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29767,"lon":-76.61252,"gp":"institution","usd":82000,"fy0":2009,"fy1":2009,"active":0,"drugs":["psilocybin","LSD","mescaline"],"pis":["AMY K GOODWIN"],"src":"https://reporter.nih.gov/project-details/7706256"},{"id":"grant-f31mh105056","eid":"nih:F31MH105056","cat":"grants","name":"NMDA Receptor Subtype-Dependent Mechanisms of Action of Memantine and Ketamine","institute":"NIMH","activity":"F31","org":"UNIVERSITY OF PITTSBURGH AT PITTSBURGH","city":"PITTSBURGH","region":"Pennsylvania","cc":"US","country":"United States","usd":81976,"fy0":2014,"fy1":2015,"active":0,"drugs":["ketamine"],"pis":["Nathan G Glasgow"],"src":"https://reporter.nih.gov/project-details/8993873"},{"id":"grant-f31da015272","eid":"nih:F31DA015272","cat":"grants","name":"Role of 5-HT2A Receptors in MDMA induced Behavior","institute":"NIDA","activity":"F31","org":"UNIVERSITY OF TEXAS MED BR GALVESTON","city":"GALVESTON","region":"Texas","cc":"US","country":"United States","usd":81352,"fy0":2002,"fy1":2004,"active":0,"drugs":["MDMA"],"pis":["David Vance Herin"],"src":"https://reporter.nih.gov/project-details/6719032"},{"id":"grant-f31da015259","eid":"nih:F31DA015259","cat":"grants","name":"Role of 5HT2cR in Behavioral Effects of Chronic MDMA","institute":"NIDA","activity":"F31","org":"UNIVERSITY OF TEXAS MED BR GALVESTON","city":"GALVESTON","region":"Texas","cc":"US","country":"United States","usd":81352,"fy0":2002,"fy1":2004,"active":0,"drugs":["MDMA"],"pis":["Marcy Bubar Jordan"],"src":"https://reporter.nih.gov/project-details/6751683"},{"id":"grant-r01da001836","eid":"nih:R01DA001836","cat":"grants","name":"CENTRAL ACTIONS OF ABUSED DRUGS:  HALLUCINOGENS","institute":"NIDA","activity":"R01","org":"MICHIGAN STATE UNIVERSITY","city":"EAST LANSING","region":"Michigan","cc":"US","country":"United States","lat":42.72912,"lon":-84.48533,"gp":"institution","usd":77429,"fy0":1985,"fy1":1985,"active":0,"drugs":["LSD","DMT","mescaline"],"pis":["RICHARD H RECH"],"src":"https://reporter.nih.gov/project-details/3207005"},{"id":"grant-r01da003454","eid":"nih:R01DA003454","cat":"grants","name":"NEURAL BASIS FOR OPIATE AND MESCALINE TOXIC BEHAVIOR","institute":"NIDA","activity":"R01","org":"PENNSYLVANIA STATE UNIV HERSHEY MED CTR","city":"HERSHEY","region":"Pennsylvania","cc":"US","country":"United States","usd":75948,"fy0":1985,"fy1":1985,"active":0,"drugs":["mescaline"],"pis":["JOHN D CONNOR"],"src":"https://reporter.nih.gov/project-details/3207922"},{"id":"grant-f30da014238","eid":"nih:F30DA014238","cat":"grants","name":"Hallucinogens--Serotonergic Glutamatergic Interactions","institute":"NIDA","activity":"F30","org":"STATE UNIVERSITY OF NEW YORK AT BUFFALO","city":"BUFFALO","region":"New York","cc":"US","country":"United States","usd":75765,"fy0":2001,"fy1":2003,"active":0,"pis":["MEREDITH J REGINA"],"src":"https://reporter.nih.gov/project-details/6634375"},{"id":"grant-f30mh119763","eid":"nih:F30MH119763","cat":"grants","name":"Whole-Brain Oscillatory and Behavioral Responses to Noninvasive Local Ketamine Uncaging in the Medial Prefrontal Cortex","institute":"NIMH","activity":"F30","org":"STANFORD UNIVERSITY","city":"STANFORD","region":"California","cc":"US","country":"United States","lat":37.41983,"lon":-122.17375,"gp":"institution","usd":75424,"fy0":2020,"fy1":2021,"active":0,"drugs":["ketamine"],"pis":["Jeffrey Bond Wang"],"src":"https://reporter.nih.gov/project-details/10168468"},{"id":"grant-r43da009204","eid":"nih:R43DA009204","cat":"grants","name":"IBOGAINE ANALYSIS","institute":"NIDA","activity":"R43","org":"IONICS INTERNATIONAL, INC.","city":"HOUSTON","region":"Texas","cc":"US","country":"United States","usd":75000,"fy0":1994,"fy1":1994,"active":0,"drugs":["ibogaine"],"pis":["STEPHEN R MISSLER"],"src":"https://reporter.nih.gov/project-details/2122278"},{"id":"grant-r43da009206","eid":"nih:R43DA009206","cat":"grants","name":"IBOGAINE AND METABOLITES IN URINE AND PLASMA","institute":"NIDA","activity":"R43","org":"CEDRA CORPORATION","city":"AUSTIN","region":"Texas","cc":"US","country":"United States","usd":75000,"fy0":1994,"fy1":1994,"active":0,"drugs":["ibogaine"],"pis":["DAVID B GARCIA"],"src":"https://reporter.nih.gov/project-details/2122279"},{"id":"grant-p51rr000163","eid":"nih:P51RR000163","cat":"grants","name":"FUNCTIONAL CONSEQUENCES OF MDMA","institute":"NCRR","activity":"P51","org":"OREGON REGIONAL PRIMATE RESEARCH CENTER","city":"BEAVERTON","region":"Oregon","cc":"US","country":"United States","usd":74210,"fy0":1998,"fy1":1998,"active":0,"drugs":["MDMA"],"pis":["CYNTHIA Louise BETHEA"],"src":"https://reporter.nih.gov/project-details/6277386"},{"id":"grant-r43da009202","eid":"nih:R43DA009202","cat":"grants","name":"QUANTITATIVE GC/MS METHOD FOR IBOGAINE AND PRIMARY METAB","institute":"NIDA","activity":"R43","org":"TOXICOLOGY TESTING SERVICE, INC.","city":"MIAMI","region":"Florida","cc":"US","country":"United States","usd":66375,"fy0":1994,"fy1":1994,"active":0,"drugs":["ibogaine"],"pis":["TERRY D HALL"],"src":"https://reporter.nih.gov/project-details/2122276"},{"id":"grant-f31mh110096","eid":"nih:F31MH110096","cat":"grants","name":"Effects of NMDA Receptor Antagonists on Hippocampal Circuits","institute":"NIMH","activity":"F31","org":"UNIVERSITY OF ALABAMA AT BIRMINGHAM","city":"BIRMINGHAM","region":"Alabama","cc":"US","country":"United States","lat":33.51139,"lon":-86.81308,"gp":"institution","usd":64400,"fy0":2016,"fy1":2017,"active":0,"drugs":["ketamine"],"pis":["Allie Widman"],"src":"https://reporter.nih.gov/project-details/9377503"},{"id":"grant-f31da020209","eid":"nih:F31DA020209","cat":"grants","name":"Effects of MDMA on Striatal Physiology and Morphology","institute":"NIDA","activity":"F31","org":"TRUSTEES OF INDIANA UNIVERSITY","city":"BLOOMINGTON","region":"Indiana","cc":"US","country":"United States","usd":64306,"fy0":2005,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["KEVIN T BALL"],"src":"https://reporter.nih.gov/project-details/7118685"},{"id":"grant-r03da006491","eid":"nih:R03DA006491","cat":"grants","name":"ROLE OF DOPAMINE IN MDMA-INDUCED SEROTONIN DEPLETION","institute":"NIDA","activity":"R03","org":"CASE WESTERN RESERVE UNIVERSITY","city":"CLEVELAND","region":"Ohio","cc":"US","country":"United States","lat":41.49842,"lon":-81.69979,"gp":"institution","usd":61220,"fy0":1990,"fy1":1991,"active":0,"drugs":["MDMA"],"pis":["J F NASH"],"src":"https://reporter.nih.gov/project-details/3424101"},{"id":"grant-f30da021048","eid":"nih:F30DA021048","cat":"grants","name":"The Role of Glutamate in the Action of LSD","institute":"NIDA","activity":"F30","org":"STATE UNIVERSITY OF NEW YORK AT BUFFALO","city":"AMHERST","region":"New York","cc":"US","country":"United States","usd":59808,"fy0":2007,"fy1":2008,"active":0,"drugs":["MDMA","LSD","ketamine"],"pis":["DAVID J LEE"],"src":"https://reporter.nih.gov/project-details/7386661"},{"id":"grant-f31mh123066","eid":"nih:F31MH123066","cat":"grants","name":"Synaptic mechanisms underlying the rapid antidepressant properties of the (2R,6R)-hydroxynorketamine metabolite","institute":"NIMH","activity":"F31","org":"UNIVERSITY OF MARYLAND BALTIMORE","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.27838,"lon":-76.61478,"gp":"institution","usd":55446,"fy0":2020,"fy1":2021,"active":0,"drugs":["ketamine"],"pis":["Lace Riggs"],"src":"https://reporter.nih.gov/project-details/10227667"},{"id":"grant-f31da018469","eid":"nih:F31DA018469","cat":"grants","name":"MDMA Modulation of Sensory Information Processing","institute":"NIDA","activity":"F31","org":"DREXEL UNIVERSITY","city":"PHILADELPHIA","region":"Pennsylvania","cc":"US","country":"United States","lat":39.94386,"lon":-75.17402,"gp":"institution","usd":55324,"fy0":2005,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["MELANIE L ALEXANDER"],"src":"https://reporter.nih.gov/project-details/7228393"},{"id":"grant-f32da055459","eid":"nih:F32DA055459","cat":"grants","name":"Examining Neural Modulatory Effects of Serotonergic Psychedelic Compounds in Relation to Neuroticism","institute":"NIDA","activity":"F32","org":"IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE","city":"LONDON","cc":"GB","country":"United Kingdom","lat":51.5162,"lon":-0.1288,"gp":"institution","usd":52744,"fy0":2022,"fy1":2022,"active":0,"pis":["Brandon Weiss"],"src":"https://reporter.nih.gov/project-details/10535571"},{"id":"grant-f31da005923","eid":"nih:F31DA005923","cat":"grants","name":"INTRAVENOUS SELF ADMINISTRATION OF MDMA","institute":"NIDA","activity":"F31","org":"UNIVERSITY OF MICHIGAN AT ANN ARBOR","city":"ANN ARBOR","region":"Michigan","cc":"US","country":"United States","usd":52497,"fy0":1999,"fy1":2001,"active":0,"drugs":["MDMA","LSD"],"pis":["William E Fantegrossi"],"src":"https://reporter.nih.gov/project-details/6378437"},{"id":"grant-m01rr000079","eid":"nih:M01RR000079","cat":"grants","name":"PSYCHOPHARMACOLOGY OF TWO ORAL DOSES OF 3,4 METHYLENE DIOXYMETHAMPHETAMINE","institute":"NCRR","activity":"M01","org":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","lat":37.78458,"lon":-122.4077,"gp":"institution","usd":51559,"fy0":1999,"fy1":1999,"active":0,"drugs":["MDMA"],"pis":["JOHN E. MENDELSON"],"src":"https://reporter.nih.gov/project-details/6264395"},{"id":"grant-f32hl154559","eid":"nih:F32HL154559","cat":"grants","name":"Ketamine-induced Hypertensive Episodes: Adverse Central and Peripheral Neurovascular Actions","institute":"NHLBI","activity":"F32","org":"UT SOUTHWESTERN MEDICAL CENTER","city":"DALLAS","region":"Texas","cc":"US","country":"United States","usd":50398,"fy0":2021,"fy1":2021,"active":0,"drugs":["ketamine"],"pis":["Joseph Watso"],"src":"https://reporter.nih.gov/project-details/10232905"},{"id":"grant-f31da006071","eid":"nih:F31DA006071","cat":"grants","name":"THREE LEVER DISCRIMINATION OF MDMA AND LSD IN RATS","institute":"NIDA","activity":"F31","org":"WESTERN MICHIGAN UNIVERSITY","city":"KALAMAZOO","region":"Michigan","cc":"US","country":"United States","lat":42.28517,"lon":-85.58502,"gp":"institution","usd":45592,"fy0":2000,"fy1":2001,"active":0,"drugs":["MDMA","LSD"],"pis":["AMY K GOODWIN"],"src":"https://reporter.nih.gov/project-details/6464039"},{"id":"grant-f31mh122187","eid":"nih:F31MH122187","cat":"grants","name":"Elucidating the mechanisms underlying ketamine-induced protection against fear overgeneralization","institute":"NIMH","activity":"F31","org":"COLUMBIA UNIVERSITY HEALTH SCIENCES","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":45520,"fy0":2020,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["Josephine McGowan"],"src":"https://reporter.nih.gov/project-details/9911605"},{"id":"grant-f31da060559","eid":"nih:F31DA060559","cat":"grants","name":"Mass Spectrometry Techniques to Identify and Characterize New Indole/Tryptamine Chemical Probes for Understanding Psychedelics' Therapeutic Mechanism in Substance Use Disorders","institute":"NIDA","activity":"F31","org":"UNIVERSITY OF FLORIDA","city":"GAINESVILLE","region":"Florida","cc":"US","country":"United States","lat":29.66278,"lon":-82.31867,"gp":"institution","usd":44466,"fy0":2025,"fy1":2025,"active":0,"drugs":["psilocybin"],"pis":["Michael Christopher"],"src":"https://reporter.nih.gov/project-details/11070559"},{"id":"grant-f31da020281","eid":"nih:F31DA020281","cat":"grants","name":"Role of Thermoregulation in MDMA Abuse","institute":"NIDA","activity":"F31","org":"WAKE FOREST UNIVERSITY HEALTH SCIENCES","city":"WINSTON-SALEM","region":"North Carolina","cc":"US","country":"United States","lat":36.1016,"lon":-80.23269,"gp":"institution","usd":43582,"fy0":2005,"fy1":2006,"active":0,"drugs":["MDMA"],"pis":["Matthew L Banks"],"src":"https://reporter.nih.gov/project-details/7117263"},{"id":"grant-f99ns124182","eid":"nih:F99NS124182","cat":"grants","name":"Dissecting the Contribution of the Ventral Hippocampus to (R,S)-Ketamine's Fear Buffering Effects","institute":"NINDS","activity":"F99","org":"COLUMBIA UNIVERSITY HEALTH SCIENCES","city":"NEW YORK","region":"New York","cc":"US","country":"United States","usd":42030,"fy0":2021,"fy1":2021,"active":0,"drugs":["ketamine"],"pis":["Josephine McGowan"],"src":"https://reporter.nih.gov/project-details/10319316"},{"id":"grant-m01rr002558","eid":"nih:M01RR002558","cat":"grants","name":"SEROTONIN, DRUG USE, AND MDMA INDUCED DEFICITS","institute":"NCRR","activity":"M01","org":"UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","city":"HOUSTON","region":"Texas","cc":"US","country":"United States","usd":40538,"fy0":2005,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["FREDERICK Gerard MOELLER"],"src":"https://reporter.nih.gov/project-details/7204633"},{"id":"grant-f31da057818","eid":"nih:F31DA057818","cat":"grants","name":"Molecular target and circuitry underlying the preclinical effects of psychedelics in models of opioid use disorder","institute":"NIDA","activity":"F31","org":"VIRGINIA COMMONWEALTH UNIVERSITY","city":"RICHMOND","region":"Virginia","cc":"US","country":"United States","lat":37.56576,"lon":-77.46642,"gp":"institution","usd":39388,"fy0":2023,"fy1":2023,"active":0,"drugs":["psilocybin"],"pis":["Alaina Jaster"],"src":"https://reporter.nih.gov/project-details/10751173"},{"id":"grant-f31ns143421","eid":"nih:F31NS143421","cat":"grants","name":"Investigating the Cortical Action of Psilocybin in Chronic Pain","institute":"NINDS","activity":"F31","org":"UNIVERSITY OF PENNSYLVANIA","city":"PHILADELPHIA","region":"Pennsylvania","cc":"US","country":"United States","lat":39.95149,"lon":-75.16715,"gp":"institution","usd":39382,"fy0":2025,"fy1":2025,"active":0,"drugs":["psilocybin"],"pis":["Sophie Rogers"],"src":"https://reporter.nih.gov/project-details/11165327"},{"id":"grant-f32da005740","eid":"nih:F32DA005740","cat":"grants","name":"METHYLENEDIOXYMETHAMPHETAMINE DEVELOPMENTAL NEUROTOXICIT","institute":"NIDA","activity":"F32","org":"CINCINNATI CHILDRENS HOSP MED CTR","city":"CINCINNATI","region":"Ohio","cc":"US","country":"United States","lat":39.13873,"lon":-84.52074,"gp":"institution","usd":38132,"fy0":1996,"fy1":1997,"active":0,"drugs":["MDMA"],"pis":["HARRY W BROENING"],"src":"https://reporter.nih.gov/project-details/2545588"},{"id":"grant-f31mh010638","eid":"nih:F31MH010638","cat":"grants","name":"SEROTONIN RECEPTOR INVOLVEMENT IN HALLUCINOGEN EFFECTS","institute":"NIMH","activity":"F31","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.72715,"lon":-117.16703,"gp":"institution","usd":37816,"fy0":1993,"fy1":1995,"active":0,"pis":["KIRSTEN K THOMSON"],"src":"https://reporter.nih.gov/project-details/2241913"},{"id":"grant-r03mh044454","eid":"nih:R03MH044454","cat":"grants","name":"ROLE OF CORTICOSTERONE IN A MODEL OF PSYCHOSIS","institute":"NIMH","activity":"R03","org":"UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH","city":"SALT LAKE CITY","region":"Utah","cc":"US","country":"United States","usd":36750,"fy0":1988,"fy1":1988,"active":0,"drugs":["MDMA"],"pis":["MICHEL JOHNSON"],"src":"https://reporter.nih.gov/project-details/3428924"},{"id":"grant-z01da000529","eid":"nih:Z01DA000529","cat":"grants","name":"Medicinal Chemistry of Hallucinogenic Drugs","institute":"NIDA","activity":"Z01","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.97639,"lon":-77.11207,"gp":"institution","usd":36235,"fy0":2008,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["Kenner Rice"],"src":"https://reporter.nih.gov/project-details/7733858"},{"id":"grant-f32da005260","eid":"nih:F32DA005260","cat":"grants","name":"5-HYDROXTRYTAMINE SITES OF HALLUCINOGEN DRUG ACTION","institute":"NIDA","activity":"F32","org":"VIRGINIA COMMONWEALTH UNIVERSITY","city":"RICHMOND","region":"Virginia","cc":"US","country":"United States","lat":37.55014,"lon":-77.45965,"gp":"institution","usd":32502,"fy0":1985,"fy1":1986,"active":0,"pis":["DAVID James MOKLER"],"src":"https://reporter.nih.gov/project-details/3035089"},{"id":"grant-f31da005640","eid":"nih:F31DA005640","cat":"grants","name":"INTERACTIONS BETWEEN MORPHINE AND IBOGAINE","institute":"NIDA","activity":"F31","org":"ALBANY MEDICAL COLLEGE","city":"ALBANY","region":"New York","cc":"US","country":"United States","lat":42.66232,"lon":-73.76663,"gp":"institution","usd":17344,"fy0":1994,"fy1":1996,"active":0,"drugs":["ibogaine"],"pis":["SANDRA M PEARL"],"src":"https://reporter.nih.gov/project-details/2118044"},{"id":"grant-f31da005735","eid":"nih:F31DA005735","cat":"grants","name":"BEHAVIORAL AND PHARMACOLOGICAL ASSESSMENT OF IBOGAINE","institute":"NIDA","activity":"F31","org":"STATE UNIVERSITY OF NEW YORK AT BUFFALO","city":"BUFFALO","region":"New York","cc":"US","country":"United States","usd":17228,"fy0":1996,"fy1":1996,"active":0,"drugs":["ibogaine"],"pis":["SCOTT E HELSLEY"],"src":"https://reporter.nih.gov/project-details/2118207"},{"id":"grant-m01rr000095","eid":"nih:M01RR000095","cat":"grants","name":"MR ANALYSIS OF PERSISTENT CNS DAMAGE IN HUMAN MDMA","institute":"NCRR","activity":"M01","org":"VANDERBILT UNIVERSITY","city":"Nashville","region":"Tennessee","cc":"US","country":"United States","lat":36.17544,"lon":-86.78948,"gp":"institution","usd":11888,"fy0":2005,"fy1":2008,"active":0,"drugs":["MDMA"],"pis":["RONALD L COWAN"],"src":"https://reporter.nih.gov/project-details/7731389"},{"id":"grant-f31da005438","eid":"nih:F31DA005438","cat":"grants","name":"NEURONAL MECHANISMS OF MDMA EFFECTS ON BEHAVIOR","institute":"NIDA","activity":"F31","org":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","city":"LA JOLLA","region":"California","cc":"US","country":"United States","lat":32.70823,"lon":-117.17051,"gp":"institution","usd":11800,"fy0":1991,"fy1":1991,"active":0,"drugs":["MDMA"],"pis":["Clifton W. Callaway"],"src":"https://reporter.nih.gov/project-details/3024401"},{"id":"grant-f31da020300","eid":"nih:F31DA020300","cat":"grants","name":"Mitochondria and Proteosome Dysfunction with MDMA","institute":"NIDA","activity":"F31","org":"BOSTON UNIVERSITY MEDICAL CAMPUS","city":"BOSTON","region":"Massachusetts","cc":"US","country":"United States","usd":7301,"fy0":2005,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["Nicole E Sparling"],"src":"https://reporter.nih.gov/project-details/7000057"},{"id":"grant-m01rr000036","eid":"nih:M01RR000036","cat":"grants","name":"KIDS KETAMINE","institute":"NCRR","activity":"M01","org":"WASHINGTON UNIVERSITY","city":"SAINT LOUIS","region":"Missouri","cc":"US","country":"United States","lat":38.63447,"lon":-90.20067,"gp":"institution","usd":5956,"fy0":2006,"fy1":2007,"active":0,"drugs":["ketamine"],"pis":["JOHN W. NEWCOMER"],"src":"https://reporter.nih.gov/project-details/7603389"},{"id":"grant-ziamh002940","eid":"nih:ZIAMH002940","cat":"grants","name":"Pathophysiological Mechanisms  in Major Depression and Bipolar Disorder","institute":"NIMH","activity":"ZIA","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":3590,"fy0":2014,"fy1":2014,"active":0,"drugs":["ketamine"],"pis":["PHILIP W GOLD"],"src":"https://reporter.nih.gov/project-details/8940016"},{"id":"grant-m01rr000865","eid":"nih:M01RR000865","cat":"grants","name":"NEUROPSYCHOLOGICAL AND AFFECTIVE SEQUELAE OF 5-HT DEPLETION IN MDMA USERS","institute":"NCRR","activity":"M01","org":"UNIVERSITY OF CALIFORNIA LOS ANGELES","city":"LOS ANGELES","region":"California","cc":"US","country":"United States","lat":34.0439,"lon":-118.23686,"gp":"institution","usd":2364,"fy0":2005,"fy1":2007,"active":0,"drugs":["MDMA"],"pis":["Thomas Frederick Newton"],"src":"https://reporter.nih.gov/project-details/7606743"},{"id":"grant-p41rr006009","eid":"nih:P41RR006009","cat":"grants","name":"Distinctive Receptor Actions in Hallucinogen Mechanisms and the Molecular basis","institute":"NCRR","activity":"P41","org":"MELLON PITTS CORPORATION (MPC CORP)","city":"PITTSBURGH","region":"Pennsylvania","cc":"US","country":"United States","usd":1063,"fy0":2004,"fy1":2004,"active":0,"pis":["HAREL WEINSTEIN"],"src":"https://reporter.nih.gov/project-details/6980104"},{"id":"grant-z01da000338","eid":"nih:Z01DA000338","cat":"grants","name":"AGE SPECIFIC TRENDS IN THE PREVALENCE OF HALLUCINOGEN USE FROM 1988-1992","institute":"NIDA","activity":"Z01","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.98778,"lon":-77.09974,"gp":"institution","usd":0,"fy0":1994,"fy1":1994,"active":0,"pis":["H CHILCOAT"],"src":"https://reporter.nih.gov/project-details/3752904"},{"id":"grant-z01mh002701","eid":"nih:Z01MH002701","cat":"grants","name":"AMPHETAMINE-INDUCED SEROTONIN NEUROTOXICITY--ROLE OF SEROTONIN IN ANXIETY","institute":"NIMH","activity":"Z01","org":"NATIONAL INSTITUTE OF MENTAL HEALTH","cc":"US","country":"United States","usd":0,"fy0":1995,"fy1":1996,"active":0,"drugs":["MDMA"],"pis":["U MC CANN"],"src":"https://reporter.nih.gov/project-details/2578831"},{"id":"grant-z01da000073","eid":"nih:Z01DA000073","cat":"grants","name":"ANORECTIC EFFECTS OF METABOLITES OF MDA AND MDMA","institute":"NIDA","activity":"Z01","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.97742,"lon":-77.09278,"gp":"institution","usd":0,"fy0":1992,"fy1":1993,"active":0,"drugs":["MDMA"],"pis":["S Y YEH"],"src":"https://reporter.nih.gov/project-details/3775001"},{"id":"grant-z01da000153","eid":"nih:Z01DA000153","cat":"grants","name":"Analysis of ecstasy (MDMA)-induced transcription","institute":"NIDA","activity":"Z01","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.98147,"lon":-77.11226,"gp":"institution","usd":0,"fy0":1996,"fy1":2005,"active":0,"drugs":["MDMA"],"pis":["Jean Lud Cadet"],"src":"https://reporter.nih.gov/project-details/7149273"},{"id":"grant-i01cx001142","eid":"nih:I01CX001142","cat":"grants","name":"CAP-Ketamine for antidepressant resistant PTSD","institute":"VA","activity":"I01","org":"VA CONNECTICUT HEALTHCARE SYSTEM","city":"WEST HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.26373,"lon":-72.93524,"gp":"institution","usd":0,"fy0":2016,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["John H. Krystal","JOHN D ROACHE"],"src":"https://reporter.nih.gov/project-details/9856940"},{"id":"grant-i01cx001611","eid":"nih:I01CX001611","cat":"grants","name":"Clinical and Imaging Biomarker Trial of Uridine for Veterans with Suicidal Ideation","institute":"VA","activity":"I01","org":"VA SALT LAKE CITY HEALTHCARE SYSTEM","city":"SALT LAKE CITY","region":"Utah","cc":"US","country":"United States","lat":40.76629,"lon":-111.88714,"gp":"institution","usd":0,"fy0":2018,"fy1":2024,"active":0,"drugs":["ketamine"],"pis":["Douglas Gavin Kondo"],"src":"https://reporter.nih.gov/project-details/10948887"},{"id":"grant-z01dk059802","eid":"nih:Z01DK059802","cat":"grants","name":"ELUCIDATION OF THE STRUCTURE AND FUNCTION OF SIGMA RECEPTORS","institute":"NIDDK","activity":"Z01","org":"NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES","cc":"US","country":"United States","lat":38.98636,"lon":-77.0989,"gp":"institution","usd":0,"fy0":1995,"fy1":1995,"active":0,"drugs":["ibogaine"],"pis":["W D BOWEN"],"src":"https://reporter.nih.gov/project-details/5202060"},{"id":"grant-ik2cx002606","eid":"nih:IK2CX002606","cat":"grants","name":"Examining ketamine effects on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease","institute":"VA","activity":"IK2","org":"VETERANS AFFAIRS MED CTR SAN FRANCISCO","city":"SAN FRANCISCO","region":"California","cc":"US","country":"United States","usd":0,"fy0":2025,"fy1":2026,"active":0,"drugs":["ketamine"],"pis":["Ellen R Bradley"],"src":"https://reporter.nih.gov/project-details/11206874"},{"id":"grant-i01bx004062","eid":"nih:I01BX004062","cat":"grants","name":"Hydroxynorketamine for the Treatment of PTSD and Anhedonia","institute":"VA","activity":"I01","org":"BALTIMORE VA MEDICAL CENTER","city":"BALTIMORE","region":"Maryland","cc":"US","country":"United States","lat":39.29024,"lon":-76.62306,"gp":"institution","usd":0,"fy0":2019,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["Todd D Gould"],"src":"https://reporter.nih.gov/project-details/10626710"},{"id":"grant-z01aa000077","eid":"nih:Z01AA000077","cat":"grants","name":"Impaired CNS Serotonin Activity: Tolerance, Neuroimaging","institute":"NIAAA","activity":"Z01","org":"NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM","cc":"US","country":"United States","lat":38.98542,"lon":-77.09673,"gp":"institution","usd":0,"fy0":2001,"fy1":2001,"active":0,"drugs":["ketamine"],"pis":["James Dee Higley"],"src":"https://reporter.nih.gov/project-details/6535854"},{"id":"grant-i01cx001191","eid":"nih:I01CX001191","cat":"grants","name":"Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant Depression","institute":"VA","activity":"I01","org":"MINNEAPOLIS VA  MEDICAL CENTER","city":"MINNEAPOLIS","region":"Minnesota","cc":"US","country":"United States","lat":44.99188,"lon":-93.26483,"gp":"institution","usd":0,"fy0":2015,"fy1":2018,"active":0,"drugs":["ketamine"],"pis":["Paulo R. Shiroma"],"src":"https://reporter.nih.gov/project-details/9465413"},{"id":"grant-i01cx001379","eid":"nih:I01CX001379","cat":"grants","name":"Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder","institute":"VA","activity":"I01","org":"VA CONNECTICUT HEALTHCARE SYSTEM","city":"WEST HAVEN","region":"Connecticut","cc":"US","country":"United States","lat":41.27107,"lon":-72.93684,"gp":"institution","usd":0,"fy0":2017,"fy1":2023,"active":0,"drugs":["ketamine"],"pis":["Gihyun Yoon"],"src":"https://reporter.nih.gov/project-details/10709651"},{"id":"grant-i01cx001205","eid":"nih:I01CX001205","cat":"grants","name":"Ketamine for Treatment Resistant Late-Life Depression","institute":"VA","activity":"I01","org":"MICHAEL E DEBAKEY VA MEDICAL CENTER","city":"HOUSTON","region":"Texas","cc":"US","country":"United States","lat":29.75664,"lon":-95.36351,"gp":"institution","usd":0,"fy0":2016,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["SANJAY J MATHEW"],"src":"https://reporter.nih.gov/project-details/9812843"},{"id":"grant-ik2cx002646","eid":"nih:IK2CX002646","cat":"grants","name":"Ketamine-assisted integrative treatment for Veterans with chronic low back pain and comorbid depression","institute":"VA","activity":"IK2","org":"VETERANS HEALTH ADMINISTRATION","city":"ANN ARBOR","region":"Michigan","cc":"US","country":"United States","lat":38.90203,"lon":-77.04517,"gp":"institution","usd":0,"fy0":2024,"fy1":2026,"active":0,"drugs":["ketamine"],"pis":["Victoria Diane Powell"],"src":"https://reporter.nih.gov/project-details/11172251"},{"id":"grant-z01da000302","eid":"nih:Z01DA000302","cat":"grants","name":"NEUROTOXIC EFFECTS OF MDA AND MDMA","institute":"NIDA","activity":"Z01","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.99079,"lon":-77.09052,"gp":"institution","usd":0,"fy0":1991,"fy1":1991,"active":0,"drugs":["MDMA"],"pis":["E B DE SOUZA"],"src":"https://reporter.nih.gov/project-details/3853741"},{"id":"grant-m01rr005280","eid":"nih:M01RR005280","cat":"grants","name":"PHASE I CLINICAL TRIAL OF IBOGAINE HYDROCHLORIDE","institute":"NCRR","activity":"M01","usd":0,"fy0":1996,"fy1":1996,"active":0,"drugs":["ibogaine"],"pis":["JUAN SANCHEZ-RAMOS"],"src":"https://reporter.nih.gov/project-details/5225006"},{"id":"grant-z01hl001993","eid":"nih:Z01HL001993","cat":"grants","name":"RECEPTOR ALTERATIONS INDUCED BY ACUTE METHYLENE DIOXYMETHAMPHLETAMINE","institute":"NHLBI","activity":"Z01","org":"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE","cc":"US","country":"United States","lat":38.99163,"lon":-77.09014,"gp":"institution","usd":0,"fy0":1986,"fy1":1986,"active":0,"drugs":["MDMA"],"pis":["D R GEHLERT"],"src":"https://reporter.nih.gov/project-details/3966598"},{"id":"grant-i01cx001803","eid":"nih:I01CX001803","cat":"grants","name":"Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD","institute":"VA","activity":"I01","org":"MINNEAPOLIS VA  MEDICAL CENTER","city":"MINNEAPOLIS","region":"Minnesota","cc":"US","country":"United States","lat":44.98971,"lon":-93.27349,"gp":"institution","usd":0,"fy0":2021,"fy1":2025,"active":0,"drugs":["ketamine"],"pis":["Paulo R. Shiroma"],"src":"https://reporter.nih.gov/project-details/11044043"},{"id":"grant-i01bx000559","eid":"nih:I01BX000559","cat":"grants","name":"Selective negative allosteric modulators of alpha 5-GABAA receptors: novel psychotherapeutic drugs","institute":"VA","activity":"I01","org":"SOUTH TEXAS VETERANS HEALTH CARE SYSTEM","city":"SAN ANTONIO","region":"Texas","cc":"US","country":"United States","lat":29.41908,"lon":-98.4981,"gp":"institution","usd":0,"fy0":2019,"fy1":2022,"active":0,"drugs":["ketamine"],"pis":["David A Morilak"],"src":"https://reporter.nih.gov/project-details/10374014"},{"id":"grant-z01da000154","eid":"nih:Z01DA000154","cat":"grants","name":"TOXICITY OF AMPHETAMINE ANALOGS","institute":"NIDA","activity":"Z01","org":"NATIONAL INSTITUTE ON DRUG ABUSE","cc":"US","country":"United States","lat":38.97272,"lon":-77.10322,"gp":"institution","usd":0,"fy0":1995,"fy1":1995,"active":0,"drugs":["MDMA"],"pis":["J CADET"],"src":"https://reporter.nih.gov/project-details/5201662"},{"id":"grant-i01bx003512","eid":"nih:I01BX003512","cat":"grants","name":"Treating PTSD and depression: Mechanisms of pharmacotherapy and psychotherapy in rats","institute":"VA","activity":"I01","org":"SOUTH TEXAS VETERANS HEALTH CARE SYSTEM","city":"SAN ANTONIO","region":"Texas","cc":"US","country":"United States","lat":29.41767,"lon":-98.49688,"gp":"institution","usd":0,"fy0":2017,"fy1":2020,"active":0,"drugs":["ketamine"],"pis":["ALAN FRAZER","David A Morilak"],"src":"https://reporter.nih.gov/project-details/9859330"}]}